id	sid	tid	token	lemma	pos
ajird-1099	1	1	american	american	PROPN
ajird-1099	1	2	journal	journal	PROPN
ajird-1099	1	3	of	of	ADP
ajird-1099	1	4	interdisciplinary	interdisciplinary	ADJ
ajird-1099	1	5	research	research	NOUN
ajird-1099	1	6	and	and	CCONJ
ajird-1099	1	7	development	development	NOUN
ajird-1099	1	8	issn	issn	PROPN
ajird-1099	1	9	online	online	NOUN
ajird-1099	1	10	:	:	PUNCT
ajird-1099	1	11	2771	2771	NUM
ajird-1099	1	12	-	-	SYM
ajird-1099	1	13	8948	8948	NUM
ajird-1099	1	14	website	website	NOUN
ajird-1099	1	15	:	:	PUNCT
ajird-1099	1	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1099	1	17	volume	volume	NOUN
ajird-1099	1	18	28	28	NUM
ajird-1099	1	19	,	,	PUNCT
ajird-1099	1	20	may	may	AUX
ajird-1099	1	21	2024	2024	NUM
ajird-1099	1	22	27	27	NUM
ajird-1099	1	23	|	|	ADV
ajird-1099	1	24	p	p	NOUN
ajird-1099	1	25	a	a	DET
ajird-1099	1	26	g	g	NOUN
ajird-1099	1	27	e	e	NOUN
ajird-1099	1	28	“	"	PUNCT
ajird-1099	1	29	frequency	frequency	NOUN
ajird-1099	1	30	of	of	ADP
ajird-1099	1	31	endogenous	endogenous	ADJ
ajird-1099	1	32	hypercortisolism	hypercortisolism	NOUN
ajird-1099	1	33	in	in	ADP
ajird-1099	1	34	women	woman	NOUN
ajird-1099	1	35	with	with	ADP
ajird-1099	1	36	polycystic	polycystic	ADJ
ajird-1099	1	37	ovary	ovary	ADJ
ajird-1099	1	38	syndrome	syndrome	NOUN
ajird-1099	1	39	according	accord	VERB
ajird-1099	1	40	to	to	ADP
ajird-1099	1	41	referral	referral	ADJ
ajird-1099	1	42	data	datum	NOUN
ajird-1099	1	43	urmanova	urmanova	PROPN
ajird-1099	1	44	yu	yu	PROPN
ajird-1099	1	45	.	.	PROPN
ajird-1099	1	46	m.	m.	PROPN
ajird-1099	1	47	abulaiuly	abulaiuly	PROPN
ajird-1099	1	48	zhangentkhan	zhangentkhan	PROPN
ajird-1099	1	49	,	,	PUNCT
ajird-1099	1	50	bolshakova	bolshakova	PROPN
ajird-1099	1	51	s.	s.	PROPN
ajird-1099	1	52	v.	v.	ADP
ajird-1099	1	53	nasyrova	nasyrova	PROPN
ajird-1099	2	1	kh	kh	PROPN
ajird-1099	2	2	.	.	PUNCT
ajird-1099	3	1	k.	k.	PROPN
ajird-1099	4	1	kazakh	kazakh	PROPN
ajird-1099	4	2	national	national	PROPN
ajird-1099	4	3	medical	medical	PROPN
ajird-1099	4	4	university	university	PROPN
ajird-1099	4	5	named	name	VERB
ajird-1099	4	6	after	after	ADP
ajird-1099	4	7	s.	s.	PROPN
ajird-1099	4	8	d.	d.	PROPN
ajird-1099	4	9	asfandiyarova	asfandiyarova	PROPN
ajird-1099	4	10	,	,	PUNCT
ajird-1099	4	11	department	department	NOUN
ajird-1099	4	12	of	of	ADP
ajird-1099	4	13	endocrinology	endocrinology	NOUN
ajird-1099	4	14	,	,	PUNCT
ajird-1099	4	15	the	the	DET
ajird-1099	4	16	republic	republic	NOUN
ajird-1099	4	17	of	of	ADP
ajird-1099	4	18	kazakhstan	kazakhstan	PROPN
ajird-1099	4	19	,	,	PUNCT
ajird-1099	4	20	almaty	almaty	PROPN
ajird-1099	4	21	st	st	PROPN
ajird-1099	4	22	.	.	PROPN
ajird-1099	4	23	tolebi	tolebi	PROPN
ajird-1099	4	24	,	,	PUNCT
ajird-1099	4	25	no	no	INTJ
ajird-1099	4	26	.	.	NOUN
ajird-1099	4	27	94	94	NUM
ajird-1099	4	28	tashkent	tashkent	PROPN
ajird-1099	4	29	pediatric	pediatric	PROPN
ajird-1099	4	30	medical	medical	PROPN
ajird-1099	4	31	institute	institute	PROPN
ajird-1099	4	32	,	,	PUNCT
ajird-1099	4	33	department	department	NOUN
ajird-1099	4	34	of	of	ADP
ajird-1099	4	35	endocrinology	endocrinology	NOUN
ajird-1099	4	36	with	with	ADP
ajird-1099	4	37	pediatric	pediatric	ADJ
ajird-1099	4	38	endocrinology	endocrinology	NOUN
ajird-1099	4	39	,	,	PUNCT
ajird-1099	4	40	the	the	DET
ajird-1099	4	41	republic	republic	NOUN
ajird-1099	4	42	of	of	ADP
ajird-1099	4	43	uzbekistan	uzbekistan	PROPN
ajird-1099	4	44	,	,	PUNCT
ajird-1099	4	45	100125	100125	NUM
ajird-1099	4	46	,	,	PUNCT
ajird-1099	4	47	g.	g.	PROPN
ajird-1099	4	48	tashkent	tashkent	PROPN
ajird-1099	4	49	,	,	PUNCT
ajird-1099	4	50	st	st	PROPN
ajird-1099	4	51	.	.	PROPN
ajird-1099	4	52	bogishamol	bogishamol	PROPN
ajird-1099	4	53	223	223	NUM
ajird-1099	4	54	abstract	abstract	ADJ
ajird-1099	4	55	the	the	DET
ajird-1099	4	56	main	main	ADJ
ajird-1099	4	57	investigation	investigation	NOUN
ajird-1099	4	58	-	-	PUNCT
ajird-1099	4	59	to	to	PART
ajird-1099	4	60	study	study	VERB
ajird-1099	4	61	the	the	DET
ajird-1099	4	62	frequency	frequency	NOUN
ajird-1099	4	63	of	of	ADP
ajird-1099	4	64	subclinic	subclinic	ADJ
ajird-1099	4	65	cushingoid	cushingoid	NOUN
ajird-1099	4	66	at	at	ADP
ajird-1099	4	67	women	woman	NOUN
ajird-1099	4	68	with	with	ADP
ajird-1099	4	69	polycystic	polycystic	ADJ
ajird-1099	4	70	ovaries	ovary	NOUN
ajird-1099	4	71	syndrome	syndrome	NOUN
ajird-1099	4	72	(	(	PUNCT
ajird-1099	4	73	pcos	pcos	PROPN
ajird-1099	4	74	)	)	PUNCT
ajird-1099	4	75	material	material	NOUN
ajird-1099	4	76	and	and	CCONJ
ajird-1099	4	77	methods	method	NOUN
ajird-1099	4	78	of	of	ADP
ajird-1099	4	79	investigation.120	investigation.120	ADJ
ajird-1099	4	80	patients	patient	NOUN
ajird-1099	4	81	of	of	ADP
ajird-1099	4	82	fertile	fertile	ADJ
ajird-1099	4	83	age	age	NOUN
ajird-1099	4	84	were	be	AUX
ajird-1099	4	85	examined	examine	VERB
ajird-1099	4	86	with	with	ADP
ajird-1099	4	87	polycystic	polycystic	ADJ
ajird-1099	4	88	ovary	ovary	ADJ
ajird-1099	4	89	syndrome	syndrome	NOUN
ajird-1099	4	90	(	(	PUNCT
ajird-1099	4	91	pcos	pcos	PROPN
ajird-1099	4	92	)	)	PUNCT
ajird-1099	4	93	..	..	PUNCT
ajird-1099	5	1	middle	middle	ADJ
ajird-1099	5	2	age	age	NOUN
ajird-1099	5	3	of	of	ADP
ajird-1099	5	4	patients	patient	NOUN
ajird-1099	5	5	25.5	25.5	NUM
ajird-1099	5	6	±	±	NUM
ajird-1099	5	7	4	4	NUM
ajird-1099	5	8	.	.	NOUN
ajird-1099	5	9	3	3	NUM
ajird-1099	5	10	years	year	NOUN
ajird-1099	5	11	.	.	PUNCT
ajird-1099	5	12	.	.	PUNCT
ajird-1099	6	1	the	the	DET
ajird-1099	6	2	remoteness	remoteness	NOUN
ajird-1099	6	3	of	of	ADP
ajird-1099	6	4	disease	disease	NOUN
ajird-1099	6	5	doubted	doubt	VERB
ajird-1099	6	6	within	within	ADP
ajird-1099	6	7	limits	limit	NOUN
ajird-1099	6	8	from	from	ADP
ajird-1099	6	9	7	7	NUM
ajird-1099	6	10	months	month	NOUN
ajird-1099	6	11	to	to	ADP
ajird-1099	6	12	9	9	NUM
ajird-1099	6	13	years	year	NOUN
ajird-1099	6	14	.	.	PUNCT
ajird-1099	7	1	20	20	NUM
ajird-1099	7	2	healthy	healthy	ADJ
ajird-1099	7	3	women	woman	NOUN
ajird-1099	7	4	of	of	ADP
ajird-1099	7	5	corresponding	correspond	VERB
ajird-1099	7	6	age	age	NOUN
ajird-1099	7	7	made	make	VERB
ajird-1099	7	8	a	a	DET
ajird-1099	7	9	control	control	NOUN
ajird-1099	7	10	group	group	NOUN
ajird-1099	7	11	.	.	PUNCT
ajird-1099	8	1	the	the	DET
ajird-1099	8	2	complex	complex	NOUN
ajird-1099	8	3	of	of	ADP
ajird-1099	8	4	researches	research	NOUN
ajird-1099	8	5	,	,	PUNCT
ajird-1099	8	6	including	include	VERB
ajird-1099	8	7	clinical	clinical	ADJ
ajird-1099	8	8	(	(	PUNCT
ajird-1099	8	9	global	global	ADJ
ajird-1099	8	10	analysis	analysis	NOUN
ajird-1099	8	11	of	of	ADP
ajird-1099	8	12	blood	blood	NOUN
ajird-1099	8	13	and	and	CCONJ
ajird-1099	8	14	urine	urine	NOUN
ajird-1099	8	15	)	)	PUNCT
ajird-1099	8	16	,	,	PUNCT
ajird-1099	8	17	biochemical	biochemical	NOUN
ajird-1099	8	18	(	(	PUNCT
ajird-1099	8	19	glucose	glucose	NOUN
ajird-1099	8	20	of	of	ADP
ajird-1099	8	21	blood	blood	NOUN
ajird-1099	8	22	,	,	PUNCT
ajird-1099	8	23	test	test	NOUN
ajird-1099	8	24	of	of	ADP
ajird-1099	8	25	tolerance	tolerance	NOUN
ajird-1099	8	26	to	to	PART
ajird-1099	8	27	glucose	glucose	VERB
ajird-1099	8	28	)	)	PUNCT
ajird-1099	8	29	hormonal	hormonal	NOUN
ajird-1099	8	30	(	(	PUNCT
ajird-1099	8	31	lh	lh	PROPN
ajird-1099	8	32	,	,	PUNCT
ajird-1099	8	33	fsh	fsh	ADJ
ajird-1099	8	34	,	,	PUNCT
ajird-1099	8	35	prolactin	prolactin	NOUN
ajird-1099	8	36	,	,	PUNCT
ajird-1099	8	37	estradiol	estradiol	PROPN
ajird-1099	8	38	,	,	PUNCT
ajird-1099	8	39	progesteron	progesteron	NOUN
ajird-1099	8	40	,	,	PUNCT
ajird-1099	8	41	free	free	ADJ
ajird-1099	8	42	orchidic	orchidic	ADJ
ajird-1099	8	43	hormone	hormone	NOUN
ajird-1099	8	44	,	,	PUNCT
ajird-1099	8	45	dehydroepiandrostendion	dehydroepiandrostendion	NOUN
ajird-1099	8	46	(	(	PUNCT
ajird-1099	8	47	dhea	dhea	PROPN
ajird-1099	8	48	)	)	PUNCT
ajird-1099	8	49	,	,	PUNCT
ajird-1099	8	50	17	17	NUM
ajird-1099	8	51	–	–	PUNCT
ajird-1099	8	52	oxyprogesterone	oxyprogesterone	NOUN
ajird-1099	8	53	,	,	PUNCT
ajird-1099	8	54	antimuller	antimuller	NOUN
ajird-1099	8	55	hormone	hormone	NOUN
ajird-1099	8	56	(	(	PUNCT
ajird-1099	8	57	amh	amh	PROPN
ajird-1099	8	58	)	)	PUNCT
ajird-1099	8	59	,	,	PUNCT
ajird-1099	8	60	insulin	insulin	NOUN
ajird-1099	8	61	on	on	ADP
ajird-1099	8	62	14	14	NUM
ajird-1099	8	63	day	day	NOUN
ajird-1099	8	64	of	of	ADP
ajird-1099	8	65	cycle	cycle	NOUN
ajird-1099	8	66	)	)	PUNCT
ajird-1099	8	67	,	,	PUNCT
ajird-1099	8	68	was	be	AUX
ajird-1099	8	69	executed	execute	VERB
ajird-1099	8	70	all	all	DET
ajird-1099	8	71	patients	patient	NOUN
ajird-1099	8	72	,	,	PUNCT
ajird-1099	8	73	ultrasonic	ultrasonic	NOUN
ajird-1099	8	74	of	of	ADP
ajird-1099	8	75	uterus	uterus	NOUN
ajird-1099	8	76	and	and	CCONJ
ajird-1099	8	77	ovaries	ovary	NOUN
ajird-1099	8	78	(	(	PUNCT
ajird-1099	8	79	transabdominal	transabdominal	NOUN
ajird-1099	8	80	and	and	CCONJ
ajird-1099	8	81	transvaginal	transvaginal	NOUN
ajird-1099	8	82	)	)	PUNCT
ajird-1099	8	83	on	on	ADP
ajird-1099	8	84	14	14	NUM
ajird-1099	8	85	day	day	NOUN
ajird-1099	8	86	of	of	ADP
ajird-1099	8	87	cycle	cycle	NOUN
ajird-1099	8	88	with	with	ADP
ajird-1099	8	89	follikulometriya	follikulometriya	NOUN
ajird-1099	8	90	in	in	ADP
ajird-1099	8	91	a	a	DET
ajird-1099	8	92	dynamics	dynamic	NOUN
ajird-1099	8	93	,	,	PUNCT
ajird-1099	8	94	and	and	CCONJ
ajird-1099	8	95	also	also	ADV
ajird-1099	8	96	mri	mri	NOUN
ajird-1099	8	97	of	of	ADP
ajird-1099	8	98	pituitary	pituitary	NOUN
ajird-1099	8	99	.	.	PUNCT
ajird-1099	9	1	results.patients	results.patient	NOUN
ajird-1099	9	2	were	be	AUX
ajird-1099	9	3	divided	divide	VERB
ajird-1099	9	4	into	into	ADP
ajird-1099	9	5	three	three	NUM
ajird-1099	9	6	groups	group	NOUN
ajird-1099	9	7	:	:	PUNCT
ajird-1099	9	8	1	1	NUM
ajird-1099	9	9	group	group	NOUN
ajird-1099	9	10	.	.	PUNCT
ajird-1099	10	1	are	be	AUX
ajird-1099	10	2	patients	patient	NOUN
ajird-1099	10	3	with	with	ADP
ajird-1099	10	4	primary	primary	ADJ
ajird-1099	10	5	pcos	pcos	PROPN
ajird-1099	10	6	23	23	NUM
ajird-1099	10	7	cases	case	NOUN
ajird-1099	10	8	(	(	PUNCT
ajird-1099	10	9	19	19	NUM
ajird-1099	10	10	%	%	NOUN
ajird-1099	10	11	)	)	PUNCT
ajird-1099	10	12	,	,	PUNCT
ajird-1099	10	13	2	2	NUM
ajird-1099	10	14	gr	gr	NOUN
ajird-1099	10	15	.	.	PROPN
ajird-1099	11	1	are	be	AUX
ajird-1099	11	2	patients	patient	NOUN
ajird-1099	11	3	with	with	ADP
ajird-1099	11	4	secondary	secondary	ADJ
ajird-1099	11	5	pcos	pcos	NOUN
ajird-1099	11	6	at	at	ADP
ajird-1099	11	7	obesity	obesity	NOUN
ajird-1099	11	8	are	be	AUX
ajird-1099	11	9	89	89	NUM
ajird-1099	11	10	cases	case	NOUN
ajird-1099	11	11	(	(	PUNCT
ajird-1099	11	12	74	74	NUM
ajird-1099	11	13	%	%	NOUN
ajird-1099	11	14	)	)	PUNCT
ajird-1099	11	15	,	,	PUNCT
ajird-1099	11	16	3	3	NUM
ajird-1099	11	17	gr	gr	NOUN
ajird-1099	11	18	.	.	PROPN
ajird-1099	12	1	are	be	AUX
ajird-1099	12	2	patients	patient	NOUN
ajird-1099	12	3	with	with	ADP
ajird-1099	12	4	secondary	secondary	ADJ
ajird-1099	12	5	pcos	pco	NOUN
ajird-1099	12	6	and	and	CCONJ
ajird-1099	12	7	subclinical	subclinical	ADJ
ajird-1099	12	8	cushingoid	cushingoid	NOUN
ajird-1099	12	9	are	be	AUX
ajird-1099	12	10	8	8	NUM
ajird-1099	12	11	cases	case	NOUN
ajird-1099	12	12	(	(	PUNCT
ajird-1099	12	13	7	7	NUM
ajird-1099	12	14	%	%	NOUN
ajird-1099	12	15	)	)	PUNCT
ajird-1099	12	16	.	.	PUNCT
ajird-1099	13	1	a	a	DET
ajird-1099	13	2	control	control	NOUN
ajird-1099	13	3	group	group	NOUN
ajird-1099	13	4	is	be	AUX
ajird-1099	13	5	20	20	NUM
ajird-1099	13	6	women	woman	NOUN
ajird-1099	13	7	of	of	ADP
ajird-1099	13	8	similar	similar	ADJ
ajird-1099	13	9	age	age	NOUN
ajird-1099	13	10	.	.	PUNCT
ajird-1099	14	1	in	in	ADP
ajird-1099	14	2	our	our	PRON
ajird-1099	14	3	research	research	NOUN
ajird-1099	14	4	prevailed	prevail	VERB
ajird-1099	14	5	on	on	ADP
ajird-1099	14	6	the	the	DET
ajird-1099	14	7	whole	whole	ADJ
ajird-1099	14	8	2	2	NUM
ajird-1099	14	9	degree	degree	NOUN
ajird-1099	14	10	of	of	ADP
ajird-1099	14	11	obesity	obesity	NOUN
ajird-1099	14	12	in	in	ADP
ajird-1099	14	13	2	2	NUM
ajird-1099	14	14	and	and	CCONJ
ajird-1099	14	15	3	3	NUM
ajird-1099	14	16	groups	group	NOUN
ajird-1099	14	17	of	of	ADP
ajird-1099	14	18	patients	patient	NOUN
ajird-1099	14	19	53	53	NUM
ajird-1099	14	20	cases	case	NOUN
ajird-1099	14	21	from	from	ADP
ajird-1099	14	22	120	120	NUM
ajird-1099	14	23	(	(	PUNCT
ajird-1099	14	24	44.1	44.1	NUM
ajird-1099	14	25	%	%	NOUN
ajird-1099	14	26	)	)	PUNCT
ajird-1099	14	27	.	.	PUNCT
ajird-1099	15	1	in	in	ADP
ajird-1099	15	2	the	the	DET
ajird-1099	15	3	1	1	NUM
ajird-1099	15	4	group	group	NOUN
ajird-1099	15	5	of	of	ADP
ajird-1099	15	6	patients	patient	NOUN
ajird-1099	15	7	the	the	DET
ajird-1099	15	8	reliable	reliable	ADJ
ajird-1099	15	9	decline	decline	NOUN
ajird-1099	15	10	of	of	ADP
ajird-1099	15	11	both	both	CCONJ
ajird-1099	15	12	pituitary	pituitary	ADJ
ajird-1099	15	13	and	and	CCONJ
ajird-1099	15	14	ovarian	ovarian	ADJ
ajird-1099	15	15	hormones	hormone	NOUN
ajird-1099	15	16	registered	register	VERB
ajird-1099	15	17	on	on	ADP
ajird-1099	15	18	a	a	DET
ajird-1099	15	19	background	background	NOUN
ajird-1099	15	20	of	of	ADP
ajird-1099	15	21	hyperandrogenemia	hyperandrogenemia	PROPN
ajird-1099	15	22	.	.	PUNCT
ajird-1099	16	1	so	so	ADV
ajird-1099	16	2	,	,	PUNCT
ajird-1099	16	3	as	as	SCONJ
ajird-1099	16	4	compared	compare	VERB
ajird-1099	16	5	to	to	ADP
ajird-1099	16	6	the	the	DET
ajird-1099	16	7	group	group	NOUN
ajird-1099	16	8	of	of	ADP
ajird-1099	16	9	control	control	NOUN
ajird-1099	16	10	on	on	ADP
ajird-1099	16	11	the	the	DET
ajird-1099	16	12	14th	14th	ADJ
ajird-1099	16	13	day	day	NOUN
ajird-1099	16	14	of	of	ADP
ajird-1099	16	15	cycle	cycle	NOUN
ajird-1099	16	16	were	be	AUX
ajird-1099	16	17	for	for	ADP
ajird-1099	16	18	lh	lh	PROPN
ajird-1099	16	19	,	,	PUNCT
ajird-1099	16	20	fsh	fsh	NOUN
ajird-1099	16	21	,	,	PUNCT
ajird-1099	16	22	igf-1	igf-1	NOUN
ajird-1099	16	23	and	and	CCONJ
ajird-1099	16	24	also	also	ADV
ajird-1099	16	25	estradiol	estradiol	PROPN
ajird-1099	16	26	,	,	PUNCT
ajird-1099	16	27	progesterone	progesterone	NOUN
ajird-1099	16	28	,	,	PUNCT
ajird-1099	16	29	while	while	SCONJ
ajird-1099	16	30	free	free	ADJ
ajird-1099	16	31	testosterone	testosterone	NOUN
ajird-1099	16	32	,	,	PUNCT
ajird-1099	16	33	dgea	dgea	NOUN
ajird-1099	16	34	were	be	AUX
ajird-1099	16	35	enhanceable	enhanceable	ADJ
ajird-1099	16	36	as	as	SCONJ
ajird-1099	16	37	compared	compare	VERB
ajird-1099	16	38	to	to	ADP
ajird-1099	16	39	control	control	VERB
ajird-1099	16	40	data	datum	NOUN
ajird-1099	16	41	.	.	PUNCT
ajird-1099	17	1	further	far	ADV
ajird-1099	17	2	in	in	ADP
ajird-1099	17	3	the	the	DET
ajird-1099	17	4	second	second	ADJ
ajird-1099	17	5	group	group	NOUN
ajird-1099	17	6	of	of	ADP
ajird-1099	17	7	patients	patient	NOUN
ajird-1099	17	8	the	the	DET
ajird-1099	17	9	reliable	reliable	ADJ
ajird-1099	17	10	decline	decline	NOUN
ajird-1099	17	11	of	of	ADP
ajird-1099	17	12	pituitary	pituitary	ADJ
ajird-1099	17	13	hormones	hormone	NOUN
ajird-1099	17	14	was	be	AUX
ajird-1099	17	15	also	also	ADV
ajird-1099	17	16	educated	educate	VERB
ajird-1099	17	17	on	on	ADP
ajird-1099	17	18	a	a	DET
ajird-1099	17	19	background	background	NOUN
ajird-1099	17	20	hyperandrogenemia	hyperandrogenemia	NOUN
ajird-1099	17	21	,	,	PUNCT
ajird-1099	17	22	while	while	SCONJ
ajird-1099	17	23	an	an	DET
ajird-1099	17	24	ovarian	ovarian	ADJ
ajird-1099	17	25	function	function	NOUN
ajird-1099	17	26	was	be	AUX
ajird-1099	17	27	within	within	ADP
ajird-1099	17	28	the	the	DET
ajird-1099	17	29	limits	limit	NOUN
ajird-1099	17	30	of	of	ADP
ajird-1099	17	31	norm	norm	NOUN
ajird-1099	17	32	.	.	PUNCT
ajird-1099	18	1	so	so	ADV
ajird-1099	18	2	,	,	PUNCT
ajird-1099	18	3	as	as	SCONJ
ajird-1099	18	4	compared	compare	VERB
ajird-1099	18	5	to	to	ADP
ajird-1099	18	6	the	the	DET
ajird-1099	18	7	group	group	NOUN
ajird-1099	18	8	of	of	ADP
ajird-1099	18	9	control	control	NOUN
ajird-1099	18	10	on	on	ADP
ajird-1099	18	11	the	the	DET
ajird-1099	18	12	14	14	NUM
ajird-1099	18	13	day	day	NOUN
ajird-1099	18	14	of	of	ADP
ajird-1099	18	15	cycle	cycle	NOUN
ajird-1099	18	16	american	american	PROPN
ajird-1099	18	17	journal	journal	PROPN
ajird-1099	18	18	of	of	ADP
ajird-1099	18	19	interdisciplinary	interdisciplinary	ADJ
ajird-1099	18	20	research	research	NOUN
ajird-1099	18	21	and	and	CCONJ
ajird-1099	18	22	development	development	NOUN
ajird-1099	18	23	issn	issn	PROPN
ajird-1099	18	24	online	online	NOUN
ajird-1099	18	25	:	:	PUNCT
ajird-1099	18	26	2771	2771	NUM
ajird-1099	18	27	-	-	SYM
ajird-1099	18	28	8948	8948	NUM
ajird-1099	18	29	website	website	NOUN
ajird-1099	18	30	:	:	PUNCT
ajird-1099	18	31	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1099	18	32	volume	volume	NOUN
ajird-1099	18	33	28	28	NUM
ajird-1099	18	34	,	,	PUNCT
ajird-1099	18	35	may	may	AUX
ajird-1099	18	36	2024	2024	NUM
ajird-1099	18	37	28	28	NUM
ajird-1099	19	1	|	|	ADV
ajird-1099	19	2	p	p	X
ajird-1099	19	3	a	a	DET
ajird-1099	19	4	g	g	NOUN
ajird-1099	19	5	e	e	NOUN
ajird-1099	19	6	in	in	ADP
ajird-1099	19	7	the	the	DET
ajird-1099	19	8	third	third	ADJ
ajird-1099	19	9	group	group	NOUN
ajird-1099	19	10	of	of	ADP
ajird-1099	19	11	patients	patient	NOUN
ajird-1099	19	12	,	,	PUNCT
ajird-1099	19	13	the	the	DET
ajird-1099	19	14	reliable	reliable	ADJ
ajird-1099	19	15	decline	decline	NOUN
ajird-1099	19	16	of	of	ADP
ajird-1099	19	17	pituitary	pituitary	ADJ
ajird-1099	19	18	hormones	hormone	NOUN
ajird-1099	19	19	was	be	AUX
ajird-1099	19	20	also	also	ADV
ajird-1099	19	21	educated	educate	VERB
ajird-1099	19	22	on	on	ADP
ajird-1099	19	23	a	a	DET
ajird-1099	19	24	background	background	NOUN
ajird-1099	19	25	hyperandrogenemia	hyperandrogenemia	NOUN
ajird-1099	19	26	,	,	PUNCT
ajird-1099	19	27	while	while	SCONJ
ajird-1099	19	28	an	an	DET
ajird-1099	19	29	ovarian	ovarian	ADJ
ajird-1099	19	30	function	function	NOUN
ajird-1099	19	31	was	be	AUX
ajird-1099	19	32	within	within	ADP
ajird-1099	19	33	the	the	DET
ajird-1099	19	34	limits	limit	NOUN
ajird-1099	19	35	of	of	ADP
ajird-1099	19	36	norm	norm	NOUN
ajird-1099	19	37	.	.	PUNCT
ajird-1099	20	1	so	so	ADV
ajird-1099	20	2	,	,	PUNCT
ajird-1099	20	3	as	as	SCONJ
ajird-1099	20	4	compared	compare	VERB
ajird-1099	20	5	to	to	ADP
ajird-1099	20	6	the	the	DET
ajird-1099	20	7	group	group	NOUN
ajird-1099	20	8	of	of	ADP
ajird-1099	20	9	control	control	NOUN
ajird-1099	20	10	on	on	ADP
ajird-1099	20	11	the	the	DET
ajird-1099	20	12	14th	14th	ADJ
ajird-1099	20	13	day	day	NOUN
ajird-1099	20	14	of	of	ADP
ajird-1099	20	15	cycle	cycle	NOUN
ajird-1099	20	16	were	be	AUX
ajird-1099	20	17	for	for	ADP
ajird-1099	20	18	lh	lh	PROPN
ajird-1099	20	19	,	,	PUNCT
ajird-1099	20	20	fsh	fsh	NOUN
ajird-1099	20	21	,	,	PUNCT
ajird-1099	20	22	igf-1	igf-1	NOUN
ajird-1099	20	23	,	,	PUNCT
ajird-1099	20	24	here	here	ADV
ajird-1099	20	25	free	free	ADJ
ajird-1099	20	26	testosterone	testosterone	NOUN
ajird-1099	20	27	,	,	PUNCT
ajird-1099	20	28	dhea	dhea	PROPN
ajird-1099	20	29	,	,	PUNCT
ajird-1099	20	30	17	17	NUM
ajird-1099	20	31	oks	ok	NOUN
ajird-1099	20	32	,	,	PUNCT
ajird-1099	20	33	insulin	insulin	NOUN
ajird-1099	20	34	,	,	PUNCT
ajird-1099	20	35	were	be	AUX
ajird-1099	20	36	for	for	ADP
ajird-1099	20	37	certain	certain	ADJ
ajird-1099	20	38	enhanceable	enhanceable	ADJ
ajird-1099	20	39	as	as	ADP
ajird-1099	20	40	compared	compare	VERB
ajird-1099	20	41	to	to	ADP
ajird-1099	20	42	control	control	VERB
ajird-1099	20	43	data	data	PROPN
ajird-1099	20	44	.	.	PUNCT
ajird-1099	21	1	conclusions.1	conclusions.1	NOUN
ajird-1099	21	2	)	)	PUNCT
ajird-1099	21	3	frequency	frequency	NOUN
ajird-1099	21	4	of	of	ADP
ajird-1099	21	5	met	meet	VERB
ajird-1099	21	6	subclinical	subclinical	ADJ
ajird-1099	21	7	cushing	cushing	NOUN
ajird-1099	21	8	among	among	ADP
ajird-1099	21	9	women	woman	NOUN
ajird-1099	21	10	with	with	ADP
ajird-1099	21	11	pcos	pcos	PROPN
ajird-1099	21	12	6.6	6.6	NUM
ajird-1099	21	13	%	%	NOUN
ajird-1099	21	14	is	be	AUX
ajird-1099	21	15	equal	equal	ADJ
ajird-1099	21	16	.	.	PUNCT
ajird-1099	22	1	;	;	PUNCT
ajird-1099	22	2	2	2	X
ajird-1099	22	3	)	)	PUNCT
ajird-1099	22	4	in	in	ADP
ajird-1099	22	5	all	all	DET
ajird-1099	22	6	groups	group	NOUN
ajird-1099	22	7	on	on	ADP
ajird-1099	22	8	14	14	NUM
ajird-1099	22	9	day	day	NOUN
ajird-1099	22	10	of	of	ADP
ajird-1099	22	11	cycle	cycle	NOUN
ajird-1099	22	12	the	the	DET
ajird-1099	22	13	reliable	reliable	ADJ
ajird-1099	22	14	decline	decline	NOUN
ajird-1099	22	15	of	of	ADP
ajird-1099	22	16	basale	basale	ADJ
ajird-1099	22	17	values	value	NOUN
ajird-1099	22	18	of	of	ADP
ajird-1099	22	19	for	for	ADP
ajird-1099	22	20	lh	lh	PROPN
ajird-1099	22	21	,	,	PUNCT
ajird-1099	22	22	fsh	fsh	PROPN
ajird-1099	22	23	,	,	PUNCT
ajird-1099	22	24	igf-1	igf-1	PRON
ajird-1099	22	25	was	be	AUX
ajird-1099	22	26	marked	mark	VERB
ajird-1099	22	27	,	,	PUNCT
ajird-1099	22	28	progesterone	progesterone	NOUN
ajird-1099	22	29	,	,	PUNCT
ajird-1099	22	30	estradiol	estradiol	PROPN
ajird-1099	22	31	on	on	ADP
ajird-1099	22	32	a	a	DET
ajird-1099	22	33	background	background	NOUN
ajird-1099	22	34	hyperandrogenemia	hyperandrogenemia	NOUN
ajird-1099	22	35	(	(	PUNCT
ajird-1099	22	36	enhanceable	enhanceable	ADJ
ajird-1099	22	37	level	level	NOUN
ajird-1099	22	38	of	of	ADP
ajird-1099	22	39	free	free	ADJ
ajird-1099	22	40	testosterone	testosterone	NOUN
ajird-1099	22	41	.	.	PUNCT
ajird-1099	22	42	)	)	PUNCT
ajird-1099	22	43	.	.	PUNCT
ajird-1099	23	1	thus	thus	ADV
ajird-1099	23	2	in	in	ADP
ajird-1099	23	3	2	2	NUM
ajird-1099	23	4	and	and	CCONJ
ajird-1099	23	5	3	3	NUM
ajird-1099	23	6	groups	group	NOUN
ajird-1099	23	7	a	a	DET
ajird-1099	23	8	hyperinsulinemia	hyperinsulinemia	NOUN
ajird-1099	23	9	was	be	AUX
ajird-1099	23	10	marked	mark	VERB
ajird-1099	23	11	.	.	PUNCT
ajird-1099	24	1	only	only	ADV
ajird-1099	24	2	for	for	ADP
ajird-1099	24	3	patients	patient	NOUN
ajird-1099	24	4	3	3	NUM
ajird-1099	24	5	groups	group	NOUN
ajird-1099	24	6	were	be	AUX
ajird-1099	24	7	marked	mark	VERB
ajird-1099	24	8	for	for	ADP
ajird-1099	24	9	certain	certain	ADJ
ajird-1099	24	10	enhanceable	enhanceable	ADJ
ajird-1099	24	11	values	value	NOUN
ajird-1099	24	12	of	of	ADP
ajird-1099	24	13	dhea	dhea	PROPN
ajird-1099	24	14	,	,	PUNCT
ajird-1099	24	15	17	17	NUM
ajird-1099	24	16	oks	ok	NOUN
ajird-1099	24	17	and	and	CCONJ
ajird-1099	24	18	cortisol	cortisol	NOUN
ajird-1099	24	19	of	of	ADP
ajird-1099	24	20	blood	blood	NOUN
ajird-1099	24	21	.	.	PUNCT
ajird-1099	25	1	mean	mean	VERB
ajird-1099	25	2	values	value	NOUN
ajird-1099	25	3	of	of	ADP
ajird-1099	25	4	prolactin	prolactin	NOUN
ajird-1099	25	5	,	,	PUNCT
ajird-1099	25	6	amg	amg	PROPN
ajird-1099	25	7	were	be	AUX
ajird-1099	25	8	in	in	ADP
ajird-1099	25	9	a	a	DET
ajird-1099	25	10	norm	norm	NOUN
ajird-1099	25	11	.	.	PUNCT
ajird-1099	26	1	3	3	X
ajird-1099	26	2	)	)	PUNCT
ajird-1099	26	3	a	a	DET
ajird-1099	26	4	further	further	ADJ
ajird-1099	26	5	supervision	supervision	NOUN
ajird-1099	26	6	is	be	AUX
ajird-1099	26	7	needed	need	VERB
ajird-1099	26	8	in	in	ADP
ajird-1099	26	9	a	a	DET
ajird-1099	26	10	dynamic	dynamic	NOUN
ajird-1099	26	11	after	after	ADP
ajird-1099	26	12	probability	probability	NOUN
ajird-1099	26	13	of	of	ADP
ajird-1099	26	14	renewal	renewal	NOUN
ajird-1099	26	15	of	of	ADP
ajird-1099	26	16	fertile	fertile	ADJ
ajird-1099	26	17	function	function	NOUN
ajird-1099	26	18	in	in	ADP
ajird-1099	26	19	all	all	DET
ajird-1099	26	20	groups	group	NOUN
ajird-1099	26	21	of	of	ADP
ajird-1099	26	22	patients	patient	NOUN
ajird-1099	26	23	with	with	ADP
ajird-1099	26	24	pcos	pcos	PROPN
ajird-1099	26	25	keywords	keyword	NOUN
ajird-1099	26	26	:	:	PUNCT
ajird-1099	26	27	androgen	androgen	NOUN
ajird-1099	26	28	excess	excess	NOUN
ajird-1099	26	29	;	;	PUNCT
ajird-1099	26	30	polycystic	polycystic	ADJ
ajird-1099	26	31	ovary	ovary	ADJ
ajird-1099	26	32	syndrome	syndrome	NOUN
ajird-1099	26	33	;	;	PUNCT
ajird-1099	26	34	prevalence	prevalence	NOUN
ajird-1099	26	35	cushing	cushe	VERB
ajird-1099	26	36	syndrome	syndrome	NOUN
ajird-1099	26	37	.	.	PUNCT
ajird-1099	27	1	introduction	introduction	NOUN
ajird-1099	27	2	today	today	NOUN
ajird-1099	27	3	,	,	PUNCT
ajird-1099	27	4	ks	ks	PROPN
ajird-1099	27	5	is	be	AUX
ajird-1099	27	6	still	still	ADV
ajird-1099	27	7	associated	associate	VERB
ajird-1099	27	8	with	with	ADP
ajird-1099	27	9	an	an	DET
ajird-1099	27	10	increased	increase	VERB
ajird-1099	27	11	incidence	incidence	NOUN
ajird-1099	27	12	of	of	ADP
ajird-1099	27	13	subclinical	subclinical	ADJ
ajird-1099	27	14	disease	disease	NOUN
ajird-1099	27	15	[	[	X
ajird-1099	27	16	1	1	NUM
ajird-1099	27	17	]	]	PUNCT
ajird-1099	27	18	,	,	PUNCT
ajird-1099	27	19	but	but	CCONJ
ajird-1099	27	20	excess	excess	ADJ
ajird-1099	27	21	mortality	mortality	NOUN
ajird-1099	27	22	has	have	AUX
ajird-1099	27	23	also	also	ADV
ajird-1099	27	24	been	be	AUX
ajird-1099	27	25	reported	report	VERB
ajird-1099	27	26	in	in	ADP
ajird-1099	27	27	patients	patient	NOUN
ajird-1099	27	28	with	with	ADP
ajird-1099	27	29	cushing	cushing	NOUN
ajird-1099	27	30	's	's	PART
ajird-1099	27	31	disease	disease	NOUN
ajird-1099	28	1	[	[	X
ajird-1099	28	2	2–5	2–5	X
ajird-1099	28	3	]	]	PUNCT
ajird-1099	28	4	and	and	CCONJ
ajird-1099	28	5	in	in	ADP
ajird-1099	28	6	patients	patient	NOUN
ajird-1099	28	7	with	with	ADP
ajird-1099	28	8	subclinical	subclinical	ADJ
ajird-1099	28	9	cushingoid	cushingoid	NOUN
ajird-1099	29	1	[	[	X
ajird-1099	29	2	6	6	NUM
ajird-1099	29	3	]	]	PUNCT
ajird-1099	29	4	.	.	PUNCT
ajird-1099	30	1	in	in	ADP
ajird-1099	30	2	contrast	contrast	NOUN
ajird-1099	30	3	,	,	PUNCT
ajird-1099	30	4	the	the	DET
ajird-1099	30	5	mortality	mortality	NOUN
ajird-1099	30	6	rate	rate	NOUN
ajird-1099	30	7	was	be	AUX
ajird-1099	30	8	not	not	PART
ajird-1099	30	9	as	as	ADV
ajird-1099	30	10	high	high	ADJ
ajird-1099	30	11	in	in	ADP
ajird-1099	30	12	patients	patient	NOUN
ajird-1099	30	13	with	with	ADP
ajird-1099	30	14	cushing	cushing	NOUN
ajird-1099	30	15	's	's	PART
ajird-1099	30	16	disease	disease	NOUN
ajird-1099	30	17	who	who	PRON
ajird-1099	30	18	recovered	recover	VERB
ajird-1099	30	19	after	after	ADP
ajird-1099	30	20	initial	initial	ADJ
ajird-1099	30	21	surgery	surgery	NOUN
ajird-1099	30	22	[	[	X
ajird-1099	30	23	7,8	7,8	NUM
ajird-1099	30	24	]	]	PUNCT
ajird-1099	30	25	.	.	PUNCT
ajird-1099	31	1	this	this	PRON
ajird-1099	31	2	is	be	AUX
ajird-1099	31	3	obviously	obviously	ADV
ajird-1099	31	4	reassuring	reassure	VERB
ajird-1099	31	5	that	that	SCONJ
ajird-1099	31	6	treatment	treatment	NOUN
ajird-1099	31	7	reduces	reduce	VERB
ajird-1099	31	8	mortality	mortality	NOUN
ajird-1099	31	9	,	,	PUNCT
ajird-1099	31	10	but	but	CCONJ
ajird-1099	31	11	the	the	DET
ajird-1099	31	12	data	datum	NOUN
ajird-1099	31	13	also	also	ADV
ajird-1099	31	14	highlight	highlight	VERB
ajird-1099	31	15	the	the	DET
ajird-1099	31	16	need	need	NOUN
ajird-1099	31	17	to	to	PART
ajird-1099	31	18	start	start	VERB
ajird-1099	31	19	treatment	treatment	NOUN
ajird-1099	31	20	as	as	ADV
ajird-1099	31	21	early	early	ADV
ajird-1099	31	22	as	as	ADP
ajird-1099	31	23	possible	possible	ADJ
ajird-1099	31	24	and	and	CCONJ
ajird-1099	31	25	to	to	PART
ajird-1099	31	26	pay	pay	VERB
ajird-1099	31	27	special	special	ADJ
ajird-1099	31	28	attention	attention	NOUN
ajird-1099	31	29	to	to	ADP
ajird-1099	31	30	patients	patient	NOUN
ajird-1099	31	31	with	with	ADP
ajird-1099	31	32	cushing	cushing	NOUN
ajird-1099	31	33	's	's	PART
ajird-1099	31	34	disease	disease	NOUN
ajird-1099	31	35	who	who	PRON
ajird-1099	31	36	have	have	AUX
ajird-1099	31	37	not	not	PART
ajird-1099	31	38	recovered	recover	VERB
ajird-1099	31	39	from	from	ADP
ajird-1099	31	40	initial	initial	ADJ
ajird-1099	31	41	surgery	surgery	NOUN
ajird-1099	31	42	.	.	PUNCT
ajird-1099	32	1	a	a	DET
ajird-1099	32	2	reliable	reliable	ADJ
ajird-1099	32	3	therapeutic	therapeutic	ADJ
ajird-1099	32	4	approach	approach	NOUN
ajird-1099	32	5	remains	remain	VERB
ajird-1099	32	6	open	open	ADJ
ajird-1099	32	7	to	to	ADP
ajird-1099	32	8	debate	debate	VERB
ajird-1099	32	9	,	,	PUNCT
ajird-1099	32	10	but	but	CCONJ
ajird-1099	32	11	the	the	DET
ajird-1099	32	12	opinion	opinion	NOUN
ajird-1099	32	13	regarding	regard	VERB
ajird-1099	32	14	staged	stage	VERB
ajird-1099	32	15	bilateral	bilateral	ADJ
ajird-1099	32	16	adrenalectomy	adrenalectomy	NOUN
ajird-1099	32	17	should	should	AUX
ajird-1099	32	18	not	not	PART
ajird-1099	32	19	be	be	AUX
ajird-1099	32	20	forgotten	forget	VERB
ajird-1099	32	21	.	.	PUNCT
ajird-1099	33	1	in	in	ADP
ajird-1099	33	2	conclusion	conclusion	NOUN
ajird-1099	33	3	,	,	PUNCT
ajird-1099	33	4	ks	ks	NOUN
ajird-1099	33	5	remains	remain	VERB
ajird-1099	33	6	a	a	DET
ajird-1099	33	7	diagnostic	diagnostic	ADJ
ajird-1099	33	8	and	and	CCONJ
ajird-1099	33	9	therapeutic	therapeutic	ADJ
ajird-1099	33	10	challenge	challenge	NOUN
ajird-1099	33	11	.	.	PUNCT
ajird-1099	34	1	available	available	ADJ
ajird-1099	34	2	data	datum	NOUN
ajird-1099	34	3	show	show	VERB
ajird-1099	34	4	that	that	SCONJ
ajird-1099	34	5	early	early	ADJ
ajird-1099	34	6	and	and	CCONJ
ajird-1099	34	7	effective	effective	ADJ
ajird-1099	34	8	treatment	treatment	NOUN
ajird-1099	34	9	improves	improve	VERB
ajird-1099	34	10	survival	survival	NOUN
ajird-1099	34	11	,	,	PUNCT
ajird-1099	34	12	but	but	CCONJ
ajird-1099	34	13	later	later	ADV
ajird-1099	34	14	relapses	relapse	NOUN
ajird-1099	34	15	after	after	ADP
ajird-1099	34	16	initial	initial	ADJ
ajird-1099	34	17	successful	successful	ADJ
ajird-1099	34	18	surgery	surgery	NOUN
ajird-1099	34	19	occur	occur	VERB
ajird-1099	34	20	even	even	ADV
ajird-1099	34	21	in	in	ADP
ajird-1099	34	22	the	the	DET
ajird-1099	34	23	best	good	ADJ
ajird-1099	34	24	centers	center	NOUN
ajird-1099	34	25	.	.	PUNCT
ajird-1099	35	1	[	[	X
ajird-1099	35	2	9	9	NUM
ajird-1099	35	3	]	]	PUNCT
ajird-1099	35	4	.	.	PUNCT
ajird-1099	36	1	all	all	PRON
ajird-1099	36	2	of	of	ADP
ajird-1099	36	3	the	the	DET
ajird-1099	36	4	above	above	ADJ
ajird-1099	36	5	determines	determine	VERB
ajird-1099	36	6	a	a	DET
ajird-1099	36	7	possibly	possibly	ADV
ajird-1099	36	8	high	high	ADJ
ajird-1099	36	9	frequency	frequency	NOUN
ajird-1099	36	10	of	of	ADP
ajird-1099	36	11	cases	case	NOUN
ajird-1099	36	12	of	of	ADP
ajird-1099	36	13	ks	k	NOUN
ajird-1099	36	14	due	due	ADP
ajird-1099	36	15	to	to	ADP
ajird-1099	36	16	undiagnosed	undiagnosed	ADJ
ajird-1099	36	17	cases	case	NOUN
ajird-1099	36	18	of	of	ADP
ajird-1099	36	19	subclinical	subclinical	ADJ
ajird-1099	36	20	variants	variant	NOUN
ajird-1099	36	21	of	of	ADP
ajird-1099	36	22	the	the	DET
ajird-1099	36	23	disease	disease	NOUN
ajird-1099	36	24	.	.	PUNCT
ajird-1099	37	1	widespread	widespread	ADJ
ajird-1099	37	2	coverage	coverage	NOUN
ajird-1099	37	3	,	,	PUNCT
ajird-1099	37	4	active	active	ADJ
ajird-1099	37	5	detection	detection	NOUN
ajird-1099	37	6	of	of	ADP
ajird-1099	37	7	latent	latent	NOUN
ajird-1099	37	8	forms	form	NOUN
ajird-1099	37	9	through	through	ADP
ajird-1099	37	10	screening	screen	VERB
ajird-1099	37	11	studies	study	NOUN
ajird-1099	37	12	in	in	ADP
ajird-1099	37	13	individuals	individual	NOUN
ajird-1099	37	14	with	with	ADP
ajird-1099	37	15	phenotypic	phenotypic	ADJ
ajird-1099	37	16	cushingoid	cushingoid	NOUN
ajird-1099	37	17	,	,	PUNCT
ajird-1099	37	18	contributes	contribute	VERB
ajird-1099	37	19	to	to	ADP
ajird-1099	37	20	early	early	ADJ
ajird-1099	37	21	detection	detection	NOUN
ajird-1099	37	22	,	,	PUNCT
ajird-1099	37	23	timely	timely	ADJ
ajird-1099	37	24	treatment	treatment	NOUN
ajird-1099	37	25	and	and	CCONJ
ajird-1099	37	26	improvement	improvement	NOUN
ajird-1099	37	27	of	of	ADP
ajird-1099	37	28	irreversible	irreversible	ADJ
ajird-1099	37	29	and	and	CCONJ
ajird-1099	37	30	severe	severe	ADJ
ajird-1099	37	31	outcomes	outcome	NOUN
ajird-1099	37	32	and	and	CCONJ
ajird-1099	37	33	prognoses	prognosis	NOUN
ajird-1099	37	34	of	of	ADP
ajird-1099	37	35	this	this	DET
ajird-1099	37	36	disease	disease	NOUN
ajird-1099	37	37	.	.	PUNCT
ajird-1099	38	1	the	the	DET
ajird-1099	38	2	relevance	relevance	NOUN
ajird-1099	38	3	of	of	ADP
ajird-1099	38	4	this	this	DET
ajird-1099	38	5	problem	problem	NOUN
ajird-1099	38	6	is	be	AUX
ajird-1099	38	7	due	due	ADJ
ajird-1099	38	8	to	to	ADP
ajird-1099	38	9	the	the	DET
ajird-1099	38	10	fact	fact	NOUN
ajird-1099	38	11	that	that	SCONJ
ajird-1099	38	12	timely	timely	ADJ
ajird-1099	38	13	diagnosis	diagnosis	NOUN
ajird-1099	38	14	will	will	AUX
ajird-1099	38	15	allow	allow	VERB
ajird-1099	38	16	us	we	PRON
ajird-1099	38	17	to	to	PART
ajird-1099	38	18	identify	identify	VERB
ajird-1099	38	19	this	this	DET
ajird-1099	38	20	category	category	NOUN
ajird-1099	38	21	of	of	ADP
ajird-1099	38	22	patients	patient	NOUN
ajird-1099	38	23	and	and	CCONJ
ajird-1099	38	24	refer	refer	VERB
ajird-1099	38	25	them	they	PRON
ajird-1099	38	26	for	for	ADP
ajird-1099	38	27	further	further	ADJ
ajird-1099	38	28	examination	examination	NOUN
ajird-1099	38	29	and	and	CCONJ
ajird-1099	38	30	treatment	treatment	NOUN
ajird-1099	38	31	to	to	ADP
ajird-1099	38	32	specialized	specialized	ADJ
ajird-1099	38	33	endocrinological	endocrinological	ADJ
ajird-1099	38	34	centers	center	NOUN
ajird-1099	38	35	.	.	PUNCT
ajird-1099	39	1	the	the	DET
ajird-1099	39	2	real	real	ADJ
ajird-1099	39	3	impact	impact	NOUN
ajird-1099	39	4	of	of	ADP
ajird-1099	39	5	these	these	DET
ajird-1099	39	6	studies	study	NOUN
ajird-1099	39	7	will	will	AUX
ajird-1099	39	8	be	be	AUX
ajird-1099	39	9	an	an	DET
ajird-1099	39	10	increase	increase	NOUN
ajird-1099	39	11	in	in	ADP
ajird-1099	39	12	the	the	DET
ajird-1099	39	13	duration	duration	NOUN
ajird-1099	39	14	and	and	CCONJ
ajird-1099	39	15	quality	quality	NOUN
ajird-1099	39	16	of	of	ADP
ajird-1099	39	17	life	life	NOUN
ajird-1099	39	18	of	of	ADP
ajird-1099	39	19	patients	patient	NOUN
ajird-1099	39	20	with	with	ADP
ajird-1099	39	21	ks	ks	PROPN
ajird-1099	39	22	and	and	CCONJ
ajird-1099	39	23	the	the	DET
ajird-1099	39	24	creation	creation	NOUN
ajird-1099	39	25	of	of	ADP
ajird-1099	39	26	an	an	DET
ajird-1099	39	27	objective	objective	ADJ
ajird-1099	39	28	system	system	NOUN
ajird-1099	39	29	for	for	ADP
ajird-1099	39	30	their	their	PRON
ajird-1099	39	31	monitoring.[10	monitoring.[10	NOUN
ajird-1099	39	32	]	]	PUNCT
ajird-1099	39	33	.	.	PUNCT
ajird-1099	40	1	the	the	DET
ajird-1099	40	2	results	result	NOUN
ajird-1099	40	3	of	of	ADP
ajird-1099	40	4	a	a	DET
ajird-1099	40	5	mass	mass	ADJ
ajird-1099	40	6	examination	examination	NOUN
ajird-1099	40	7	of	of	ADP
ajird-1099	40	8	patients	patient	NOUN
ajird-1099	40	9	for	for	ADP
ajird-1099	40	10	ks	ks	PROPN
ajird-1099	40	11	in	in	ADP
ajird-1099	40	12	target	target	NOUN
ajird-1099	40	13	population	population	NOUN
ajird-1099	40	14	groups	group	NOUN
ajird-1099	40	15	show	show	VERB
ajird-1099	40	16	a	a	DET
ajird-1099	40	17	prevailing	prevail	VERB
ajird-1099	40	18	number	number	NOUN
ajird-1099	40	19	of	of	ADP
ajird-1099	40	20	undiagnosed	undiagnosed	ADJ
ajird-1099	40	21	and	and	CCONJ
ajird-1099	40	22	subclinical	subclinical	ADJ
ajird-1099	40	23	cases	case	NOUN
ajird-1099	40	24	[	[	X
ajird-1099	40	25	11	11	NUM
ajird-1099	40	26	,	,	PUNCT
ajird-1099	40	27	12	12	NUM
ajird-1099	40	28	]	]	PUNCT
ajird-1099	40	29	,	,	PUNCT
ajird-1099	40	30	and	and	CCONJ
ajird-1099	40	31	there	there	PRON
ajird-1099	40	32	is	be	VERB
ajird-1099	40	33	accumulated	accumulate	VERB
ajird-1099	40	34	american	american	ADJ
ajird-1099	40	35	journal	journal	NOUN
ajird-1099	40	36	of	of	ADP
ajird-1099	40	37	interdisciplinary	interdisciplinary	ADJ
ajird-1099	40	38	research	research	NOUN
ajird-1099	40	39	and	and	CCONJ
ajird-1099	40	40	development	development	NOUN
ajird-1099	40	41	issn	issn	PROPN
ajird-1099	40	42	online	online	NOUN
ajird-1099	40	43	:	:	PUNCT
ajird-1099	40	44	2771	2771	NUM
ajird-1099	40	45	-	-	SYM
ajird-1099	40	46	8948	8948	NUM
ajird-1099	40	47	website	website	NOUN
ajird-1099	40	48	:	:	PUNCT
ajird-1099	40	49	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1099	40	50	volume	volume	NOUN
ajird-1099	40	51	28	28	NUM
ajird-1099	40	52	,	,	PUNCT
ajird-1099	40	53	may	may	AUX
ajird-1099	40	54	2024	2024	NUM
ajird-1099	40	55	29	29	NUM
ajird-1099	40	56	|	|	ADV
ajird-1099	40	57	p	p	NOUN
ajird-1099	40	58	a	a	DET
ajird-1099	40	59	g	g	NOUN
ajird-1099	40	60	e	e	NOUN
ajird-1099	40	61	experience	experience	NOUN
ajird-1099	40	62	to	to	PART
ajird-1099	40	63	suggest	suggest	VERB
ajird-1099	40	64	subclinical	subclinical	ADJ
ajird-1099	40	65	cushing	cushing	NOUN
ajird-1099	40	66	's	's	PART
ajird-1099	40	67	syndrome	syndrome	NOUN
ajird-1099	40	68	(	(	PUNCT
ajird-1099	40	69	ccs	ccs	PROPN
ajird-1099	40	70	)	)	PUNCT
ajird-1099	40	71	in	in	ADP
ajird-1099	40	72	most	most	ADJ
ajird-1099	40	73	cases	case	NOUN
ajird-1099	40	74	as	as	ADP
ajird-1099	40	75	an	an	DET
ajird-1099	40	76	incidental	incidental	ADJ
ajird-1099	40	77	adrenal	adrenal	ADJ
ajird-1099	40	78	gland	gland	NOUN
ajird-1099	40	79	.	.	PUNCT
ajird-1099	41	1	in	in	ADP
ajird-1099	41	2	general	general	ADJ
ajird-1099	41	3	,	,	PUNCT
ajird-1099	41	4	there	there	PRON
ajird-1099	41	5	are	be	VERB
ajird-1099	41	6	few	few	ADJ
ajird-1099	41	7	works	work	NOUN
ajird-1099	41	8	in	in	ADP
ajird-1099	41	9	the	the	DET
ajird-1099	41	10	literature	literature	NOUN
ajird-1099	41	11	devoted	devote	VERB
ajird-1099	41	12	to	to	ADP
ajird-1099	41	13	this	this	DET
ajird-1099	41	14	topic	topic	NOUN
ajird-1099	41	15	,	,	PUNCT
ajird-1099	41	16	which	which	PRON
ajird-1099	41	17	was	be	AUX
ajird-1099	41	18	the	the	DET
ajird-1099	41	19	reason	reason	NOUN
ajird-1099	41	20	for	for	ADP
ajird-1099	41	21	carrying	carry	VERB
ajird-1099	41	22	out	out	ADP
ajird-1099	41	23	our	our	PRON
ajird-1099	41	24	study	study	NOUN
ajird-1099	41	25	.	.	PUNCT
ajird-1099	42	1	purpose	purpose	NOUN
ajird-1099	42	2	of	of	ADP
ajird-1099	42	3	the	the	DET
ajird-1099	42	4	study	study	NOUN
ajird-1099	42	5	study	study	NOUN
ajird-1099	42	6	frequency	frequency	NOUN
ajird-1099	42	7	of	of	ADP
ajird-1099	42	8	occurrence	occurrence	NOUN
ajird-1099	42	9	and	and	CCONJ
ajird-1099	42	10	characteristics	characteristic	NOUN
ajird-1099	42	11	of	of	ADP
ajird-1099	42	12	subclinical	subclinical	ADJ
ajird-1099	42	13	cushingoid	cushingoid	NOUN
ajird-1099	42	14	in	in	ADP
ajird-1099	42	15	women	woman	NOUN
ajird-1099	42	16	with	with	ADP
ajird-1099	42	17	pcos	pcos	PROPN
ajird-1099	42	18	.	.	PUNCT
ajird-1099	43	1	material	material	NOUN
ajird-1099	43	2	and	and	CCONJ
ajird-1099	43	3	research	research	NOUN
ajird-1099	43	4	methods	method	NOUN
ajird-1099	43	5	under	under	ADP
ajird-1099	43	6	our	our	PRON
ajird-1099	43	7	supervision	supervision	NOUN
ajird-1099	43	8	,	,	PUNCT
ajird-1099	43	9	the	the	DET
ajird-1099	43	10	republican	republican	ADJ
ajird-1099	43	11	scientific	scientific	ADJ
ajird-1099	43	12	research	research	NOUN
ajird-1099	43	13	and	and	CCONJ
ajird-1099	43	14	medical	medical	ADJ
ajird-1099	43	15	center	center	NOUN
ajird-1099	43	16	of	of	ADP
ajird-1099	43	17	endocrinology	endocrinology	NOUN
ajird-1099	43	18	m3	m3	PROPN
ajird-1099	43	19	of	of	ADP
ajird-1099	43	20	the	the	DET
ajird-1099	43	21	republic	republic	NOUN
ajird-1099	43	22	of	of	ADP
ajird-1099	43	23	uzbekistan	uzbekistan	PROPN
ajird-1099	43	24	named	name	VERB
ajird-1099	43	25	after	after	ADP
ajird-1099	43	26	acad	acad	PROPN
ajird-1099	43	27	.	.	PUNCT
ajird-1099	44	1	y.h	y.h	PROPN
ajird-1099	44	2	.	.	PROPN
ajird-1099	44	3	turakulov	turakulov	NOUN
ajird-1099	44	4	,	,	PUNCT
ajird-1099	44	5	120	120	NUM
ajird-1099	44	6	patients	patient	NOUN
ajird-1099	44	7	of	of	ADP
ajird-1099	44	8	fertile	fertile	ADJ
ajird-1099	44	9	age	age	NOUN
ajird-1099	44	10	with	with	ADP
ajird-1099	44	11	pcos	pcos	PROPN
ajird-1099	44	12	(	(	PUNCT
ajird-1099	44	13	primary	primary	ADJ
ajird-1099	44	14	and	and	CCONJ
ajird-1099	44	15	secondary	secondary	ADJ
ajird-1099	44	16	)	)	PUNCT
ajird-1099	44	17	were	be	AUX
ajird-1099	44	18	examined	examine	VERB
ajird-1099	44	19	on	on	ADP
ajird-1099	44	20	an	an	DET
ajird-1099	44	21	outpatient	outpatient	NOUN
ajird-1099	44	22	basis	basis	NOUN
ajird-1099	44	23	for	for	ADP
ajird-1099	44	24	primary	primary	ADJ
ajird-1099	44	25	or	or	CCONJ
ajird-1099	44	26	secondary	secondary	ADJ
ajird-1099	44	27	infertility	infertility	NOUN
ajird-1099	44	28	in	in	ADP
ajird-1099	44	29	the	the	DET
ajird-1099	44	30	period	period	NOUN
ajird-1099	44	31	from	from	ADP
ajird-1099	44	32	september	september	PROPN
ajird-1099	44	33	2022	2022	NUM
ajird-1099	44	34	to	to	ADP
ajird-1099	44	35	december	december	PROPN
ajird-1099	44	36	2023	2023	NUM
ajird-1099	44	37	.	.	PUNCT
ajird-1099	45	1	the	the	DET
ajird-1099	45	2	average	average	ADJ
ajird-1099	45	3	age	age	NOUN
ajird-1099	45	4	of	of	ADP
ajird-1099	45	5	the	the	DET
ajird-1099	45	6	patients	patient	NOUN
ajird-1099	45	7	was	be	AUX
ajird-1099	45	8	25.5	25.5	NUM
ajird-1099	45	9	±	±	NUM
ajird-1099	45	10	4.3	4.3	NUM
ajird-1099	45	11	years	year	NOUN
ajird-1099	45	12	.	.	PUNCT
ajird-1099	46	1	the	the	DET
ajird-1099	46	2	duration	duration	NOUN
ajird-1099	46	3	of	of	ADP
ajird-1099	46	4	the	the	DET
ajird-1099	46	5	disease	disease	NOUN
ajird-1099	46	6	ranged	range	VERB
ajird-1099	46	7	from	from	ADP
ajird-1099	46	8	7	7	NUM
ajird-1099	46	9	months	month	NOUN
ajird-1099	46	10	to	to	ADP
ajird-1099	46	11	9	9	NUM
ajird-1099	46	12	years	year	NOUN
ajird-1099	46	13	.	.	PUNCT
ajird-1099	47	1	20	20	NUM
ajird-1099	47	2	healthy	healthy	ADJ
ajird-1099	47	3	women	woman	NOUN
ajird-1099	47	4	of	of	ADP
ajird-1099	47	5	the	the	DET
ajird-1099	47	6	appropriate	appropriate	ADJ
ajird-1099	47	7	age	age	NOUN
ajird-1099	47	8	formed	form	VERB
ajird-1099	47	9	the	the	DET
ajird-1099	47	10	control	control	NOUN
ajird-1099	47	11	group	group	NOUN
ajird-1099	47	12	.	.	PUNCT
ajird-1099	48	1	all	all	DET
ajird-1099	48	2	patients	patient	NOUN
ajird-1099	48	3	underwent	undergo	VERB
ajird-1099	48	4	a	a	DET
ajird-1099	48	5	complex	complex	NOUN
ajird-1099	48	6	of	of	ADP
ajird-1099	48	7	studies	study	NOUN
ajird-1099	48	8	,	,	PUNCT
ajird-1099	48	9	including	include	VERB
ajird-1099	48	10	general	general	ADJ
ajird-1099	48	11	clinical	clinical	ADJ
ajird-1099	48	12	(	(	PUNCT
ajird-1099	48	13	general	general	ADJ
ajird-1099	48	14	blood	blood	NOUN
ajird-1099	48	15	and	and	CCONJ
ajird-1099	48	16	urine	urine	NOUN
ajird-1099	48	17	analysis	analysis	NOUN
ajird-1099	48	18	)	)	PUNCT
ajird-1099	48	19	,	,	PUNCT
ajird-1099	48	20	biochemical	biochemical	ADJ
ajird-1099	48	21	(	(	PUNCT
ajird-1099	48	22	blood	blood	NOUN
ajird-1099	48	23	glucose	glucose	NOUN
ajird-1099	48	24	,	,	PUNCT
ajird-1099	48	25	glucose	glucose	NOUN
ajird-1099	48	26	tolerance	tolerance	NOUN
ajird-1099	48	27	test	test	NOUN
ajird-1099	48	28	)	)	PUNCT
ajird-1099	48	29	,	,	PUNCT
ajird-1099	48	30	hormonal	hormonal	NOUN
ajird-1099	48	31	(	(	PUNCT
ajird-1099	48	32	lh	lh	PROPN
ajird-1099	48	33	,	,	PUNCT
ajird-1099	48	34	fsh	fsh	ADJ
ajird-1099	48	35	,	,	PUNCT
ajird-1099	48	36	prolactin	prolactin	NOUN
ajird-1099	48	37	,	,	PUNCT
ajird-1099	48	38	estradiol	estradiol	PROPN
ajird-1099	48	39	,	,	PUNCT
ajird-1099	48	40	progesterone	progesterone	NOUN
ajird-1099	48	41	,	,	PUNCT
ajird-1099	48	42	free	free	ADJ
ajird-1099	48	43	testosterone	testosterone	NOUN
ajird-1099	48	44	,	,	PUNCT
ajird-1099	48	45	dehydroepiandrostenedione	dehydroepiandrostenedione	PROPN
ajird-1099	48	46	(	(	PUNCT
ajird-1099	48	47	dhea	dhea	PROPN
ajird-1099	48	48	)	)	PUNCT
ajird-1099	48	49	,	,	PUNCT
ajird-1099	48	50	17	17	NUM
ajird-1099	48	51	-	-	PUNCT
ajird-1099	48	52	hydroxyprogesterone	hydroxyprogesterone	NOUN
ajird-1099	48	53	(	(	PUNCT
ajird-1099	48	54	17	17	NUM
ajird-1099	48	55	acs	ac	NOUN
ajird-1099	48	56	)	)	PUNCT
ajird-1099	48	57	,	,	PUNCT
ajird-1099	48	58	anti	anti	ADJ
ajird-1099	48	59	-	-	ADJ
ajird-1099	48	60	mullerian	mullerian	ADJ
ajird-1099	48	61	hormone	hormone	NOUN
ajird-1099	48	62	(	(	PUNCT
ajird-1099	48	63	amh	amh	PROPN
ajird-1099	48	64	)	)	PUNCT
ajird-1099	48	65	,	,	PUNCT
ajird-1099	48	66	insulin	insulin	NOUN
ajird-1099	48	67	on	on	ADP
ajird-1099	48	68	the	the	DET
ajird-1099	48	69	14th	14th	ADJ
ajird-1099	48	70	day	day	NOUN
ajird-1099	48	71	of	of	ADP
ajird-1099	48	72	the	the	DET
ajird-1099	48	73	cycle	cycle	NOUN
ajird-1099	48	74	)	)	PUNCT
ajird-1099	48	75	,	,	PUNCT
ajird-1099	48	76	ultrasound	ultrasound	NOUN
ajird-1099	48	77	of	of	ADP
ajird-1099	48	78	the	the	DET
ajird-1099	48	79	uterus	uterus	NOUN
ajird-1099	48	80	and	and	CCONJ
ajird-1099	48	81	ovaries	ovary	NOUN
ajird-1099	48	82	(	(	PUNCT
ajird-1099	48	83	transabdominal	transabdominal	NOUN
ajird-1099	48	84	and	and	CCONJ
ajird-1099	48	85	transvaginal	transvaginal	NOUN
ajird-1099	48	86	)	)	PUNCT
ajird-1099	48	87	on	on	ADP
ajird-1099	48	88	the	the	DET
ajird-1099	48	89	14th	14th	ADJ
ajird-1099	48	90	day	day	NOUN
ajird-1099	48	91	of	of	ADP
ajird-1099	48	92	the	the	DET
ajird-1099	48	93	cycle	cycle	NOUN
ajird-1099	48	94	with	with	ADP
ajird-1099	48	95	dynamic	dynamic	ADJ
ajird-1099	48	96	folliculometry	folliculometry	NOUN
ajird-1099	48	97	,	,	PUNCT
ajird-1099	48	98	as	as	ADV
ajird-1099	48	99	well	well	ADV
ajird-1099	48	100	as	as	ADP
ajird-1099	48	101	magnetic	magnetic	ADJ
ajird-1099	48	102	resonance	resonance	NOUN
ajird-1099	48	103	imaging	imaging	NOUN
ajird-1099	48	104	(	(	PUNCT
ajird-1099	48	105	mri	mri	NOUN
ajird-1099	48	106	)	)	PUNCT
ajird-1099	48	107	of	of	ADP
ajird-1099	48	108	the	the	DET
ajird-1099	48	109	sella	sella	NOUN
ajird-1099	48	110	turcica	turcica	NOUN
ajird-1099	48	111	(	(	PUNCT
ajird-1099	48	112	clinic	clinic	NOUN
ajird-1099	48	113	“	"	PUNCT
ajird-1099	48	114	diermedic	diermedic	ADJ
ajird-1099	48	115	center	center	NOUN
ajird-1099	48	116	,	,	PUNCT
ajird-1099	48	117	tashkent	tashkent	NOUN
ajird-1099	48	118	)	)	PUNCT
ajird-1099	48	119	and	and	CCONJ
ajird-1099	48	120	questioning	question	VERB
ajird-1099	48	121	of	of	ADP
ajird-1099	48	122	patients	patient	NOUN
ajird-1099	48	123	.	.	PUNCT
ajird-1099	49	1	if	if	SCONJ
ajird-1099	49	2	necessary	necessary	ADJ
ajird-1099	49	3	,	,	PUNCT
ajird-1099	49	4	a	a	DET
ajird-1099	49	5	glucose	glucose	NOUN
ajird-1099	49	6	tolerance	tolerance	NOUN
ajird-1099	49	7	test	test	NOUN
ajird-1099	49	8	and	and	CCONJ
ajird-1099	49	9	determination	determination	NOUN
ajird-1099	49	10	of	of	ADP
ajird-1099	49	11	cortisol	cortisol	NOUN
ajird-1099	49	12	in	in	ADP
ajird-1099	49	13	the	the	DET
ajird-1099	49	14	blood	blood	NOUN
ajird-1099	49	15	and	and	CCONJ
ajird-1099	49	16	free	free	ADJ
ajird-1099	49	17	cortisol	cortisol	NOUN
ajird-1099	49	18	in	in	ADP
ajird-1099	49	19	24	24	NUM
ajird-1099	49	20	-	-	PUNCT
ajird-1099	49	21	hour	hour	NOUN
ajird-1099	49	22	urine	urine	NOUN
ajird-1099	49	23	were	be	AUX
ajird-1099	49	24	performed	perform	VERB
ajird-1099	49	25	.	.	PUNCT
ajird-1099	50	1	anthropometric	anthropometric	ADJ
ajird-1099	50	2	study	study	NOUN
ajird-1099	50	3	-	-	PUNCT
ajird-1099	50	4	was	be	AUX
ajird-1099	50	5	carried	carry	VERB
ajird-1099	50	6	out	out	ADP
ajird-1099	50	7	immediately	immediately	ADV
ajird-1099	50	8	during	during	ADP
ajird-1099	50	9	the	the	DET
ajird-1099	50	10	initial	initial	ADJ
ajird-1099	50	11	examination	examination	NOUN
ajird-1099	50	12	,	,	PUNCT
ajird-1099	50	13	in	in	ADP
ajird-1099	50	14	dynamics	dynamic	NOUN
ajird-1099	50	15	and	and	CCONJ
ajird-1099	50	16	included	include	VERB
ajird-1099	50	17	determination	determination	NOUN
ajird-1099	50	18	of	of	ADP
ajird-1099	50	19	height	height	NOUN
ajird-1099	50	20	,	,	PUNCT
ajird-1099	50	21	bw	bw	NOUN
ajird-1099	50	22	,	,	PUNCT
ajird-1099	50	23	determination	determination	NOUN
ajird-1099	50	24	of	of	ADP
ajird-1099	50	25	body	body	NOUN
ajird-1099	50	26	mass	mass	NOUN
ajird-1099	50	27	index	index	NOUN
ajird-1099	50	28	(	(	PUNCT
ajird-1099	50	29	bmi	bmi	PROPN
ajird-1099	50	30	)	)	PUNCT
ajird-1099	50	31	(	(	PUNCT
ajird-1099	50	32	quetelet	quetelet	PROPN
ajird-1099	50	33	index	index	NOUN
ajird-1099	50	34	)	)	PUNCT
ajird-1099	50	35	,	,	PUNCT
ajird-1099	50	36	calculated	calculate	VERB
ajird-1099	50	37	by	by	ADP
ajird-1099	50	38	the	the	DET
ajird-1099	50	39	formula	formula	NOUN
ajird-1099	50	40	:	:	PUNCT
ajird-1099	50	41	bmi	bmi	PROPN
ajird-1099	50	42	(	(	PUNCT
ajird-1099	50	43	kg	kg	NOUN
ajird-1099	50	44	/	/	SYM
ajird-1099	50	45	m2	m2	PROPN
ajird-1099	50	46	)	)	PUNCT
ajird-1099	50	47	=	=	PRON
ajird-1099	50	48	(	(	PUNCT
ajird-1099	50	49	bw	bw	NOUN
ajird-1099	50	50	,	,	PUNCT
ajird-1099	50	51	kg	kg	PROPN
ajird-1099	50	52	)	)	PUNCT
ajird-1099	50	53	/	/	SYM
ajird-1099	50	54	(	(	PUNCT
ajird-1099	50	55	height	height	NOUN
ajird-1099	50	56	,	,	PUNCT
ajird-1099	50	57	m)2	m)2	PROPN
ajird-1099	50	58	.	.	PUNCT
ajird-1099	51	1	the	the	DET
ajird-1099	51	2	degree	degree	NOUN
ajird-1099	51	3	of	of	ADP
ajird-1099	51	4	obesity	obesity	NOUN
ajird-1099	51	5	was	be	AUX
ajird-1099	51	6	determined	determine	VERB
ajird-1099	51	7	in	in	ADP
ajird-1099	51	8	accordance	accordance	NOUN
ajird-1099	51	9	with	with	ADP
ajird-1099	51	10	the	the	DET
ajird-1099	51	11	bmi	bmi	NOUN
ajird-1099	51	12	values	value	NOUN
ajird-1099	51	13	recommended	recommend	VERB
ajird-1099	51	14	by	by	ADP
ajird-1099	51	15	who	who	PRON
ajird-1099	51	16	(	(	PUNCT
ajird-1099	51	17	1997	1997	NUM
ajird-1099	51	18	)	)	PUNCT
ajird-1099	51	19	.	.	PUNCT
ajird-1099	52	1	the	the	DET
ajird-1099	52	2	patients	patient	NOUN
ajird-1099	52	3	were	be	AUX
ajird-1099	52	4	prescribed	prescribe	VERB
ajird-1099	52	5	non	non	ADJ
ajird-1099	52	6	-	-	ADJ
ajird-1099	52	7	drug	drug	ADJ
ajird-1099	52	8	and	and	CCONJ
ajird-1099	52	9	etiopathogenetic	etiopathogenetic	ADJ
ajird-1099	52	10	therapy	therapy	NOUN
ajird-1099	52	11	to	to	PART
ajird-1099	52	12	reduce	reduce	VERB
ajird-1099	52	13	body	body	NOUN
ajird-1099	52	14	weight	weight	NOUN
ajird-1099	52	15	.	.	PUNCT
ajird-1099	53	1	non	non	ADJ
ajird-1099	53	2	-	-	ADJ
ajird-1099	53	3	drug	drug	ADJ
ajird-1099	53	4	therapy	therapy	NOUN
ajird-1099	53	5	included	include	VERB
ajird-1099	53	6	general	general	ADJ
ajird-1099	53	7	recommendations	recommendation	NOUN
ajird-1099	53	8	for	for	ADP
ajird-1099	53	9	measuring	measure	VERB
ajird-1099	53	10	weight	weight	NOUN
ajird-1099	53	11	every	every	DET
ajird-1099	53	12	day	day	NOUN
ajird-1099	53	13	before	before	ADV
ajird-1099	53	14	and	and	CCONJ
ajird-1099	53	15	after	after	ADP
ajird-1099	53	16	exercise	exercise	NOUN
ajird-1099	53	17	therapy	therapy	NOUN
ajird-1099	53	18	,	,	PUNCT
ajird-1099	53	19	counting	count	VERB
ajird-1099	53	20	daily	daily	ADJ
ajird-1099	53	21	calories	calorie	NOUN
ajird-1099	53	22	,	,	PUNCT
ajird-1099	53	23	and	and	CCONJ
ajird-1099	53	24	avoiding	avoid	VERB
ajird-1099	53	25	easily	easily	ADV
ajird-1099	53	26	digestible	digestible	ADJ
ajird-1099	53	27	carbohydrates	carbohydrate	NOUN
ajird-1099	53	28	.	.	PUNCT
ajird-1099	54	1	etiopathogenetic	etiopathogenetic	ADJ
ajird-1099	54	2	therapy	therapy	NOUN
ajird-1099	54	3	included	include	VERB
ajird-1099	54	4	3	3	NUM
ajird-1099	54	5	treatment	treatment	NOUN
ajird-1099	54	6	regimens	regimen	NOUN
ajird-1099	54	7	in	in	ADP
ajird-1099	54	8	3	3	NUM
ajird-1099	54	9	groups	group	NOUN
ajird-1099	54	10	of	of	ADP
ajird-1099	54	11	patients	patient	NOUN
ajird-1099	54	12	for	for	ADP
ajird-1099	54	13	6	6	NUM
ajird-1099	54	14	months	month	NOUN
ajird-1099	54	15	:	:	PUNCT
ajird-1099	54	16	group	group	NOUN
ajird-1099	54	17	1	1	NUM
ajird-1099	54	18	was	be	AUX
ajird-1099	54	19	prescribed	prescribe	VERB
ajird-1099	54	20	a	a	DET
ajird-1099	54	21	combination	combination	NOUN
ajird-1099	54	22	of	of	ADP
ajird-1099	54	23	siofor	siofor	NOUN
ajird-1099	54	24	1000	1000	NUM
ajird-1099	54	25	mg	mg	NOUN
ajird-1099	54	26	per	per	ADP
ajird-1099	54	27	day	day	NOUN
ajird-1099	54	28	+	+	CCONJ
ajird-1099	54	29	iodomarine	iodomarine	VERB
ajird-1099	54	30	100	100	NUM
ajird-1099	54	31	mg	mg	NOUN
ajird-1099	54	32	in	in	ADP
ajird-1099	54	33	the	the	DET
ajird-1099	54	34	morning	morning	NOUN
ajird-1099	54	35	+	+	CCONJ
ajird-1099	54	36	levothyroxine	levothyroxine	PROPN
ajird-1099	54	37	50	50	NUM
ajird-1099	54	38	mg	mg	NOUN
ajird-1099	54	39	in	in	ADP
ajird-1099	54	40	the	the	DET
ajird-1099	54	41	morning	morning	NOUN
ajird-1099	55	1	+	+	X
ajird-1099	55	2	antiandrogens	antiandrogen	NOUN
ajird-1099	55	3	(	(	PUNCT
ajird-1099	55	4	yarina	yarina	PROPN
ajird-1099	55	5	,	,	PUNCT
ajird-1099	55	6	jess	jess	PROPN
ajird-1099	55	7	,	,	PUNCT
ajird-1099	55	8	dexamethasone	dexamethasone	NOUN
ajird-1099	55	9	,	,	PUNCT
ajird-1099	55	10	etc	etc	X
ajird-1099	55	11	.	.	X
ajird-1099	55	12	)	)	PUNCT
ajird-1099	55	13	.	.	PUNCT
ajird-1099	56	1	group	group	NOUN
ajird-1099	56	2	2	2	NUM
ajird-1099	56	3	was	be	AUX
ajird-1099	56	4	prescribed	prescribe	VERB
ajird-1099	56	5	a	a	DET
ajird-1099	56	6	combination	combination	NOUN
ajird-1099	56	7	of	of	ADP
ajird-1099	56	8	siofor	siofor	NOUN
ajird-1099	56	9	1000	1000	NUM
ajird-1099	56	10	mg	mg	NOUN
ajird-1099	56	11	per	per	ADP
ajird-1099	56	12	day	day	NOUN
ajird-1099	56	13	+	+	CCONJ
ajird-1099	56	14	veroshpiron	veroshpiron	NOUN
ajird-1099	56	15	75	75	NUM
ajird-1099	56	16	mg	mg	NOUN
ajird-1099	56	17	twice	twice	DET
ajird-1099	56	18	a	a	DET
ajird-1099	56	19	week	week	NOUN
ajird-1099	56	20	+	+	CCONJ
ajird-1099	56	21	iodomarine	iodomarine	VERB
ajird-1099	56	22	100	100	NUM
ajird-1099	56	23	mg	mg	NOUN
ajird-1099	56	24	in	in	ADP
ajird-1099	56	25	the	the	DET
ajird-1099	56	26	morning	morning	NOUN
ajird-1099	56	27	+	+	CCONJ
ajird-1099	56	28	levothyroxine	levothyroxine	PROPN
ajird-1099	56	29	50	50	NUM
ajird-1099	56	30	mg	mg	NOUN
ajird-1099	56	31	in	in	ADP
ajird-1099	56	32	the	the	DET
ajird-1099	56	33	morning	morning	NOUN
ajird-1099	56	34	+	+	CCONJ
ajird-1099	56	35	reduxin	reduxin	VERB
ajird-1099	56	36	15	15	NUM
ajird-1099	56	37	mg	mg	NOUN
ajird-1099	56	38	in	in	ADP
ajird-1099	56	39	the	the	DET
ajird-1099	56	40	morning	morning	NOUN
ajird-1099	56	41	after	after	ADP
ajird-1099	56	42	meals	meal	NOUN
ajird-1099	56	43	.	.	PUNCT
ajird-1099	57	1	american	american	ADJ
ajird-1099	57	2	journal	journal	PROPN
ajird-1099	57	3	of	of	ADP
ajird-1099	57	4	interdisciplinary	interdisciplinary	ADJ
ajird-1099	57	5	research	research	NOUN
ajird-1099	57	6	and	and	CCONJ
ajird-1099	57	7	development	development	NOUN
ajird-1099	57	8	issn	issn	PROPN
ajird-1099	57	9	online	online	NOUN
ajird-1099	57	10	:	:	PUNCT
ajird-1099	57	11	2771	2771	NUM
ajird-1099	57	12	-	-	SYM
ajird-1099	57	13	8948	8948	NUM
ajird-1099	57	14	website	website	NOUN
ajird-1099	57	15	:	:	PUNCT
ajird-1099	57	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1099	57	17	volume	volume	NOUN
ajird-1099	57	18	28	28	NUM
ajird-1099	57	19	,	,	PUNCT
ajird-1099	57	20	may	may	AUX
ajird-1099	57	21	2024	2024	NUM
ajird-1099	57	22	30	30	NUM
ajird-1099	57	23	|	|	ADV
ajird-1099	57	24	p	p	NOUN
ajird-1099	57	25	a	a	DET
ajird-1099	57	26	g	g	PROPN
ajird-1099	57	27	e	e	PROPN
ajird-1099	57	28	group	group	NOUN
ajird-1099	57	29	3	3	NUM
ajird-1099	57	30	was	be	AUX
ajird-1099	57	31	prescribed	prescribe	VERB
ajird-1099	57	32	a	a	DET
ajird-1099	57	33	combination	combination	NOUN
ajird-1099	57	34	of	of	ADP
ajird-1099	57	35	siofor	siofor	NOUN
ajird-1099	57	36	1000	1000	NUM
ajird-1099	57	37	mg	mg	NOUN
ajird-1099	57	38	per	per	ADP
ajird-1099	57	39	day	day	NOUN
ajird-1099	57	40	+	+	CCONJ
ajird-1099	57	41	veroshpiron	veroshpiron	NOUN
ajird-1099	57	42	75	75	NUM
ajird-1099	57	43	mg	mg	NOUN
ajird-1099	57	44	twice	twice	DET
ajird-1099	57	45	a	a	DET
ajird-1099	57	46	week	week	NOUN
ajird-1099	57	47	+	+	CCONJ
ajird-1099	57	48	iodomarine	iodomarine	VERB
ajird-1099	57	49	100	100	NUM
ajird-1099	57	50	mg	mg	NOUN
ajird-1099	57	51	in	in	ADP
ajird-1099	57	52	the	the	DET
ajird-1099	57	53	morning	morning	NOUN
ajird-1099	57	54	+	+	CCONJ
ajird-1099	57	55	levothyroxine	levothyroxine	PROPN
ajird-1099	57	56	50	50	NUM
ajird-1099	57	57	mg	mg	NOUN
ajird-1099	57	58	in	in	ADP
ajird-1099	57	59	the	the	DET
ajird-1099	57	60	morning	morning	NOUN
ajird-1099	57	61	+	+	CCONJ
ajird-1099	57	62	steroidogenesis	steroidogenesis	NOUN
ajird-1099	57	63	blockers	blocker	NOUN
ajird-1099	57	64	(	(	PUNCT
ajird-1099	57	65	ketoconazole	ketoconazole	NOUN
ajird-1099	57	66	200	200	NUM
ajird-1099	57	67	mg	mg	NOUN
ajird-1099	57	68	twice	twice	DET
ajird-1099	57	69	a	a	DET
ajird-1099	57	70	day	day	NOUN
ajird-1099	57	71	)	)	PUNCT
ajird-1099	58	1	+	+	CCONJ
ajird-1099	58	2	cabergoline	cabergoline	NOUN
ajird-1099	58	3	5	5	NUM
ajird-1099	58	4	mg	mg	NOUN
ajird-1099	58	5	per	per	ADP
ajird-1099	58	6	week	week	NOUN
ajird-1099	58	7	.	.	PUNCT
ajird-1099	59	1	the	the	DET
ajird-1099	59	2	second	second	ADJ
ajird-1099	59	3	stage	stage	NOUN
ajird-1099	59	4	included	include	VERB
ajird-1099	59	5	stimulation	stimulation	NOUN
ajird-1099	59	6	of	of	ADP
ajird-1099	59	7	ovulation	ovulation	NOUN
ajird-1099	59	8	,	,	PUNCT
ajird-1099	59	9	antiandrogens	antiandrogen	NOUN
ajird-1099	59	10	(	(	PUNCT
ajird-1099	59	11	dexamethasone	dexamethasone	NOUN
ajird-1099	59	12	tab	tab	NOUN
ajird-1099	59	13	.	.	PUNCT
ajird-1099	59	14	)	)	PUNCT
ajird-1099	59	15	,	,	PUNCT
ajird-1099	59	16	progestins	progestin	NOUN
ajird-1099	59	17	,	,	PUNCT
ajird-1099	59	18	etc	etc	X
ajird-1099	59	19	.	.	X
ajird-1099	60	1	in	in	ADP
ajird-1099	60	2	order	order	NOUN
ajird-1099	60	3	to	to	PART
ajird-1099	60	4	achieve	achieve	VERB
ajird-1099	60	5	fertility	fertility	NOUN
ajird-1099	60	6	.	.	PUNCT
ajird-1099	61	1	the	the	DET
ajird-1099	61	2	obtained	obtain	VERB
ajird-1099	61	3	data	datum	NOUN
ajird-1099	61	4	were	be	AUX
ajird-1099	61	5	processed	process	VERB
ajird-1099	61	6	using	use	VERB
ajird-1099	61	7	microsoft	microsoft	PROPN
ajird-1099	61	8	excel	excel	PROPN
ajird-1099	61	9	and	and	CCONJ
ajird-1099	61	10	statistica_6	statistica_6	PROPN
ajird-1099	61	11	computer	computer	NOUN
ajird-1099	61	12	programs	program	NOUN
ajird-1099	61	13	.	.	PUNCT
ajird-1099	62	1	the	the	DET
ajird-1099	62	2	significance	significance	NOUN
ajird-1099	62	3	of	of	ADP
ajird-1099	62	4	differences	difference	NOUN
ajird-1099	62	5	in	in	ADP
ajird-1099	62	6	quantitative	quantitative	ADJ
ajird-1099	62	7	indicators	indicator	NOUN
ajird-1099	62	8	(	(	PUNCT
ajird-1099	62	9	n>12	n>12	ADV
ajird-1099	62	10	)	)	PUNCT
ajird-1099	62	11	was	be	AUX
ajird-1099	62	12	determined	determine	VERB
ajird-1099	62	13	using	use	VERB
ajird-1099	62	14	the	the	DET
ajird-1099	62	15	wilcoxon	wilcoxon	ADJ
ajird-1099	62	16	method	method	NOUN
ajird-1099	62	17	for	for	ADP
ajird-1099	62	18	unrelated	unrelated	ADJ
ajird-1099	62	19	ranges	range	NOUN
ajird-1099	62	20	;	;	PUNCT
ajird-1099	62	21	to	to	PART
ajird-1099	62	22	determine	determine	VERB
ajird-1099	62	23	the	the	DET
ajird-1099	62	24	significance	significance	NOUN
ajird-1099	62	25	of	of	ADP
ajird-1099	62	26	small	small	ADJ
ajird-1099	62	27	samples	sample	NOUN
ajird-1099	62	28	(	(	PUNCT
ajird-1099	62	29	n<12	n<12	NOUN
ajird-1099	62	30	)	)	PUNCT
ajird-1099	62	31	,	,	PUNCT
ajird-1099	62	32	the	the	DET
ajird-1099	62	33	nonparametric	nonparametric	PROPN
ajird-1099	62	34	fisher	fisher	PROPN
ajird-1099	62	35	component	component	NOUN
ajird-1099	62	36	randomization	randomization	NOUN
ajird-1099	62	37	test	test	NOUN
ajird-1099	62	38	was	be	AUX
ajird-1099	62	39	used	use	VERB
ajird-1099	62	40	for	for	ADP
ajird-1099	62	41	independent	independent	ADJ
ajird-1099	62	42	samples	sample	NOUN
ajird-1099	62	43	;	;	PUNCT
ajird-1099	62	44	for	for	ADP
ajird-1099	62	45	qualitative	qualitative	ADJ
ajird-1099	62	46	values	value	NOUN
ajird-1099	62	47	,	,	PUNCT
ajird-1099	62	48	the	the	DET
ajird-1099	62	49	fisher	fisher	PROPN
ajird-1099	62	50	-	-	PUNCT
ajird-1099	62	51	irvine	irvine	PROPN
ajird-1099	62	52	exact	exact	ADJ
ajird-1099	62	53	test	test	NOUN
ajird-1099	62	54	was	be	AUX
ajird-1099	62	55	used	use	VERB
ajird-1099	62	56	.	.	PUNCT
ajird-1099	63	1	differences	difference	NOUN
ajird-1099	63	2	between	between	ADP
ajird-1099	63	3	groups	group	NOUN
ajird-1099	63	4	were	be	AUX
ajird-1099	63	5	considered	consider	VERB
ajird-1099	63	6	statistically	statistically	ADV
ajird-1099	63	7	significant	significant	ADJ
ajird-1099	63	8	at	at	ADP
ajird-1099	63	9	p	p	NOUN
ajird-1099	63	10	0.05	0.05	NUM
ajird-1099	63	11	.	.	PUNCT
ajird-1099	64	1	mean	mean	ADJ
ajird-1099	64	2	values	value	NOUN
ajird-1099	64	3	(	(	PUNCT
ajird-1099	64	4	m	m	NOUN
ajird-1099	64	5	)	)	PUNCT
ajird-1099	64	6	and	and	CCONJ
ajird-1099	64	7	standard	standard	ADJ
ajird-1099	64	8	deviations	deviation	NOUN
ajird-1099	64	9	of	of	ADP
ajird-1099	64	10	means	mean	NOUN
ajird-1099	64	11	(	(	PUNCT
ajird-1099	64	12	m	m	NOUN
ajird-1099	64	13	)	)	PUNCT
ajird-1099	64	14	were	be	AUX
ajird-1099	64	15	calculated	calculate	VERB
ajird-1099	64	16	.	.	PUNCT
ajird-1099	65	1	research	research	NOUN
ajird-1099	65	2	results	result	VERB
ajird-1099	65	3	the	the	DET
ajird-1099	65	4	patients	patient	NOUN
ajird-1099	65	5	were	be	AUX
ajird-1099	65	6	divided	divide	VERB
ajird-1099	65	7	into	into	ADP
ajird-1099	65	8	three	three	NUM
ajird-1099	65	9	groups	group	NOUN
ajird-1099	65	10	:	:	PUNCT
ajird-1099	65	11	1	1	NUM
ajird-1099	65	12	gr	gr	NOUN
ajird-1099	65	13	.	.	PUNCT
ajird-1099	66	1	–	–	PUNCT
ajird-1099	66	2	patients	patient	NOUN
ajird-1099	66	3	with	with	ADP
ajird-1099	66	4	primary	primary	ADJ
ajird-1099	66	5	pcos	pcos	NOUN
ajird-1099	66	6	–	–	PUNCT
ajird-1099	66	7	23	23	NUM
ajird-1099	66	8	cases	case	NOUN
ajird-1099	66	9	(	(	PUNCT
ajird-1099	66	10	19	19	NUM
ajird-1099	66	11	%	%	NOUN
ajird-1099	66	12	)	)	PUNCT
ajird-1099	66	13	,	,	PUNCT
ajird-1099	66	14	2	2	NUM
ajird-1099	66	15	gr	gr	NOUN
ajird-1099	66	16	.	.	PUNCT
ajird-1099	66	17	–	–	PUNCT
ajird-1099	66	18	patients	patient	NOUN
ajird-1099	66	19	with	with	ADP
ajird-1099	66	20	secondary	secondary	ADJ
ajird-1099	66	21	pcos	pcos	NOUN
ajird-1099	66	22	with	with	ADP
ajird-1099	66	23	obesity	obesity	NOUN
ajird-1099	66	24	–	–	PUNCT
ajird-1099	66	25	89	89	NUM
ajird-1099	66	26	cases	case	NOUN
ajird-1099	66	27	(	(	PUNCT
ajird-1099	66	28	74	74	NUM
ajird-1099	66	29	%	%	NOUN
ajird-1099	66	30	)	)	PUNCT
ajird-1099	66	31	,	,	PUNCT
ajird-1099	66	32	3	3	NUM
ajird-1099	66	33	gr	gr	NOUN
ajird-1099	66	34	.	.	PUNCT
ajird-1099	66	35	–	–	PUNCT
ajird-1099	66	36	patients	patient	NOUN
ajird-1099	66	37	with	with	ADP
ajird-1099	66	38	secondary	secondary	ADJ
ajird-1099	66	39	pcos	pco	NOUN
ajird-1099	66	40	and	and	CCONJ
ajird-1099	66	41	subclinical	subclinical	ADJ
ajird-1099	66	42	cushingoid	cushingoid	VERB
ajird-1099	66	43	8	8	NUM
ajird-1099	66	44	cases	case	NOUN
ajird-1099	66	45	(	(	PUNCT
ajird-1099	66	46	7	7	NUM
ajird-1099	66	47	%	%	NOUN
ajird-1099	66	48	)	)	PUNCT
ajird-1099	66	49	.	.	PUNCT
ajird-1099	67	1	table	table	NOUN
ajird-1099	67	2	1	1	NUM
ajird-1099	67	3	shows	show	VERB
ajird-1099	67	4	the	the	DET
ajird-1099	67	5	distribution	distribution	NOUN
ajird-1099	67	6	of	of	ADP
ajird-1099	67	7	patients	patient	NOUN
ajird-1099	67	8	by	by	ADP
ajird-1099	67	9	age	age	NOUN
ajird-1099	67	10	.	.	PUNCT
ajird-1099	68	1	table	table	NOUN
ajird-1099	68	2	1	1	NUM
ajird-1099	68	3	.	.	PUNCT
ajird-1099	69	1	distribution	distribution	NOUN
ajird-1099	69	2	of	of	ADP
ajird-1099	69	3	patients	patient	NOUN
ajird-1099	69	4	by	by	ADP
ajird-1099	69	5	age	age	NOUN
ajird-1099	69	6	(	(	PUNCT
ajird-1099	69	7	who	who	PRON
ajird-1099	69	8	)	)	PUNCT
ajird-1099	69	9	.	.	PUNCT
ajird-1099	70	1	age	age	NOUN
ajird-1099	70	2	,	,	PUNCT
ajird-1099	70	3	years	year	NOUN
ajird-1099	70	4	1	1	NUM
ajird-1099	70	5	group	group	NOUN
ajird-1099	70	6	2nd	2nd	PROPN
ajird-1099	70	7	group	group	NOUN
ajird-1099	70	8	3	3	NUM
ajird-1099	70	9	group	group	NOUN
ajird-1099	70	10	18	18	NUM
ajird-1099	70	11	–	–	SYM
ajird-1099	70	12	29	29	NUM
ajird-1099	70	13	21	21	NUM
ajird-1099	70	14	86	86	NUM
ajird-1099	70	15	5	5	NUM
ajird-1099	70	16	30	30	NUM
ajird-1099	70	17	-	-	SYM
ajird-1099	70	18	44	44	NUM
ajird-1099	70	19	2	2	NUM
ajird-1099	70	20	3	3	NUM
ajird-1099	70	21	3	3	NUM
ajird-1099	70	22	45	45	NUM
ajird-1099	70	23	-	-	SYM
ajird-1099	70	24	59	59	NUM
ajird-1099	70	25	60	60	NUM
ajird-1099	70	26	-	-	SYM
ajird-1099	70	27	74	74	NUM
ajird-1099	70	28	75	75	NUM
ajird-1099	70	29	and	and	CCONJ
ajird-1099	70	30	>	>	PUNCT
ajird-1099	70	31	total	total	NOUN
ajird-1099	70	32	23	23	NUM
ajird-1099	70	33	89	89	NUM
ajird-1099	70	34	8	8	NUM
ajird-1099	70	35	table	table	NOUN
ajird-1099	70	36	2	2	NUM
ajird-1099	70	37	givesaveragesbmi	givesaveragesbmi	NOUN
ajird-1099	70	38	by	by	ADP
ajird-1099	70	39	group	group	NOUN
ajird-1099	70	40	before	before	SCONJ
ajird-1099	70	41	treatment.as	treatment.as	PRON
ajird-1099	70	42	can	can	AUX
ajird-1099	70	43	be	be	AUX
ajird-1099	70	44	seen	see	VERB
ajird-1099	70	45	from	from	ADP
ajird-1099	70	46	table	table	NOUN
ajird-1099	70	47	2	2	NUM
ajird-1099	70	48	,	,	PUNCT
ajird-1099	70	49	in	in	ADP
ajird-1099	70	50	our	our	PRON
ajird-1099	70	51	study	study	NOUN
ajird-1099	70	52	,	,	PUNCT
ajird-1099	70	53	degree	degree	NOUN
ajird-1099	70	54	2	2	NUM
ajird-1099	70	55	obesity	obesity	NOUN
ajird-1099	70	56	prevailed	prevail	VERB
ajird-1099	70	57	53	53	NUM
ajird-1099	70	58	cases	case	NOUN
ajird-1099	70	59	out	out	ADP
ajird-1099	70	60	of	of	ADP
ajird-1099	70	61	120	120	NUM
ajird-1099	70	62	(	(	PUNCT
ajird-1099	70	63	44.1	44.1	NUM
ajird-1099	70	64	%	%	NOUN
ajird-1099	70	65	)	)	PUNCT
ajird-1099	70	66	table	table	NOUN
ajird-1099	70	67	2	2	NUM
ajird-1099	70	68	.	.	PUNCT
ajird-1099	71	1	averagesbmi	averagesbmi	PROPN
ajird-1099	71	2	by	by	ADP
ajird-1099	71	3	group	group	NOUN
ajird-1099	71	4	before	before	ADP
ajird-1099	71	5	treatment	treatment	NOUN
ajird-1099	71	6	.	.	PUNCT
ajird-1099	72	1	no	no	INTJ
ajird-1099	72	2	.	.	PUNCT
ajird-1099	72	3	group	group	NOUN
ajird-1099	72	4	30.0	30.0	NUM
ajird-1099	72	5	-	-	SYM
ajird-1099	72	6	34.9	34.9	NUM
ajird-1099	72	7	kg	kg	NOUN
ajird-1099	72	8	/	/	SYM
ajird-1099	72	9	m2	m2	PROPN
ajird-1099	72	10	35.0	35.0	NUM
ajird-1099	72	11	-	-	SYM
ajird-1099	72	12	39.9	39.9	NUM
ajird-1099	72	13	kg	kg	NOUN
ajird-1099	72	14	/	/	SYM
ajird-1099	72	15	m2	m2	PROPN
ajird-1099	72	16	40	40	NUM
ajird-1099	72	17	kg	kg	NOUN
ajird-1099	72	18	/	/	SYM
ajird-1099	72	19	m2	m2	PROPN
ajird-1099	72	20	1	1	NUM
ajird-1099	72	21	1	1	NUM
ajird-1099	72	22	group	group	NOUN
ajird-1099	72	23	n=	n=	ADJ
ajird-1099	72	24	9	9	NUM
ajird-1099	72	25	32	32	NUM
ajird-1099	72	26	,	,	PUNCT
ajird-1099	72	27	6±	6±	NUM
ajird-1099	72	28	3.2	3.2	NUM
ajird-1099	72	29	n=	n=	ADJ
ajird-1099	72	30	7	7	NUM
ajird-1099	72	31	37.5±	37.5±	NUM
ajird-1099	72	32	3.8	3.8	NUM
ajird-1099	72	33	n=	n=	ADJ
ajird-1099	72	34	7	7	NUM
ajird-1099	72	35	41.6±4.2	41.6±4.2	NUM
ajird-1099	72	36	2	2	NUM
ajird-1099	72	37	2nd	2nd	NOUN
ajird-1099	72	38	group	group	NOUN
ajird-1099	72	39	n=	n=	ADJ
ajird-1099	72	40	33	33	NUM
ajird-1099	72	41	33	33	NUM
ajird-1099	72	42	,	,	PUNCT
ajird-1099	72	43	4±4.2	4±4.2	PROPN
ajird-1099	72	44	n=	n=	ADJ
ajird-1099	72	45	44	44	NUM
ajird-1099	72	46	37.9±4.2	37.9±4.2	NUM
ajird-1099	72	47	n=	n=	ADJ
ajird-1099	72	48	12	12	NUM
ajird-1099	72	49	42.7±3.9	42.7±3.9	NUM
ajird-1099	72	50	3	3	NUM
ajird-1099	72	51	3	3	NUM
ajird-1099	72	52	group	group	NOUN
ajird-1099	72	53	n=	n=	ADJ
ajird-1099	72	54	2	2	NUM
ajird-1099	72	55	35	35	NUM
ajird-1099	72	56	,	,	PUNCT
ajird-1099	72	57	7±4.3	7±4.3	NOUN
ajird-1099	72	58	n=	n=	ADJ
ajird-1099	72	59	2	2	NUM
ajird-1099	72	60	38.8±3.9	38.8±3.9	NUM
ajird-1099	72	61	n=	n=	ADJ
ajird-1099	72	62	4	4	NUM
ajird-1099	72	63	42.8±	42.8±	NOUN
ajird-1099	72	64	3.5	3.5	NUM
ajird-1099	72	65	total	total	NOUN
ajird-1099	72	66	44	44	NUM
ajird-1099	72	67	(	(	PUNCT
ajird-1099	72	68	36.6	36.6	NUM
ajird-1099	72	69	%	%	NOUN
ajird-1099	72	70	)	)	PUNCT
ajird-1099	72	71	53	53	NUM
ajird-1099	72	72	(	(	PUNCT
ajird-1099	72	73	44.1	44.1	NUM
ajird-1099	72	74	%	%	NOUN
ajird-1099	72	75	)	)	PUNCT
ajird-1099	72	76	23	23	NUM
ajird-1099	72	77	(	(	PUNCT
ajird-1099	72	78	19.1	19.1	NUM
ajird-1099	72	79	%	%	NOUN
ajird-1099	72	80	)	)	PUNCT
ajird-1099	72	81	for	for	ADP
ajird-1099	72	82	a	a	DET
ajird-1099	72	83	more	more	ADJ
ajird-1099	72	84	in	in	ADP
ajird-1099	72	85	-	-	PUNCT
ajird-1099	72	86	depth	depth	NOUN
ajird-1099	72	87	analysis	analysis	NOUN
ajird-1099	72	88	,	,	PUNCT
ajird-1099	72	89	we	we	PRON
ajird-1099	72	90	performed	perform	VERB
ajird-1099	72	91	statistical	statistical	ADJ
ajird-1099	72	92	studies	study	NOUN
ajird-1099	72	93	of	of	ADP
ajird-1099	72	94	the	the	DET
ajird-1099	72	95	average	average	ADJ
ajird-1099	72	96	values	value	NOUN
ajird-1099	72	97	of	of	ADP
ajird-1099	72	98	basal	basal	ADJ
ajird-1099	72	99	levels	level	NOUN
ajird-1099	72	100	of	of	ADP
ajird-1099	72	101	blood	blood	NOUN
ajird-1099	72	102	plasma	plasma	NOUN
ajird-1099	72	103	hormones	hormone	NOUN
ajird-1099	72	104	(	(	PUNCT
ajird-1099	72	105	on	on	ADP
ajird-1099	72	106	the	the	DET
ajird-1099	72	107	14th	14th	ADJ
ajird-1099	72	108	day	day	NOUN
ajird-1099	72	109	of	of	ADP
ajird-1099	72	110	the	the	DET
ajird-1099	72	111	cycle	cycle	NOUN
ajird-1099	72	112	)	)	PUNCT
ajird-1099	72	113	,	,	PUNCT
ajird-1099	72	114	which	which	PRON
ajird-1099	72	115	is	be	AUX
ajird-1099	72	116	presented	present	VERB
ajird-1099	72	117	in	in	ADP
ajird-1099	72	118	table	table	NOUN
ajird-1099	72	119	3	3	NUM
ajird-1099	72	120	,	,	PUNCT
ajird-1099	72	121	in	in	ADP
ajird-1099	72	122	all	all	DET
ajird-1099	72	123	3	3	NUM
ajird-1099	72	124	groups	group	NOUN
ajird-1099	72	125	.	.	PUNCT
ajird-1099	73	1	american	american	ADJ
ajird-1099	73	2	journal	journal	PROPN
ajird-1099	73	3	of	of	ADP
ajird-1099	73	4	interdisciplinary	interdisciplinary	ADJ
ajird-1099	73	5	research	research	NOUN
ajird-1099	73	6	and	and	CCONJ
ajird-1099	73	7	development	development	NOUN
ajird-1099	73	8	issn	issn	PROPN
ajird-1099	73	9	online	online	NOUN
ajird-1099	73	10	:	:	PUNCT
ajird-1099	73	11	2771	2771	NUM
ajird-1099	73	12	-	-	SYM
ajird-1099	73	13	8948	8948	NUM
ajird-1099	73	14	website	website	NOUN
ajird-1099	73	15	:	:	PUNCT
ajird-1099	73	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1099	73	17	volume	volume	NOUN
ajird-1099	73	18	28	28	NUM
ajird-1099	73	19	,	,	PUNCT
ajird-1099	73	20	may	may	AUX
ajird-1099	73	21	2024	2024	NUM
ajird-1099	73	22	31	31	NUM
ajird-1099	74	1	|	|	ADV
ajird-1099	74	2	p	p	X
ajird-1099	74	3	a	a	DET
ajird-1099	74	4	g	g	NOUN
ajird-1099	74	5	e	e	NOUN
ajird-1099	74	6	as	as	SCONJ
ajird-1099	74	7	can	can	AUX
ajird-1099	74	8	be	be	AUX
ajird-1099	74	9	seen	see	VERB
ajird-1099	74	10	from	from	ADP
ajird-1099	74	11	table	table	NOUN
ajird-1099	74	12	3	3	NUM
ajird-1099	74	13	,	,	PUNCT
ajird-1099	74	14	as	as	SCONJ
ajird-1099	74	15	can	can	AUX
ajird-1099	74	16	be	be	AUX
ajird-1099	74	17	seen	see	VERB
ajird-1099	74	18	from	from	ADP
ajird-1099	74	19	table	table	NOUN
ajird-1099	74	20	2	2	NUM
ajird-1099	74	21	,	,	PUNCT
ajird-1099	74	22	in	in	ADP
ajird-1099	74	23	group	group	NOUN
ajird-1099	74	24	1	1	NUM
ajird-1099	74	25	of	of	ADP
ajird-1099	74	26	patients	patient	NOUN
ajird-1099	74	27	there	there	PRON
ajird-1099	74	28	was	be	VERB
ajird-1099	74	29	a	a	DET
ajird-1099	74	30	significant	significant	ADJ
ajird-1099	74	31	decrease	decrease	NOUN
ajird-1099	74	32	in	in	ADP
ajird-1099	74	33	both	both	CCONJ
ajird-1099	74	34	pituitary	pituitary	ADJ
ajird-1099	74	35	and	and	CCONJ
ajird-1099	74	36	ovarian	ovarian	ADJ
ajird-1099	74	37	hormones	hormone	NOUN
ajird-1099	74	38	against	against	ADP
ajird-1099	74	39	the	the	DET
ajird-1099	74	40	background	background	NOUN
ajird-1099	74	41	of	of	ADP
ajird-1099	74	42	hyperandrogenemia	hyperandrogenemia	PROPN
ajird-1099	74	43	.	.	PUNCT
ajird-1099	75	1	thus	thus	ADV
ajird-1099	75	2	,	,	PUNCT
ajird-1099	75	3	compared	compare	VERB
ajird-1099	75	4	to	to	ADP
ajird-1099	75	5	the	the	DET
ajird-1099	75	6	control	control	NOUN
ajird-1099	75	7	group	group	NOUN
ajird-1099	75	8	,	,	PUNCT
ajird-1099	75	9	on	on	ADP
ajird-1099	75	10	the	the	DET
ajird-1099	75	11	14th	14th	ADJ
ajird-1099	75	12	day	day	NOUN
ajird-1099	75	13	of	of	ADP
ajird-1099	75	14	the	the	DET
ajird-1099	75	15	cycle	cycle	NOUN
ajird-1099	75	16	,	,	PUNCT
ajird-1099	75	17	lh	lh	NOUN
ajird-1099	75	18	,	,	PUNCT
ajird-1099	75	19	fsh	fsh	NOUN
ajird-1099	75	20	,	,	PUNCT
ajird-1099	75	21	igf-1	igf-1	NOUN
ajird-1099	75	22	,	,	PUNCT
ajird-1099	75	23	as	as	ADV
ajird-1099	75	24	well	well	ADV
ajird-1099	75	25	as	as	ADP
ajird-1099	75	26	estradiol	estradiol	NOUN
ajird-1099	75	27	,	,	PUNCT
ajird-1099	75	28	progesterone	progesterone	NOUN
ajird-1099	75	29	were	be	AUX
ajird-1099	75	30	significantly	significantly	ADV
ajird-1099	75	31	reduced	reduce	VERB
ajird-1099	75	32	,	,	PUNCT
ajird-1099	75	33	while	while	SCONJ
ajird-1099	75	34	free	free	ADJ
ajird-1099	75	35	testosterone	testosterone	NOUN
ajird-1099	75	36	and	and	CCONJ
ajird-1099	75	37	dhea	dhea	PROPN
ajird-1099	75	38	were	be	AUX
ajird-1099	75	39	increased	increase	VERB
ajird-1099	75	40	compared	compare	VERB
ajird-1099	75	41	to	to	ADP
ajird-1099	75	42	control	control	VERB
ajird-1099	75	43	data	datum	NOUN
ajird-1099	75	44	.	.	PUNCT
ajird-1099	76	1	further	far	ADV
ajird-1099	76	2	,	,	PUNCT
ajird-1099	76	3	in	in	ADP
ajird-1099	76	4	the	the	DET
ajird-1099	76	5	second	second	ADJ
ajird-1099	76	6	group	group	NOUN
ajird-1099	76	7	of	of	ADP
ajird-1099	76	8	patients	patient	NOUN
ajird-1099	76	9	,	,	PUNCT
ajird-1099	76	10	a	a	DET
ajird-1099	76	11	significant	significant	ADJ
ajird-1099	76	12	decrease	decrease	NOUN
ajird-1099	76	13	in	in	ADP
ajird-1099	76	14	pituitary	pituitary	ADJ
ajird-1099	76	15	hormones	hormone	NOUN
ajird-1099	76	16	was	be	AUX
ajird-1099	76	17	also	also	ADV
ajird-1099	76	18	revealed	reveal	VERB
ajird-1099	76	19	against	against	ADP
ajird-1099	76	20	the	the	DET
ajird-1099	76	21	background	background	NOUN
ajird-1099	76	22	of	of	ADP
ajird-1099	76	23	hyperandrogenemia	hyperandrogenemia	PROPN
ajird-1099	76	24	,	,	PUNCT
ajird-1099	76	25	while	while	SCONJ
ajird-1099	76	26	ovarian	ovarian	ADJ
ajird-1099	76	27	function	function	NOUN
ajird-1099	76	28	was	be	AUX
ajird-1099	76	29	within	within	ADP
ajird-1099	76	30	normal	normal	ADJ
ajird-1099	76	31	limits	limit	NOUN
ajird-1099	76	32	.	.	PUNCT
ajird-1099	77	1	thus	thus	ADV
ajird-1099	77	2	,	,	PUNCT
ajird-1099	77	3	compared	compare	VERB
ajird-1099	77	4	to	to	ADP
ajird-1099	77	5	the	the	DET
ajird-1099	77	6	control	control	NOUN
ajird-1099	77	7	group	group	NOUN
ajird-1099	77	8	,	,	PUNCT
ajird-1099	77	9	on	on	ADP
ajird-1099	77	10	the	the	DET
ajird-1099	77	11	14th	14th	ADJ
ajird-1099	77	12	day	day	NOUN
ajird-1099	77	13	of	of	ADP
ajird-1099	77	14	the	the	DET
ajird-1099	77	15	cycle	cycle	NOUN
ajird-1099	77	16	,	,	PUNCT
ajird-1099	77	17	lh	lh	NOUN
ajird-1099	77	18	,	,	PUNCT
ajird-1099	77	19	fsh	fsh	NOUN
ajird-1099	77	20	,	,	PUNCT
ajird-1099	77	21	igf-1	igf-1	PRON
ajird-1099	77	22	were	be	AUX
ajird-1099	77	23	significantly	significantly	ADV
ajird-1099	77	24	reduced	reduce	VERB
ajird-1099	77	25	,	,	PUNCT
ajird-1099	77	26	while	while	SCONJ
ajird-1099	77	27	free	free	ADJ
ajird-1099	77	28	testosterone	testosterone	NOUN
ajird-1099	77	29	and	and	CCONJ
ajird-1099	77	30	dhea	dhea	PROPN
ajird-1099	77	31	were	be	AUX
ajird-1099	77	32	increased	increase	VERB
ajird-1099	77	33	compared	compare	VERB
ajird-1099	77	34	to	to	ADP
ajird-1099	77	35	control	control	VERB
ajird-1099	77	36	data	datum	NOUN
ajird-1099	77	37	.	.	PUNCT
ajird-1099	78	1	in	in	ADP
ajird-1099	78	2	the	the	DET
ajird-1099	78	3	third	third	ADJ
ajird-1099	78	4	group	group	NOUN
ajird-1099	78	5	of	of	ADP
ajird-1099	78	6	patients	patient	NOUN
ajird-1099	78	7	,	,	PUNCT
ajird-1099	78	8	a	a	DET
ajird-1099	78	9	significant	significant	ADJ
ajird-1099	78	10	decrease	decrease	NOUN
ajird-1099	78	11	in	in	ADP
ajird-1099	78	12	pituitary	pituitary	ADJ
ajird-1099	78	13	hormones	hormone	NOUN
ajird-1099	78	14	was	be	AUX
ajird-1099	78	15	also	also	ADV
ajird-1099	78	16	revealed	reveal	VERB
ajird-1099	78	17	against	against	ADP
ajird-1099	78	18	the	the	DET
ajird-1099	78	19	background	background	NOUN
ajird-1099	78	20	of	of	ADP
ajird-1099	78	21	hyperandrogenemia	hyperandrogenemia	PROPN
ajird-1099	78	22	,	,	PUNCT
ajird-1099	78	23	while	while	SCONJ
ajird-1099	78	24	ovarian	ovarian	ADJ
ajird-1099	78	25	function	function	NOUN
ajird-1099	78	26	was	be	AUX
ajird-1099	78	27	within	within	ADP
ajird-1099	78	28	normal	normal	ADJ
ajird-1099	78	29	limits	limit	NOUN
ajird-1099	78	30	.	.	PUNCT
ajird-1099	79	1	thus	thus	ADV
ajird-1099	79	2	,	,	PUNCT
ajird-1099	79	3	compared	compare	VERB
ajird-1099	79	4	to	to	ADP
ajird-1099	79	5	the	the	DET
ajird-1099	79	6	control	control	NOUN
ajird-1099	79	7	group	group	NOUN
ajird-1099	79	8	,	,	PUNCT
ajird-1099	79	9	on	on	ADP
ajird-1099	79	10	the	the	DET
ajird-1099	79	11	14th	14th	ADJ
ajird-1099	79	12	day	day	NOUN
ajird-1099	79	13	of	of	ADP
ajird-1099	79	14	the	the	DET
ajird-1099	79	15	cycle	cycle	NOUN
ajird-1099	79	16	,	,	PUNCT
ajird-1099	79	17	lh	lh	NOUN
ajird-1099	79	18	,	,	PUNCT
ajird-1099	79	19	fsh	fsh	NOUN
ajird-1099	79	20	,	,	PUNCT
ajird-1099	79	21	igf-1	igf-1	PRON
ajird-1099	79	22	were	be	AUX
ajird-1099	79	23	significantly	significantly	ADV
ajird-1099	79	24	reduced	reduce	VERB
ajird-1099	79	25	,	,	PUNCT
ajird-1099	79	26	while	while	SCONJ
ajird-1099	79	27	free	free	ADJ
ajird-1099	79	28	testosterone	testosterone	NOUN
ajird-1099	79	29	,	,	PUNCT
ajird-1099	79	30	dhea	dhea	PROPN
ajird-1099	79	31	,	,	PUNCT
ajird-1099	79	32	17	17	NUM
ajird-1099	79	33	ocs	oc	NOUN
ajird-1099	79	34	,	,	PUNCT
ajird-1099	79	35	insulin	insulin	NOUN
ajird-1099	79	36	,	,	PUNCT
ajird-1099	79	37	plasma	plasma	NOUN
ajird-1099	79	38	cortisol	cortisol	NOUN
ajird-1099	79	39	were	be	AUX
ajird-1099	79	40	significantly	significantly	ADV
ajird-1099	79	41	increased	increase	VERB
ajird-1099	79	42	compared	compare	VERB
ajird-1099	79	43	to	to	ADP
ajird-1099	79	44	control	control	VERB
ajird-1099	79	45	data	datum	NOUN
ajird-1099	79	46	.	.	PUNCT
ajird-1099	80	1	so	so	ADV
ajird-1099	80	2	,	,	PUNCT
ajird-1099	80	3	in	in	ADP
ajird-1099	80	4	all	all	DET
ajird-1099	80	5	groups	group	NOUN
ajird-1099	80	6	,	,	PUNCT
ajird-1099	80	7	on	on	ADP
ajird-1099	80	8	the	the	DET
ajird-1099	80	9	14th	14th	ADJ
ajird-1099	80	10	day	day	NOUN
ajird-1099	80	11	of	of	ADP
ajird-1099	80	12	the	the	DET
ajird-1099	80	13	cycle	cycle	NOUN
ajird-1099	80	14	,	,	PUNCT
ajird-1099	80	15	there	there	PRON
ajird-1099	80	16	was	be	VERB
ajird-1099	80	17	a	a	DET
ajird-1099	80	18	significant	significant	ADJ
ajird-1099	80	19	decrease	decrease	NOUN
ajird-1099	80	20	in	in	ADP
ajird-1099	80	21	the	the	DET
ajird-1099	80	22	basal	basal	ADJ
ajird-1099	80	23	values	value	NOUN
ajird-1099	80	24	of	of	ADP
ajird-1099	80	25	lh	lh	PROPN
ajird-1099	80	26	,	,	PUNCT
ajird-1099	80	27	fsh	fsh	NOUN
ajird-1099	80	28	,	,	PUNCT
ajird-1099	80	29	igf-1	igf-1	NOUN
ajird-1099	80	30	,	,	PUNCT
ajird-1099	80	31	progesterone	progesterone	NOUN
ajird-1099	80	32	,	,	PUNCT
ajird-1099	80	33	estradiol	estradiol	PROPN
ajird-1099	80	34	against	against	ADP
ajird-1099	80	35	the	the	DET
ajird-1099	80	36	background	background	NOUN
ajird-1099	80	37	of	of	ADP
ajird-1099	80	38	hyperandrogenemia	hyperandrogenemia	PROPN
ajird-1099	80	39	(	(	PUNCT
ajird-1099	80	40	increased	increase	VERB
ajird-1099	80	41	levels	level	NOUN
ajird-1099	80	42	of	of	ADP
ajird-1099	80	43	free	free	ADJ
ajird-1099	80	44	testosterone	testosterone	NOUN
ajird-1099	80	45	)	)	PUNCT
ajird-1099	80	46	.	.	PUNCT
ajird-1099	81	1	at	at	ADP
ajird-1099	81	2	the	the	DET
ajird-1099	81	3	same	same	ADJ
ajird-1099	81	4	time	time	NOUN
ajird-1099	81	5	,	,	PUNCT
ajird-1099	81	6	hyperinsulinemia	hyperinsulinemia	NOUN
ajird-1099	81	7	was	be	AUX
ajird-1099	81	8	observed	observe	VERB
ajird-1099	81	9	in	in	ADP
ajird-1099	81	10	groups	group	NOUN
ajird-1099	81	11	2	2	NUM
ajird-1099	81	12	and	and	CCONJ
ajird-1099	81	13	3	3	NUM
ajird-1099	81	14	.	.	X
ajird-1099	82	1	only	only	ADJ
ajird-1099	82	2	patients	patient	NOUN
ajird-1099	82	3	in	in	ADP
ajird-1099	82	4	group	group	NOUN
ajird-1099	82	5	3	3	NUM
ajird-1099	82	6	showed	show	VERB
ajird-1099	82	7	significantly	significantly	ADV
ajird-1099	82	8	increased	increase	VERB
ajird-1099	82	9	values	value	NOUN
ajird-1099	82	10	of	of	ADP
ajird-1099	82	11	dhea	dhea	PROPN
ajird-1099	82	12	,	,	PUNCT
ajird-1099	82	13	17	17	NUM
ajird-1099	82	14	ocs	oc	NOUN
ajird-1099	82	15	and	and	CCONJ
ajird-1099	82	16	blood	blood	NOUN
ajird-1099	82	17	cortisol	cortisol	NOUN
ajird-1099	82	18	.	.	PUNCT
ajird-1099	83	1	the	the	DET
ajird-1099	83	2	average	average	ADJ
ajird-1099	83	3	values	value	NOUN
ajird-1099	83	4	of	of	ADP
ajird-1099	83	5	prolactin	prolactin	NOUN
ajird-1099	83	6	and	and	CCONJ
ajird-1099	83	7	amh	amh	PROPN
ajird-1099	83	8	were	be	AUX
ajird-1099	83	9	normal	normal	ADJ
ajird-1099	83	10	.	.	PUNCT
ajird-1099	84	1	table	table	NOUN
ajird-1099	84	2	3	3	NUM
ajird-1099	84	3	.	.	PUNCT
ajird-1099	85	1	average	average	ADJ
ajird-1099	85	2	values	value	NOUN
ajird-1099	85	3	of	of	ADP
ajird-1099	85	4	basal	basal	ADJ
ajird-1099	85	5	levels	level	NOUN
ajird-1099	85	6	of	of	ADP
ajird-1099	85	7	blood	blood	NOUN
ajird-1099	85	8	plasma	plasma	NOUN
ajird-1099	85	9	hormones	hormone	NOUN
ajird-1099	85	10	(	(	PUNCT
ajird-1099	85	11	on	on	ADP
ajird-1099	85	12	the	the	DET
ajird-1099	85	13	14th	14th	ADJ
ajird-1099	85	14	day	day	NOUN
ajird-1099	85	15	of	of	ADP
ajird-1099	85	16	the	the	DET
ajird-1099	85	17	cycle	cycle	NOUN
ajird-1099	85	18	)	)	PUNCT
ajird-1099	85	19	in	in	ADP
ajird-1099	85	20	group	group	NOUN
ajird-1099	85	21	1	1	NUM
ajird-1099	85	22	in	in	ADP
ajird-1099	85	23	all	all	DET
ajird-1099	85	24	groups	group	NOUN
ajird-1099	85	25	hormones	hormone	NOUN
ajird-1099	85	26	1	1	NUM
ajird-1099	85	27	group	group	NOUN
ajird-1099	85	28	2nd	2nd	PROPN
ajird-1099	85	29	group	group	NOUN
ajird-1099	85	30	3group	3group	NUM
ajird-1099	85	31	control	control	NOUN
ajird-1099	85	32	norm	norm	NOUN
ajird-1099	85	33	lh	lh	PROPN
ajird-1099	85	34	6.7	6.7	NUM
ajird-1099	85	35	±	±	NUM
ajird-1099	85	36	0.4	0.4	NUM
ajird-1099	85	37	*	*	SYM
ajird-1099	85	38	7.8	7.8	NUM
ajird-1099	85	39	±	±	NUM
ajird-1099	85	40	0.3	0.3	NUM
ajird-1099	85	41	*	*	SYM
ajird-1099	85	42	7.4	7.4	NUM
ajird-1099	85	43	±	±	NUM
ajird-1099	85	44	0.2	0.2	NUM
ajird-1099	85	45	*	*	SYM
ajird-1099	85	46	29.3	29.3	NUM
ajird-1099	85	47	±	±	NUM
ajird-1099	85	48	2.1	2.1	NUM
ajird-1099	85	49	from	from	ADP
ajird-1099	85	50	15	15	NUM
ajird-1099	85	51	to	to	PART
ajird-1099	85	52	90	90	NUM
ajird-1099	85	53	miu	miu	NOUN
ajird-1099	85	54	/	/	SYM
ajird-1099	85	55	ml	ml	NOUN
ajird-1099	85	56	fsh	fsh	NOUN
ajird-1099	85	57	2.3	2.3	NUM
ajird-1099	85	58	±	±	NUM
ajird-1099	85	59	0.2	0.2	NUM
ajird-1099	85	60	*	*	SYM
ajird-1099	85	61	2.6	2.6	NUM
ajird-1099	85	62	±	±	NUM
ajird-1099	85	63	0.4	0.4	NUM
ajird-1099	85	64	*	*	PUNCT
ajird-1099	85	65	2.1	2.1	NUM
ajird-1099	85	66	±	±	NUM
ajird-1099	85	67	0.3	0.3	NUM
ajird-1099	85	68	*	*	SYM
ajird-1099	85	69	15.2	15.2	NUM
ajird-1099	85	70	±	±	NUM
ajird-1099	85	71	4.3	4.3	NUM
ajird-1099	85	72	from	from	ADP
ajird-1099	85	73	5	5	NUM
ajird-1099	85	74	to	to	PART
ajird-1099	85	75	16	16	NUM
ajird-1099	85	76	miu	miu	PROPN
ajird-1099	85	77	/	/	SYM
ajird-1099	85	78	ml	ml	NOUN
ajird-1099	85	79	prolactin	prolactin	VERB
ajird-1099	85	80	223.5	223.5	NUM
ajird-1099	85	81	±11.3	±11.3	NUM
ajird-1099	85	82	201.2	201.2	NUM
ajird-1099	85	83	±12.3	±12.3	NUM
ajird-1099	85	84	243.9	243.9	NUM
ajird-1099	85	85	±12.3	±12.3	NUM
ajird-1099	85	86	154.3	154.3	NUM
ajird-1099	85	87	±	±	NUM
ajird-1099	85	88	9.5	9.5	NUM
ajird-1099	85	89	120	120	NUM
ajird-1099	85	90	-	-	SYM
ajird-1099	85	91	900	900	NUM
ajird-1099	85	92	miu	miu	PROPN
ajird-1099	85	93	/	/	SYM
ajird-1099	85	94	l	l	NOUN
ajird-1099	85	95	free	free	ADJ
ajird-1099	85	96	testosterone	testosterone	NOUN
ajird-1099	85	97	3.3	3.3	NUM
ajird-1099	85	98	±	±	NUM
ajird-1099	85	99	0.3	0.3	NUM
ajird-1099	85	100	*	*	SYM
ajird-1099	85	101	3.4	3.4	NUM
ajird-1099	85	102	±	±	NUM
ajird-1099	85	103	0.2	0.2	NUM
ajird-1099	85	104	*	*	PUNCT
ajird-1099	85	105	4.3	4.3	NUM
ajird-1099	85	106	±	±	NUM
ajird-1099	85	107	0.6	0.6	NUM
ajird-1099	85	108	*	*	SYM
ajird-1099	85	109	0.2	0.2	NUM
ajird-1099	85	110	±	±	NUM
ajird-1099	85	111	0.05	0.05	NUM
ajird-1099	85	112	0.2	0.2	NUM
ajird-1099	85	113	-	-	SYM
ajird-1099	85	114	1.0	1.0	NUM
ajird-1099	85	115	ng	ng	PROPN
ajird-1099	85	116	/	/	SYM
ajird-1099	85	117	ml	ml	AUX
ajird-1099	85	118	progesterone	progesterone	NOUN
ajird-1099	85	119	2.3	2.3	NUM
ajird-1099	85	120	±	±	NUM
ajird-1099	85	121	0.5	0.5	NUM
ajird-1099	85	122	*	*	NOUN
ajird-1099	85	123	4.7	4.7	NUM
ajird-1099	85	124	±	±	NUM
ajird-1099	85	125	0.8	0.8	NUM
ajird-1099	85	126	*	*	NUM
ajird-1099	85	127	3.5	3.5	NUM
ajird-1099	85	128	±	±	NUM
ajird-1099	85	129	0.4	0.4	NUM
ajird-1099	85	130	*	*	PUNCT
ajird-1099	85	131	44.3±9.3	44.3±9.3	NUM
ajird-1099	85	132	11	11	NUM
ajird-1099	85	133	-	-	SYM
ajird-1099	85	134	80	80	NUM
ajird-1099	85	135	nmol	nmol	NOUN
ajird-1099	85	136	/	/	SYM
ajird-1099	85	137	l	l	NOUN
ajird-1099	85	138	estradiol	estradiol	PROPN
ajird-1099	85	139	0.18	0.18	NUM
ajird-1099	85	140	±0.04	±0.04	PROPN
ajird-1099	85	141	*	*	PROPN
ajird-1099	85	142	0.23	0.23	NUM
ajird-1099	85	143	±0.02	±0.02	PROPN
ajird-1099	85	144	*	*	PROPN
ajird-1099	85	145	0.21	0.21	NUM
ajird-1099	85	146	±0.05	±0.05	PROPN
ajird-1099	85	147	*	*	PROPN
ajird-1099	85	148	1.7±0.1	1.7±0.1	NUM
ajird-1099	85	149	0.34	0.34	NUM
ajird-1099	85	150	–	–	PUNCT
ajird-1099	85	151	1.8	1.8	NUM
ajird-1099	85	152	nmol	nmol	NOUN
ajird-1099	85	153	/	/	SYM
ajird-1099	85	154	l	l	NOUN
ajird-1099	85	155	dhea	dhea	PROPN
ajird-1099	85	156	6.7	6.7	NUM
ajird-1099	85	157	±	±	NUM
ajird-1099	85	158	0.2	0.2	NUM
ajird-1099	85	159	*	*	PUNCT
ajird-1099	85	160	6.3	6.3	NUM
ajird-1099	85	161	±	±	NUM
ajird-1099	85	162	0.6	0.6	NUM
ajird-1099	85	163	*	*	SYM
ajird-1099	85	164	8.9	8.9	NUM
ajird-1099	85	165	±	±	NUM
ajird-1099	85	166	0.4	0.4	NUM
ajird-1099	85	167	*	*	PUNCT
ajird-1099	85	168	3.1±0.4	3.1±0.4	NUM
ajird-1099	85	169	0.29	0.29	NUM
ajird-1099	85	170	-	-	SYM
ajird-1099	85	171	7.81	7.81	NUM
ajird-1099	85	172	mcg	mcg	NOUN
ajird-1099	85	173	/	/	SYM
ajird-1099	85	174	ml	ml	X
ajird-1099	85	175	for	for	ADP
ajird-1099	85	176	ages	age	NOUN
ajird-1099	85	177	18	18	NUM
ajird-1099	85	178	to	to	PART
ajird-1099	85	179	30	30	NUM
ajird-1099	85	180	years	year	NOUN
ajird-1099	85	181	17	17	NUM
ajird-1099	85	182	-	-	PUNCT
ajird-1099	85	183	ox	ox	NOUN
ajird-1099	85	184	2.6±0.1	2.6±0.1	NUM
ajird-1099	85	185	3.5±0.4	3.5±0.4	NUM
ajird-1099	85	186	8.6±0.5	8.6±0.5	NUM
ajird-1099	85	187	*	*	SYM
ajird-1099	85	188	2.9±0.6	2.9±0.6	NUM
ajird-1099	85	189	1.54	1.54	NUM
ajird-1099	85	190	–	–	PUNCT
ajird-1099	85	191	6.1	6.1	NUM
ajird-1099	85	192	mg	mg	NUM
ajird-1099	85	193	/	/	SYM
ajird-1099	85	194	day	day	NOUN
ajird-1099	85	195	amg	amg	PROPN
ajird-1099	85	196	(	(	PUNCT
ajird-1099	85	197	on	on	ADP
ajird-1099	85	198	day	day	NOUN
ajird-1099	85	199	5	5	NUM
ajird-1099	85	200	)	)	PUNCT
ajird-1099	85	201	5.3±	5.3±	PROPN
ajird-1099	85	202	0.3	0.3	NUM
ajird-1099	85	203	3.2±0.6	3.2±0.6	NUM
ajird-1099	85	204	4.8±0.5	4.8±0.5	NUM
ajird-1099	85	205	3.9±0.6	3.9±0.6	NUM
ajird-1099	85	206	from	from	ADP
ajird-1099	85	207	1.0	1.0	NUM
ajird-1099	85	208	to	to	PART
ajird-1099	85	209	10.6	10.6	NUM
ajird-1099	85	210	ng	ng	NOUN
ajird-1099	85	211	/	/	SYM
ajird-1099	85	212	ml	ml	ADP
ajird-1099	85	213	igf-1	igf-1	SYM
ajird-1099	85	214	21.4	21.4	NUM
ajird-1099	85	215	±	±	NUM
ajird-1099	85	216	3.5	3.5	NUM
ajird-1099	85	217	*	*	SYM
ajird-1099	85	218	19.2	19.2	NUM
ajird-1099	85	219	±	±	NUM
ajird-1099	85	220	2.3	2.3	NUM
ajird-1099	85	221	*	*	SYM
ajird-1099	85	222	18.3	18.3	NUM
ajird-1099	85	223	±	±	NUM
ajird-1099	85	224	2.2	2.2	NUM
ajird-1099	85	225	*	*	SYM
ajird-1099	85	226	251.4	251.4	NUM
ajird-1099	85	227	±	±	NUM
ajird-1099	85	228	13.5	13.5	NUM
ajird-1099	85	229	233	233	NUM
ajird-1099	85	230	-	-	SYM
ajird-1099	85	231	344	344	NUM
ajird-1099	85	232	nmol	nmol	NOUN
ajird-1099	85	233	/	/	SYM
ajird-1099	85	234	ml	ml	NOUN
ajird-1099	85	235	insulin	insulin	NOUN
ajird-1099	85	236	5.4	5.4	NUM
ajird-1099	85	237	±	±	NUM
ajird-1099	85	238	0.5	0.5	NUM
ajird-1099	85	239	11.4	11.4	NUM
ajird-1099	85	240	±	±	NUM
ajird-1099	85	241	1.7	1.7	NUM
ajird-1099	85	242	*	*	SYM
ajird-1099	85	243	13.5	13.5	NUM
ajird-1099	85	244	±	±	NUM
ajird-1099	85	245	2.2	2.2	NUM
ajird-1099	85	246	*	*	NUM
ajird-1099	85	247	5.9±0.8	5.9±0.8	NUM
ajird-1099	85	248	up	up	ADP
ajird-1099	85	249	to	to	PART
ajird-1099	85	250	10	10	NUM
ajird-1099	85	251	pg	pg	NOUN
ajird-1099	85	252	/	/	SYM
ajird-1099	85	253	ml	ml	X
ajird-1099	85	254	cortisol	cortisol	VERB
ajird-1099	85	255	277.5	277.5	NUM
ajird-1099	85	256	±	±	NUM
ajird-1099	85	257	22.6	22.6	NUM
ajird-1099	85	258	287.9	287.9	NUM
ajird-1099	85	259	±	±	NUM
ajird-1099	85	260	24.7	24.7	NUM
ajird-1099	85	261	797.3	797.3	NUM
ajird-1099	85	262	±	±	NUM
ajird-1099	86	1	25.9	25.9	NUM
ajird-1099	86	2	*	*	NUM
ajird-1099	86	3	294.4	294.4	NUM
ajird-1099	86	4	±	±	NUM
ajird-1099	86	5	23.8	23.8	NUM
ajird-1099	86	6	250	250	NUM
ajird-1099	86	7	-	-	SYM
ajird-1099	86	8	720	720	NUM
ajird-1099	86	9	nmol	nmol	NOUN
ajird-1099	86	10	/	/	SYM
ajird-1099	86	11	ml	ml	NOUN
ajird-1099	86	12	american	american	PROPN
ajird-1099	86	13	journal	journal	PROPN
ajird-1099	86	14	of	of	ADP
ajird-1099	86	15	interdisciplinary	interdisciplinary	ADJ
ajird-1099	86	16	research	research	NOUN
ajird-1099	86	17	and	and	CCONJ
ajird-1099	86	18	development	development	NOUN
ajird-1099	86	19	issn	issn	PROPN
ajird-1099	86	20	online	online	NOUN
ajird-1099	86	21	:	:	PUNCT
ajird-1099	86	22	2771	2771	NUM
ajird-1099	86	23	-	-	SYM
ajird-1099	86	24	8948	8948	NUM
ajird-1099	86	25	website	website	NOUN
ajird-1099	86	26	:	:	PUNCT
ajird-1099	86	27	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1099	86	28	volume	volume	NOUN
ajird-1099	86	29	28	28	NUM
ajird-1099	86	30	,	,	PUNCT
ajird-1099	86	31	may	may	AUX
ajird-1099	86	32	2024	2024	NUM
ajird-1099	86	33	32	32	NUM
ajird-1099	87	1	|	|	ADV
ajird-1099	87	2	p	p	ADP
ajird-1099	87	3	a	a	DET
ajird-1099	87	4	g	g	NOUN
ajird-1099	87	5	e	e	NOUN
ajird-1099	87	6	note	note	NOUN
ajird-1099	87	7	:	:	PUNCT
ajird-1099	87	8	*	*	PUNCT
ajird-1099	87	9	–	–	PUNCT
ajird-1099	87	10	significance	significance	NOUN
ajird-1099	87	11	of	of	ADP
ajird-1099	87	12	differences	difference	NOUN
ajird-1099	87	13	compared	compare	VERB
ajird-1099	87	14	to	to	ADP
ajird-1099	87	15	control	control	NOUN
ajird-1099	87	16	,	,	PUNCT
ajird-1099	87	17	dhea	dhea	PROPN
ajird-1099	87	18	–	–	PUNCT
ajird-1099	87	19	dehydroepiandrostenedione	dehydroepiandrostenedione	PROPN
ajird-1099	87	20	,	,	PUNCT
ajird-1099	87	21	17	17	NUM
ajird-1099	87	22	ocs	oc	NOUN
ajird-1099	87	23	–	–	PUNCT
ajird-1099	87	24	oxyprogesterone	oxyprogesterone	NOUN
ajird-1099	87	25	,	,	PUNCT
ajird-1099	87	26	amh	amh	PROPN
ajird-1099	87	27	–	–	PUNCT
ajird-1099	87	28	anti	anti	ADJ
ajird-1099	87	29	-	-	ADJ
ajird-1099	87	30	mullerian	mullerian	ADJ
ajird-1099	87	31	hormone	hormone	NOUN
ajird-1099	87	32	table	table	NOUN
ajird-1099	87	33	4	4	NUM
ajird-1099	87	34	shows	show	VERB
ajird-1099	87	35	the	the	DET
ajird-1099	87	36	characteristics	characteristic	NOUN
ajird-1099	87	37	of	of	ADP
ajird-1099	87	38	mri	mri	NOUN
ajird-1099	87	39	data	datum	NOUN
ajird-1099	87	40	of	of	ADP
ajird-1099	87	41	the	the	DET
ajird-1099	87	42	pituitary	pituitary	ADJ
ajird-1099	87	43	gland	gland	NOUN
ajird-1099	87	44	.	.	PUNCT
ajird-1099	88	1	table	table	NOUN
ajird-1099	88	2	4	4	NUM
ajird-1099	88	3	.	.	PUNCT
ajird-1099	89	1	characteristics	characteristic	NOUN
ajird-1099	89	2	of	of	ADP
ajird-1099	89	3	pituitary	pituitary	ADJ
ajird-1099	89	4	mri	mri	NOUN
ajird-1099	89	5	datapatients	datapatient	NOUN
ajird-1099	89	6	with	with	ADP
ajird-1099	89	7	pcos	pcos	PROPN
ajird-1099	89	8	mri	mri	PROPN
ajird-1099	89	9	data	data	PROPN
ajird-1099	89	10	1	1	NUM
ajird-1099	89	11	group	group	NOUN
ajird-1099	89	12	,	,	PUNCT
ajird-1099	89	13	n	n	NOUN
ajird-1099	89	14	=	=	SYM
ajird-1099	89	15	23	23	NUM
ajird-1099	89	16	2	2	NUM
ajird-1099	89	17	group	group	NOUN
ajird-1099	89	18	,	,	PUNCT
ajird-1099	89	19	n	n	PROPN
ajird-1099	89	20	=	=	SYM
ajird-1099	89	21	89	89	NUM
ajird-1099	89	22	3	3	NUM
ajird-1099	89	23	group	group	NOUN
ajird-1099	89	24	,	,	PUNCT
ajird-1099	89	25	n=8	n=8	PROPN
ajird-1099	89	26	total	total	ADJ
ajird-1099	89	27	pituitary	pituitary	NOUN
ajird-1099	89	28	adenomatosis	adenomatosis	ADV
ajird-1099	89	29	14	14	NUM
ajird-1099	89	30	(	(	PUNCT
ajird-1099	89	31	60.8	60.8	NUM
ajird-1099	89	32	%	%	NOUN
ajird-1099	89	33	)	)	PUNCT
ajird-1099	89	34	35	35	NUM
ajird-1099	89	35	(	(	PUNCT
ajird-1099	89	36	39.2	39.2	NUM
ajird-1099	89	37	%	%	NOUN
ajird-1099	89	38	)	)	PUNCT
ajird-1099	89	39	6	6	NUM
ajird-1099	89	40	(	(	PUNCT
ajird-1099	89	41	75	75	NUM
ajird-1099	89	42	%	%	NOUN
ajird-1099	89	43	)	)	PUNCT
ajird-1099	89	44	55	55	NUM
ajird-1099	89	45	(	(	PUNCT
ajird-1099	89	46	45.8	45.8	NUM
ajird-1099	89	47	%	%	NOUN
ajird-1099	89	48	)	)	PUNCT
ajird-1099	89	49	pituitary	pituitary	ADJ
ajird-1099	89	50	microadenoma	microadenoma	NOUN
ajird-1099	89	51	2	2	NUM
ajird-1099	89	52	(	(	PUNCT
ajird-1099	89	53	6.6	6.6	NUM
ajird-1099	89	54	%	%	NOUN
ajird-1099	89	55	)	)	PUNCT
ajird-1099	89	56	14	14	NUM
ajird-1099	89	57	(	(	PUNCT
ajird-1099	89	58	15.7	15.7	NUM
ajird-1099	89	59	%	%	NOUN
ajird-1099	89	60	)	)	PUNCT
ajird-1099	89	61	2	2	NUM
ajird-1099	89	62	(	(	PUNCT
ajird-1099	89	63	25	25	NUM
ajird-1099	89	64	%	%	NOUN
ajird-1099	89	65	)	)	PUNCT
ajird-1099	89	66	18	18	NUM
ajird-1099	89	67	(	(	PUNCT
ajird-1099	89	68	15	15	NUM
ajird-1099	89	69	%	%	NOUN
ajird-1099	89	70	)	)	PUNCT
ajird-1099	89	71	empty	empty	ADJ
ajird-1099	89	72	sella	sella	NOUN
ajird-1099	89	73	syndrome	syndrome	NOUN
ajird-1099	89	74	3	3	NUM
ajird-1099	89	75	(	(	PUNCT
ajird-1099	89	76	13.0	13.0	NUM
ajird-1099	89	77	%	%	NOUN
ajird-1099	89	78	)	)	PUNCT
ajird-1099	89	79	23	23	NUM
ajird-1099	89	80	(	(	PUNCT
ajird-1099	89	81	25.8	25.8	NUM
ajird-1099	89	82	%	%	NOUN
ajird-1099	89	83	)	)	PUNCT
ajird-1099	89	84	26	26	NUM
ajird-1099	89	85	(	(	PUNCT
ajird-1099	89	86	21.7	21.7	NUM
ajird-1099	89	87	%	%	NOUN
ajird-1099	89	88	)	)	PUNCT
ajird-1099	89	89	variant	variant	NOUN
ajird-1099	89	90	of	of	ADP
ajird-1099	89	91	the	the	DET
ajird-1099	89	92	norm	norm	NOUN
ajird-1099	89	93	4	4	NUM
ajird-1099	89	94	(	(	PUNCT
ajird-1099	89	95	17.0	17.0	NUM
ajird-1099	89	96	%	%	NOUN
ajird-1099	89	97	)	)	PUNCT
ajird-1099	89	98	17	17	NUM
ajird-1099	89	99	(	(	PUNCT
ajird-1099	89	100	19.1	19.1	NUM
ajird-1099	89	101	%	%	NOUN
ajird-1099	89	102	)	)	PUNCT
ajird-1099	89	103	21	21	NUM
ajird-1099	89	104	(	(	PUNCT
ajird-1099	89	105	17.5	17.5	NUM
ajird-1099	89	106	%	%	NOUN
ajird-1099	89	107	)	)	PUNCT
ajird-1099	89	108	neuroimaging	neuroimaging	NOUN
ajird-1099	89	109	of	of	ADP
ajird-1099	89	110	the	the	DET
ajird-1099	89	111	pituitary	pituitary	ADJ
ajird-1099	89	112	gland	gland	NOUN
ajird-1099	89	113	in	in	ADP
ajird-1099	89	114	patients	patient	NOUN
ajird-1099	89	115	with	with	ADP
ajird-1099	89	116	pcos	pcos	PROPN
ajird-1099	89	117	revealed	reveal	VERB
ajird-1099	89	118	in	in	ADP
ajird-1099	89	119	many	many	ADJ
ajird-1099	89	120	cases	case	NOUN
ajird-1099	89	121	hyperplasia	hyperplasia	NOUN
ajird-1099	89	122	(	(	PUNCT
ajird-1099	89	123	adenomatosis	adenomatosis	NOUN
ajird-1099	89	124	)	)	PUNCT
ajird-1099	89	125	of	of	ADP
ajird-1099	89	126	the	the	DET
ajird-1099	89	127	pituitary	pituitary	ADJ
ajird-1099	89	128	gland	gland	NOUN
ajird-1099	89	129	55	55	NUM
ajird-1099	89	130	out	out	ADP
ajird-1099	89	131	of	of	ADP
ajird-1099	89	132	120	120	NUM
ajird-1099	89	133	cases	case	NOUN
ajird-1099	89	134	(	(	PUNCT
ajird-1099	89	135	45.8	45.8	NUM
ajird-1099	89	136	%	%	NOUN
ajird-1099	89	137	)	)	PUNCT
ajird-1099	89	138	,	,	PUNCT
ajird-1099	89	139	which	which	PRON
ajird-1099	89	140	can	can	AUX
ajird-1099	89	141	be	be	AUX
ajird-1099	89	142	explained	explain	VERB
ajird-1099	89	143	by	by	ADP
ajird-1099	89	144	ovarian	ovarian	ADJ
ajird-1099	89	145	failure	failure	NOUN
ajird-1099	89	146	in	in	ADP
ajird-1099	89	147	these	these	DET
ajird-1099	89	148	patients	patient	NOUN
ajird-1099	89	149	.	.	PUNCT
ajird-1099	90	1	in	in	ADP
ajird-1099	90	2	second	second	ADJ
ajird-1099	90	3	place	place	NOUN
ajird-1099	90	4	in	in	ADP
ajird-1099	90	5	frequency	frequency	NOUN
ajird-1099	90	6	was	be	AUX
ajird-1099	90	7	spts	spt	NOUN
ajird-1099	90	8	(	(	PUNCT
ajird-1099	90	9	empty	empty	ADJ
ajird-1099	90	10	sella	sella	NOUN
ajird-1099	90	11	syndrome	syndrome	NOUN
ajird-1099	90	12	)	)	PUNCT
ajird-1099	90	13	26	26	NUM
ajird-1099	90	14	cases	case	NOUN
ajird-1099	90	15	(	(	PUNCT
ajird-1099	90	16	21.7	21.7	NUM
ajird-1099	90	17	%	%	NOUN
ajird-1099	90	18	)	)	PUNCT
ajird-1099	90	19	,	,	PUNCT
ajird-1099	90	20	and	and	CCONJ
ajird-1099	90	21	in	in	ADP
ajird-1099	90	22	third	third	ADJ
ajird-1099	90	23	place	place	NOUN
ajird-1099	90	24	was	be	AUX
ajird-1099	90	25	pituitary	pituitary	ADJ
ajird-1099	90	26	microadenoma	microadenoma	NOUN
ajird-1099	90	27	18	18	NUM
ajird-1099	90	28	cases	case	NOUN
ajird-1099	90	29	(	(	PUNCT
ajird-1099	90	30	15	15	NUM
ajird-1099	90	31	%	%	NOUN
ajird-1099	90	32	)	)	PUNCT
ajird-1099	90	33	.	.	PUNCT
ajird-1099	91	1	next	next	ADV
ajird-1099	91	2	,	,	PUNCT
ajird-1099	91	3	we	we	PRON
ajird-1099	91	4	studied	study	VERB
ajird-1099	91	5	the	the	DET
ajird-1099	91	6	clinical	clinical	ADJ
ajird-1099	91	7	characteristics	characteristic	NOUN
ajird-1099	91	8	in	in	ADP
ajird-1099	91	9	3	3	NUM
ajird-1099	91	10	groups	group	NOUN
ajird-1099	91	11	(	(	PUNCT
ajird-1099	91	12	table	table	NOUN
ajird-1099	91	13	5	5	NUM
ajird-1099	91	14	)	)	PUNCT
ajird-1099	91	15	.	.	PUNCT
ajird-1099	92	1	table	table	NOUN
ajird-1099	92	2	5	5	NUM
ajird-1099	92	3	features	feature	NOUN
ajird-1099	92	4	of	of	ADP
ajird-1099	92	5	clinical	clinical	ADJ
ajird-1099	92	6	characteristics	characteristic	NOUN
ajird-1099	92	7	in	in	ADP
ajird-1099	92	8	3	3	NUM
ajird-1099	92	9	groups	group	NOUN
ajird-1099	92	10	.	.	PUNCT
ajird-1099	93	1	peculiarities	peculiarity	NOUN
ajird-1099	93	2	1	1	NUM
ajird-1099	93	3	group	group	NOUN
ajird-1099	93	4	,	,	PUNCT
ajird-1099	93	5	n	n	NOUN
ajird-1099	93	6	=	=	SYM
ajird-1099	93	7	23	23	NUM
ajird-1099	93	8	2	2	NUM
ajird-1099	93	9	group	group	NOUN
ajird-1099	93	10	,	,	PUNCT
ajird-1099	93	11	n	n	PROPN
ajird-1099	93	12	=	=	SYM
ajird-1099	93	13	89	89	NUM
ajird-1099	93	14	3	3	NUM
ajird-1099	93	15	group	group	NOUN
ajird-1099	93	16	,	,	PUNCT
ajird-1099	93	17	n=8	n=8	PROPN
ajird-1099	93	18	total	total	ADJ
ajird-1099	93	19	obesity	obesity	NOUN
ajird-1099	93	20	89	89	NUM
ajird-1099	93	21	(	(	PUNCT
ajird-1099	93	22	100	100	NUM
ajird-1099	93	23	%	%	NOUN
ajird-1099	93	24	)	)	PUNCT
ajird-1099	93	25	8	8	NUM
ajird-1099	93	26	(	(	PUNCT
ajird-1099	93	27	100	100	NUM
ajird-1099	93	28	%	%	NOUN
ajird-1099	93	29	)	)	PUNCT
ajird-1099	93	30	97	97	NUM
ajird-1099	93	31	(	(	PUNCT
ajird-1099	93	32	80.8	80.8	NUM
ajird-1099	93	33	%	%	NOUN
ajird-1099	93	34	)	)	PUNCT
ajird-1099	93	35	hirsutism	hirsutism	NOUN
ajird-1099	93	36	20	20	NUM
ajird-1099	93	37	(	(	PUNCT
ajird-1099	93	38	86.9	86.9	NUM
ajird-1099	93	39	%	%	NOUN
ajird-1099	93	40	)	)	PUNCT
ajird-1099	93	41	34	34	NUM
ajird-1099	93	42	(	(	PUNCT
ajird-1099	93	43	38.2	38.2	NUM
ajird-1099	93	44	%	%	NOUN
ajird-1099	93	45	)	)	PUNCT
ajird-1099	93	46	8	8	NUM
ajird-1099	93	47	(	(	PUNCT
ajird-1099	93	48	100	100	NUM
ajird-1099	93	49	%	%	NOUN
ajird-1099	93	50	)	)	PUNCT
ajird-1099	93	51	62	62	NUM
ajird-1099	93	52	(	(	PUNCT
ajird-1099	93	53	69.6	69.6	NUM
ajird-1099	93	54	%	%	NOUN
ajird-1099	93	55	)	)	PUNCT
ajird-1099	93	56	acne	acne	NOUN
ajird-1099	93	57	19	19	NUM
ajird-1099	93	58	(	(	PUNCT
ajird-1099	93	59	82.3	82.3	NUM
ajird-1099	93	60	%	%	NOUN
ajird-1099	93	61	)	)	PUNCT
ajird-1099	93	62	47	47	NUM
ajird-1099	93	63	(	(	PUNCT
ajird-1099	93	64	52.8	52.8	NUM
ajird-1099	93	65	%	%	NOUN
ajird-1099	93	66	)	)	PUNCT
ajird-1099	93	67	8	8	NUM
ajird-1099	93	68	(	(	PUNCT
ajird-1099	93	69	100	100	NUM
ajird-1099	93	70	%	%	NOUN
ajird-1099	93	71	)	)	PUNCT
ajird-1099	93	72	74	74	NUM
ajird-1099	93	73	(	(	PUNCT
ajird-1099	93	74	83.1	83.1	NUM
ajird-1099	93	75	%	%	NOUN
ajird-1099	93	76	)	)	PUNCT
ajird-1099	93	77	acanthosis	acanthosis	NOUN
ajird-1099	93	78	9	9	NUM
ajird-1099	93	79	(	(	PUNCT
ajird-1099	93	80	39.1	39.1	NUM
ajird-1099	93	81	%	%	NOUN
ajird-1099	93	82	)	)	PUNCT
ajird-1099	93	83	58	58	NUM
ajird-1099	93	84	(	(	PUNCT
ajird-1099	93	85	42.6	42.6	NUM
ajird-1099	93	86	%	%	NOUN
ajird-1099	93	87	)	)	PUNCT
ajird-1099	93	88	8	8	NUM
ajird-1099	93	89	(	(	PUNCT
ajird-1099	93	90	100	100	NUM
ajird-1099	93	91	%	%	NOUN
ajird-1099	93	92	)	)	PUNCT
ajird-1099	93	93	73	73	NUM
ajird-1099	93	94	(	(	PUNCT
ajird-1099	93	95	60.8	60.8	NUM
ajird-1099	93	96	%	%	NOUN
ajird-1099	93	97	)	)	PUNCT
ajird-1099	93	98	striae	striae	NOUN
ajird-1099	93	99	8	8	NUM
ajird-1099	93	100	(	(	PUNCT
ajird-1099	93	101	100	100	NUM
ajird-1099	93	102	%	%	NOUN
ajird-1099	93	103	)	)	PUNCT
ajird-1099	93	104	8	8	NUM
ajird-1099	93	105	(	(	PUNCT
ajird-1099	93	106	6.6	6.6	NUM
ajird-1099	93	107	%	%	NOUN
ajird-1099	93	108	)	)	PUNCT
ajird-1099	93	109	amenorrhea	amenorrhea	ADJ
ajird-1099	93	110	secondary	secondary	ADJ
ajird-1099	93	111	8	8	NUM
ajird-1099	93	112	(	(	PUNCT
ajird-1099	93	113	34.7	34.7	NUM
ajird-1099	93	114	%	%	NOUN
ajird-1099	93	115	)	)	PUNCT
ajird-1099	93	116	32	32	NUM
ajird-1099	93	117	(	(	PUNCT
ajird-1099	93	118	35.9	35.9	NUM
ajird-1099	93	119	%	%	NOUN
ajird-1099	93	120	)	)	PUNCT
ajird-1099	93	121	8	8	NUM
ajird-1099	93	122	(	(	PUNCT
ajird-1099	93	123	100	100	NUM
ajird-1099	93	124	%	%	NOUN
ajird-1099	93	125	)	)	PUNCT
ajird-1099	93	126	48	48	NUM
ajird-1099	93	127	(	(	PUNCT
ajird-1099	93	128	53.9	53.9	NUM
ajird-1099	93	129	%	%	NOUN
ajird-1099	93	130	)	)	PUNCT
ajird-1099	93	131	primary	primary	ADJ
ajird-1099	93	132	amenorrhea	amenorrhea	NOUN
ajird-1099	93	133	3	3	NUM
ajird-1099	93	134	(	(	PUNCT
ajird-1099	93	135	13.0	13.0	NUM
ajird-1099	93	136	%	%	NOUN
ajird-1099	93	137	)	)	PUNCT
ajird-1099	93	138	5	5	NUM
ajird-1099	93	139	(	(	PUNCT
ajird-1099	93	140	5.6	5.6	NUM
ajird-1099	93	141	%	%	NOUN
ajird-1099	93	142	)	)	PUNCT
ajird-1099	93	143	6	6	NUM
ajird-1099	93	144	(	(	PUNCT
ajird-1099	93	145	6.7	6.7	NUM
ajird-1099	93	146	%	%	NOUN
ajird-1099	93	147	)	)	PUNCT
ajird-1099	93	148	infertility	infertility	NOUN
ajird-1099	93	149	primary	primary	NOUN
ajird-1099	93	150	17	17	NUM
ajird-1099	93	151	(	(	PUNCT
ajird-1099	93	152	73.9	73.9	NUM
ajird-1099	93	153	%	%	NOUN
ajird-1099	93	154	)	)	PUNCT
ajird-1099	93	155	74	74	NUM
ajird-1099	93	156	(	(	PUNCT
ajird-1099	93	157	83.1	83.1	NUM
ajird-1099	93	158	%	%	NOUN
ajird-1099	93	159	)	)	PUNCT
ajird-1099	93	160	8	8	NUM
ajird-1099	93	161	(	(	PUNCT
ajird-1099	93	162	100	100	NUM
ajird-1099	93	163	%	%	NOUN
ajird-1099	93	164	)	)	PUNCT
ajird-1099	93	165	99	99	NUM
ajird-1099	93	166	(	(	PUNCT
ajird-1099	93	167	82.5	82.5	NUM
ajird-1099	93	168	%	%	NOUN
ajird-1099	93	169	)	)	PUNCT
ajird-1099	93	170	infertility	infertility	NOUN
ajird-1099	93	171	secondary	secondary	ADJ
ajird-1099	93	172	5	5	NUM
ajird-1099	93	173	(	(	PUNCT
ajird-1099	93	174	21.7	21.7	NUM
ajird-1099	93	175	%	%	NOUN
ajird-1099	93	176	)	)	PUNCT
ajird-1099	93	177	15	15	NUM
ajird-1099	93	178	(	(	PUNCT
ajird-1099	93	179	16.8	16.8	NUM
ajird-1099	93	180	%	%	NOUN
ajird-1099	93	181	)	)	PUNCT
ajird-1099	93	182	20	20	NUM
ajird-1099	93	183	(	(	PUNCT
ajird-1099	93	184	16.6	16.6	NUM
ajird-1099	93	185	%	%	NOUN
ajird-1099	93	186	)	)	PUNCT
ajird-1099	93	187	hyperpolymenorrhea	hyperpolymenorrhea	NOUN
ajird-1099	93	188	14	14	NUM
ajird-1099	93	189	(	(	PUNCT
ajird-1099	93	190	60.8	60.8	NUM
ajird-1099	93	191	%	%	NOUN
ajird-1099	93	192	)	)	PUNCT
ajird-1099	93	193	22	22	NUM
ajird-1099	93	194	(	(	PUNCT
ajird-1099	93	195	24.7	24.7	NUM
ajird-1099	93	196	%	%	NOUN
ajird-1099	93	197	)	)	PUNCT
ajird-1099	93	198	36	36	NUM
ajird-1099	93	199	(	(	PUNCT
ajird-1099	93	200	30	30	NUM
ajird-1099	93	201	%	%	NOUN
ajird-1099	93	202	)	)	PUNCT
ajird-1099	93	203	opsomenorrhea	opsomenorrhea	NOUN
ajird-1099	93	204	7	7	NUM
ajird-1099	93	205	(	(	PUNCT
ajird-1099	93	206	30.4	30.4	NUM
ajird-1099	93	207	%	%	NOUN
ajird-1099	93	208	)	)	PUNCT
ajird-1099	93	209	16	16	NUM
ajird-1099	93	210	(	(	PUNCT
ajird-1099	93	211	17.9	17.9	NUM
ajird-1099	93	212	%	%	NOUN
ajird-1099	93	213	)	)	PUNCT
ajird-1099	93	214	23	23	NUM
ajird-1099	93	215	(	(	PUNCT
ajird-1099	93	216	19.2	19.2	NUM
ajird-1099	93	217	%	%	NOUN
ajird-1099	93	218	)	)	PUNCT
ajird-1099	93	219	oligomenorrhea	oligomenorrhea	NOUN
ajird-1099	93	220	5	5	NUM
ajird-1099	93	221	(	(	PUNCT
ajird-1099	93	222	21.7	21.7	NUM
ajird-1099	93	223	%	%	NOUN
ajird-1099	93	224	)	)	PUNCT
ajird-1099	93	225	15	15	NUM
ajird-1099	93	226	(	(	PUNCT
ajird-1099	93	227	16.8	16.8	NUM
ajird-1099	93	228	%	%	NOUN
ajird-1099	93	229	)	)	PUNCT
ajird-1099	93	230	20	20	NUM
ajird-1099	93	231	(	(	PUNCT
ajird-1099	93	232	16.6	16.6	NUM
ajird-1099	93	233	%	%	NOUN
ajird-1099	93	234	)	)	PUNCT
ajird-1099	93	235	hyperandrogenemia	hyperandrogenemia	PROPN
ajird-1099	93	236	21	21	NUM
ajird-1099	93	237	(	(	PUNCT
ajird-1099	93	238	91.3	91.3	NUM
ajird-1099	93	239	%	%	NOUN
ajird-1099	93	240	)	)	PUNCT
ajird-1099	93	241	87	87	NUM
ajird-1099	93	242	(	(	PUNCT
ajird-1099	93	243	97.7	97.7	NUM
ajird-1099	93	244	%	%	NOUN
ajird-1099	93	245	)	)	PUNCT
ajird-1099	93	246	108	108	NUM
ajird-1099	93	247	(	(	PUNCT
ajird-1099	93	248	90	90	NUM
ajird-1099	93	249	%	%	NOUN
ajird-1099	93	250	)	)	PUNCT
ajird-1099	93	251	anovulation	anovulation	NOUN
ajird-1099	93	252	19	19	NUM
ajird-1099	93	253	(	(	PUNCT
ajird-1099	93	254	82.3	82.3	NUM
ajird-1099	93	255	%	%	NOUN
ajird-1099	93	256	)	)	PUNCT
ajird-1099	93	257	78	78	NUM
ajird-1099	93	258	(	(	PUNCT
ajird-1099	93	259	87.6	87.6	NUM
ajird-1099	93	260	%	%	NOUN
ajird-1099	93	261	)	)	PUNCT
ajird-1099	93	262	8	8	NUM
ajird-1099	93	263	(	(	PUNCT
ajird-1099	93	264	100	100	NUM
ajird-1099	93	265	%	%	NOUN
ajird-1099	93	266	)	)	PUNCT
ajird-1099	93	267	103	103	NUM
ajird-1099	93	268	(	(	PUNCT
ajird-1099	93	269	85.8	85.8	NUM
ajird-1099	93	270	%	%	NOUN
ajird-1099	93	271	)	)	PUNCT
ajird-1099	93	272	hypoovulatory	hypoovulatory	NOUN
ajird-1099	93	273	syndrome	syndrome	NOUN
ajird-1099	93	274	3	3	NUM
ajird-1099	93	275	(	(	PUNCT
ajird-1099	93	276	13.0	13.0	NUM
ajird-1099	93	277	%	%	NOUN
ajird-1099	93	278	)	)	PUNCT
ajird-1099	93	279	11	11	NUM
ajird-1099	93	280	(	(	PUNCT
ajird-1099	93	281	12.3	12.3	NUM
ajird-1099	93	282	%	%	NOUN
ajird-1099	93	283	)	)	PUNCT
ajird-1099	93	284	14	14	NUM
ajird-1099	93	285	(	(	PUNCT
ajird-1099	93	286	11.6	11.6	NUM
ajird-1099	93	287	%	%	NOUN
ajird-1099	93	288	)	)	PUNCT
ajird-1099	93	289	arterial	arterial	ADJ
ajird-1099	93	290	hypertension	hypertension	NOUN
ajird-1099	93	291	5	5	NUM
ajird-1099	93	292	(	(	PUNCT
ajird-1099	93	293	5.6	5.6	NUM
ajird-1099	93	294	%	%	NOUN
ajird-1099	93	295	)	)	PUNCT
ajird-1099	93	296	6	6	NUM
ajird-1099	93	297	(	(	PUNCT
ajird-1099	93	298	75	75	NUM
ajird-1099	93	299	%	%	NOUN
ajird-1099	93	300	)	)	PUNCT
ajird-1099	93	301	11	11	NUM
ajird-1099	93	302	(	(	PUNCT
ajird-1099	93	303	9.1	9.1	NUM
ajird-1099	93	304	%	%	NOUN
ajird-1099	93	305	)	)	PUNCT
ajird-1099	93	306	american	american	ADJ
ajird-1099	93	307	journal	journal	PROPN
ajird-1099	93	308	of	of	ADP
ajird-1099	93	309	interdisciplinary	interdisciplinary	ADJ
ajird-1099	93	310	research	research	NOUN
ajird-1099	93	311	and	and	CCONJ
ajird-1099	93	312	development	development	NOUN
ajird-1099	93	313	issn	issn	PROPN
ajird-1099	93	314	online	online	NOUN
ajird-1099	93	315	:	:	PUNCT
ajird-1099	93	316	2771	2771	NUM
ajird-1099	93	317	-	-	SYM
ajird-1099	93	318	8948	8948	NUM
ajird-1099	93	319	website	website	NOUN
ajird-1099	93	320	:	:	PUNCT
ajird-1099	93	321	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1099	93	322	volume	volume	NOUN
ajird-1099	93	323	28	28	NUM
ajird-1099	93	324	,	,	PUNCT
ajird-1099	93	325	may	may	AUX
ajird-1099	93	326	2024	2024	NUM
ajird-1099	93	327	33	33	NUM
ajird-1099	93	328	|	|	ADV
ajird-1099	93	329	p	p	NOUN
ajird-1099	93	330	a	a	DET
ajird-1099	93	331	g	g	NOUN
ajird-1099	93	332	e	e	NOUN
ajird-1099	93	333	as	as	SCONJ
ajird-1099	93	334	can	can	AUX
ajird-1099	93	335	be	be	AUX
ajird-1099	93	336	seen	see	VERB
ajird-1099	93	337	from	from	ADP
ajird-1099	93	338	table	table	NOUN
ajird-1099	93	339	5	5	NUM
ajird-1099	93	340	,	,	PUNCT
ajird-1099	93	341	the	the	DET
ajird-1099	93	342	most	most	ADV
ajird-1099	93	343	pronounced	pronounced	ADJ
ajird-1099	93	344	neuroendocrine	neuroendocrine	ADJ
ajird-1099	93	345	disorders	disorder	NOUN
ajird-1099	93	346	occurred	occur	VERB
ajird-1099	93	347	in	in	ADP
ajird-1099	93	348	group	group	NOUN
ajird-1099	93	349	3	3	NUM
ajird-1099	93	350	of	of	ADP
ajird-1099	93	351	patients	patient	NOUN
ajird-1099	93	352	obesity	obesity	NOUN
ajird-1099	93	353	,	,	PUNCT
ajird-1099	93	354	hirsutism	hirsutism	NOUN
ajird-1099	93	355	,	,	PUNCT
ajird-1099	93	356	acne	acne	NOUN
ajird-1099	93	357	,	,	PUNCT
ajird-1099	93	358	acanthosis	acanthosis	NOUN
ajird-1099	93	359	,	,	PUNCT
ajird-1099	93	360	secondary	secondary	ADJ
ajird-1099	93	361	amenorrhea	amenorrhea	NOUN
ajird-1099	93	362	,	,	PUNCT
ajird-1099	93	363	primary	primary	ADJ
ajird-1099	93	364	infertility	infertility	NOUN
ajird-1099	93	365	,	,	PUNCT
ajird-1099	93	366	stretch	stretch	NOUN
ajird-1099	93	367	marks	mark	NOUN
ajird-1099	93	368	,	,	PUNCT
ajird-1099	93	369	arterial	arterial	ADJ
ajird-1099	93	370	hypertension	hypertension	NOUN
ajird-1099	93	371	,	,	PUNCT
ajird-1099	93	372	anovulation	anovulation	NOUN
ajird-1099	93	373	in	in	ADP
ajird-1099	93	374	100	100	NUM
ajird-1099	93	375	%	%	NOUN
ajird-1099	93	376	of	of	ADP
ajird-1099	93	377	cases	case	NOUN
ajird-1099	93	378	.	.	PUNCT
ajird-1099	94	1	in	in	ADP
ajird-1099	94	2	groups	group	NOUN
ajird-1099	94	3	1	1	NUM
ajird-1099	94	4	and	and	CCONJ
ajird-1099	94	5	2	2	NUM
ajird-1099	94	6	the	the	DET
ajird-1099	94	7	above	above	ADJ
ajird-1099	94	8	complaints	complaint	NOUN
ajird-1099	94	9	were	be	AUX
ajird-1099	94	10	also	also	ADV
ajird-1099	94	11	encountered	encounter	VERB
ajird-1099	94	12	,	,	PUNCT
ajird-1099	94	13	but	but	CCONJ
ajird-1099	94	14	less	less	ADV
ajird-1099	94	15	frequently	frequently	ADV
ajird-1099	94	16	and	and	CCONJ
ajird-1099	94	17	in	in	ADP
ajird-1099	94	18	an	an	DET
ajird-1099	94	19	erased	erase	VERB
ajird-1099	94	20	form	form	NOUN
ajird-1099	94	21	.	.	PUNCT
ajird-1099	95	1	the	the	DET
ajird-1099	95	2	discussion	discussion	NOUN
ajird-1099	95	3	of	of	ADP
ajird-1099	95	4	the	the	DET
ajird-1099	95	5	results	result	NOUN
ajird-1099	95	6	so	so	ADV
ajird-1099	95	7	,	,	PUNCT
ajird-1099	95	8	in	in	ADP
ajird-1099	95	9	women	woman	NOUN
ajird-1099	95	10	suffering	suffer	VERB
ajird-1099	95	11	from	from	ADP
ajird-1099	95	12	pcos	pco	NOUN
ajird-1099	95	13	of	of	ADP
ajird-1099	95	14	primary	primary	ADJ
ajird-1099	95	15	,	,	PUNCT
ajird-1099	95	16	secondary	secondary	ADJ
ajird-1099	95	17	origin	origin	NOUN
ajird-1099	95	18	and	and	CCONJ
ajird-1099	95	19	pcos	pcos	PROPN
ajird-1099	95	20	with	with	ADP
ajird-1099	95	21	ks	ks	NOUN
ajird-1099	95	22	,	,	PUNCT
ajird-1099	95	23	serious	serious	ADJ
ajird-1099	95	24	reproductive	reproductive	ADJ
ajird-1099	95	25	abnormalities	abnormality	NOUN
ajird-1099	95	26	from	from	ADP
ajird-1099	95	27	dysmenorrhea	dysmenorrhea	PROPN
ajird-1099	95	28	up	up	ADP
ajird-1099	95	29	to	to	ADP
ajird-1099	95	30	infertility	infertility	NOUN
ajird-1099	95	31	were	be	AUX
ajird-1099	95	32	detected	detect	VERB
ajird-1099	95	33	;	;	PUNCT
ajird-1099	95	34	disturbances	disturbance	NOUN
ajird-1099	95	35	in	in	ADP
ajird-1099	95	36	the	the	DET
ajird-1099	95	37	gonadotropic	gonadotropic	ADJ
ajird-1099	95	38	function	function	NOUN
ajird-1099	95	39	of	of	ADP
ajird-1099	95	40	the	the	DET
ajird-1099	95	41	pituitary	pituitary	ADJ
ajird-1099	95	42	gland	gland	NOUN
ajird-1099	95	43	were	be	AUX
ajird-1099	95	44	identified	identify	VERB
ajird-1099	95	45	in	in	ADP
ajird-1099	95	46	the	the	DET
ajird-1099	95	47	form	form	NOUN
ajird-1099	95	48	of	of	ADP
ajird-1099	95	49	insufficient	insufficient	ADJ
ajird-1099	95	50	secretion	secretion	NOUN
ajird-1099	95	51	of	of	ADP
ajird-1099	95	52	lh	lh	PROPN
ajird-1099	95	53	and	and	CCONJ
ajird-1099	95	54	fsh	fsh	NOUN
ajird-1099	95	55	in	in	ADP
ajird-1099	95	56	the	the	DET
ajird-1099	95	57	middle	middle	NOUN
ajird-1099	95	58	of	of	ADP
ajird-1099	95	59	the	the	DET
ajird-1099	95	60	cycle	cycle	NOUN
ajird-1099	95	61	.	.	PUNCT
ajird-1099	96	1	almost	almost	ADV
ajird-1099	96	2	50	50	NUM
ajird-1099	96	3	%	%	NOUN
ajird-1099	96	4	of	of	ADP
ajird-1099	96	5	patients	patient	NOUN
ajird-1099	96	6	from	from	ADP
ajird-1099	96	7	group	group	NOUN
ajird-1099	96	8	3	3	NUM
ajird-1099	96	9	had	have	VERB
ajird-1099	96	10	a	a	DET
ajird-1099	96	11	bmi	bmi	NOUN
ajird-1099	96	12	above	above	ADP
ajird-1099	96	13	40	40	NUM
ajird-1099	96	14	kg	kg	NOUN
ajird-1099	96	15	/	/	SYM
ajird-1099	96	16	m2	m2	PROPN
ajird-1099	96	17	.	.	PUNCT
ajird-1099	97	1	thus	thus	ADV
ajird-1099	97	2	,	,	PUNCT
ajird-1099	97	3	the	the	DET
ajird-1099	97	4	most	most	ADV
ajird-1099	97	5	pronounced	pronounced	ADJ
ajird-1099	97	6	disorders	disorder	NOUN
ajird-1099	97	7	of	of	ADP
ajird-1099	97	8	the	the	DET
ajird-1099	97	9	pituitary	pituitary	ADJ
ajird-1099	97	10	-	-	PUNCT
ajird-1099	97	11	ovarian	ovarian	ADJ
ajird-1099	97	12	function	function	NOUN
ajird-1099	97	13	system	system	NOUN
ajird-1099	97	14	were	be	AUX
ajird-1099	97	15	found	find	VERB
ajird-1099	97	16	in	in	ADP
ajird-1099	97	17	the	the	DET
ajird-1099	97	18	third	third	ADJ
ajird-1099	97	19	group	group	NOUN
ajird-1099	97	20	of	of	ADP
ajird-1099	97	21	patients	patient	NOUN
ajird-1099	97	22	with	with	ADP
ajird-1099	97	23	pcos	pcos	PROPN
ajird-1099	97	24	with	with	ADP
ajird-1099	97	25	subclinical	subclinical	ADJ
ajird-1099	97	26	cushingoid	cushingoid	NOUN
ajird-1099	97	27	,	,	PUNCT
ajird-1099	97	28	who	who	PRON
ajird-1099	97	29	had	have	VERB
ajird-1099	97	30	a	a	DET
ajird-1099	97	31	significant	significant	ADJ
ajird-1099	97	32	decrease	decrease	NOUN
ajird-1099	97	33	in	in	ADP
ajird-1099	97	34	the	the	DET
ajird-1099	97	35	functional	functional	ADJ
ajird-1099	97	36	state	state	NOUN
ajird-1099	97	37	of	of	ADP
ajird-1099	97	38	the	the	DET
ajird-1099	97	39	pituitary	pituitary	ADJ
ajird-1099	97	40	-	-	PUNCT
ajird-1099	97	41	gonad	gonad	NOUN
ajird-1099	97	42	,	,	PUNCT
ajird-1099	97	43	namely	namely	ADV
ajird-1099	97	44	a	a	DET
ajird-1099	97	45	decrease	decrease	NOUN
ajird-1099	97	46	in	in	ADP
ajird-1099	97	47	lh	lh	PROPN
ajird-1099	97	48	,	,	PUNCT
ajird-1099	97	49	fsh	fsh	PROPN
ajird-1099	97	50	,	,	PUNCT
ajird-1099	97	51	estradiol	estradiol	PROPN
ajird-1099	97	52	and	and	CCONJ
ajird-1099	97	53	progesterone	progesterone	NOUN
ajird-1099	97	54	in	in	ADP
ajird-1099	97	55	the	the	DET
ajird-1099	97	56	blood	blood	NOUN
ajird-1099	97	57	plasma	plasma	NOUN
ajird-1099	97	58	on	on	ADP
ajird-1099	97	59	the	the	DET
ajird-1099	97	60	14th	14th	ADJ
ajird-1099	97	61	day	day	NOUN
ajird-1099	97	62	of	of	ADP
ajird-1099	97	63	menstruation	menstruation	NOUN
ajird-1099	97	64	cycle	cycle	NOUN
ajird-1099	97	65	against	against	ADP
ajird-1099	97	66	the	the	DET
ajird-1099	97	67	background	background	NOUN
ajird-1099	97	68	of	of	ADP
ajird-1099	97	69	hyperandrogenemia	hyperandrogenemia	PROPN
ajird-1099	97	70	and	and	CCONJ
ajird-1099	97	71	hypercortisolemia	hypercortisolemia	NOUN
ajird-1099	97	72	,	,	PUNCT
ajird-1099	97	73	which	which	PRON
ajird-1099	97	74	was	be	AUX
ajird-1099	97	75	confirmed	confirm	VERB
ajird-1099	97	76	by	by	ADP
ajird-1099	97	77	ultrasound	ultrasound	NOUN
ajird-1099	97	78	of	of	ADP
ajird-1099	97	79	the	the	DET
ajird-1099	97	80	uterus	uterus	NOUN
ajird-1099	97	81	and	and	CCONJ
ajird-1099	97	82	ovaries	ovary	NOUN
ajird-1099	97	83	by	by	ADP
ajird-1099	97	84	depletion	depletion	NOUN
ajird-1099	97	85	of	of	ADP
ajird-1099	97	86	the	the	DET
ajird-1099	97	87	ovarian	ovarian	ADJ
ajird-1099	97	88	follicular	follicular	ADJ
ajird-1099	97	89	apparatus	apparatus	NOUN
ajird-1099	97	90	and	and	CCONJ
ajird-1099	97	91	anovulation	anovulation	NOUN
ajird-1099	97	92	.	.	PUNCT
ajird-1099	98	1	conclusions	conclusion	NOUN
ajird-1099	98	2	:	:	PUNCT
ajird-1099	98	3	1	1	X
ajird-1099	98	4	)	)	PUNCT
ajird-1099	98	5	the	the	DET
ajird-1099	98	6	incidence	incidence	NOUN
ajird-1099	98	7	of	of	ADP
ajird-1099	98	8	subclinical	subclinical	ADJ
ajird-1099	98	9	cushingoid	cushingoid	NOUN
ajird-1099	98	10	among	among	ADP
ajird-1099	98	11	women	woman	NOUN
ajird-1099	98	12	with	with	ADP
ajird-1099	98	13	pcos	pcos	PROPN
ajird-1099	98	14	is	be	AUX
ajird-1099	98	15	6.6	6.6	NUM
ajird-1099	98	16	%	%	NOUN
ajird-1099	98	17	.	.	PUNCT
ajird-1099	99	1	2	2	X
ajird-1099	99	2	)	)	PUNCT
ajird-1099	99	3	in	in	ADP
ajird-1099	99	4	all	all	DET
ajird-1099	99	5	groups	group	NOUN
ajird-1099	99	6	,	,	PUNCT
ajird-1099	99	7	on	on	ADP
ajird-1099	99	8	the	the	DET
ajird-1099	99	9	14th	14th	ADJ
ajird-1099	99	10	day	day	NOUN
ajird-1099	99	11	of	of	ADP
ajird-1099	99	12	the	the	DET
ajird-1099	99	13	cycle	cycle	NOUN
ajird-1099	99	14	,	,	PUNCT
ajird-1099	99	15	there	there	PRON
ajird-1099	99	16	was	be	VERB
ajird-1099	99	17	a	a	DET
ajird-1099	99	18	significant	significant	ADJ
ajird-1099	99	19	decrease	decrease	NOUN
ajird-1099	99	20	in	in	ADP
ajird-1099	99	21	basal	basal	ADJ
ajird-1099	99	22	values	value	NOUN
ajird-1099	99	23	of	of	ADP
ajird-1099	99	24	lh	lh	PROPN
ajird-1099	99	25	,	,	PUNCT
ajird-1099	99	26	fsh	fsh	NOUN
ajird-1099	99	27	,	,	PUNCT
ajird-1099	99	28	igf-1	igf-1	NOUN
ajird-1099	99	29	,	,	PUNCT
ajird-1099	99	30	progesterone	progesterone	NOUN
ajird-1099	99	31	,	,	PUNCT
ajird-1099	99	32	estradiol	estradiol	PROPN
ajird-1099	99	33	against	against	ADP
ajird-1099	99	34	the	the	DET
ajird-1099	99	35	background	background	NOUN
ajird-1099	99	36	of	of	ADP
ajird-1099	99	37	hyperandrogenemia	hyperandrogenemia	PROPN
ajird-1099	99	38	(	(	PUNCT
ajird-1099	99	39	increased	increase	VERB
ajird-1099	99	40	levels	level	NOUN
ajird-1099	99	41	of	of	ADP
ajird-1099	99	42	free	free	ADJ
ajird-1099	99	43	testosterone	testosterone	NOUN
ajird-1099	99	44	.	.	PUNCT
ajird-1099	99	45	)	)	PUNCT
ajird-1099	99	46	.	.	PUNCT
ajird-1099	100	1	at	at	ADP
ajird-1099	100	2	the	the	DET
ajird-1099	100	3	same	same	ADJ
ajird-1099	100	4	time	time	NOUN
ajird-1099	100	5	,	,	PUNCT
ajird-1099	100	6	hyperinsulinemia	hyperinsulinemia	NOUN
ajird-1099	100	7	was	be	AUX
ajird-1099	100	8	observed	observe	VERB
ajird-1099	100	9	in	in	ADP
ajird-1099	100	10	groups	group	NOUN
ajird-1099	100	11	2	2	NUM
ajird-1099	100	12	and	and	CCONJ
ajird-1099	100	13	3	3	NUM
ajird-1099	100	14	.	.	X
ajird-1099	101	1	only	only	ADJ
ajird-1099	101	2	patients	patient	NOUN
ajird-1099	101	3	in	in	ADP
ajird-1099	101	4	group	group	NOUN
ajird-1099	101	5	3	3	NUM
ajird-1099	101	6	showed	show	VERB
ajird-1099	101	7	significantly	significantly	ADV
ajird-1099	101	8	increased	increase	VERB
ajird-1099	101	9	values	value	NOUN
ajird-1099	101	10	of	of	ADP
ajird-1099	101	11	dhea	dhea	PROPN
ajird-1099	101	12	,	,	PUNCT
ajird-1099	101	13	17	17	NUM
ajird-1099	101	14	ocs	oc	NOUN
ajird-1099	101	15	and	and	CCONJ
ajird-1099	101	16	blood	blood	NOUN
ajird-1099	101	17	cortisol	cortisol	NOUN
ajird-1099	101	18	.	.	PUNCT
ajird-1099	102	1	the	the	DET
ajird-1099	102	2	average	average	ADJ
ajird-1099	102	3	values	value	NOUN
ajird-1099	102	4	of	of	ADP
ajird-1099	102	5	prolactin	prolactin	NOUN
ajird-1099	102	6	and	and	CCONJ
ajird-1099	102	7	amh	amh	PROPN
ajird-1099	102	8	were	be	AUX
ajird-1099	102	9	normal	normal	ADJ
ajird-1099	102	10	.	.	PUNCT
ajird-1099	103	1	3	3	X
ajird-1099	103	2	)	)	PUNCT
ajird-1099	103	3	it	it	PRON
ajird-1099	103	4	is	be	AUX
ajird-1099	103	5	necessary	necessary	ADJ
ajird-1099	103	6	to	to	PART
ajird-1099	103	7	further	far	ADV
ajird-1099	103	8	monitor	monitor	VERB
ajird-1099	103	9	the	the	DET
ajird-1099	103	10	dynamics	dynamic	NOUN
ajird-1099	103	11	of	of	ADP
ajird-1099	103	12	the	the	DET
ajird-1099	103	13	likelihood	likelihood	NOUN
ajird-1099	103	14	of	of	ADP
ajird-1099	103	15	restoration	restoration	NOUN
ajird-1099	103	16	of	of	ADP
ajird-1099	103	17	fertile	fertile	ADJ
ajird-1099	103	18	function	function	NOUN
ajird-1099	103	19	in	in	ADP
ajird-1099	103	20	all	all	DET
ajird-1099	103	21	groups	group	NOUN
ajird-1099	103	22	of	of	ADP
ajird-1099	103	23	patients	patient	NOUN
ajird-1099	103	24	with	with	ADP
ajird-1099	103	25	pcos	pcos	PROPN
ajird-1099	103	26	.	.	PUNCT
ajird-1099	104	1	information	information	NOUN
ajird-1099	104	2	about	about	ADP
ajird-1099	104	3	authors	author	NOUN
ajird-1099	104	4	:	:	PUNCT
ajird-1099	104	5	1	1	NUM
ajird-1099	104	6	)	)	PUNCT
ajird-1099	104	7	urmanova	urmanova	ADJ
ajird-1099	104	8	yulduz	yulduz	NOUN
ajird-1099	104	9	makhkamovna	makhkamovna	NOUN
ajird-1099	104	10	–	–	PUNCT
ajird-1099	104	11	dsc	dsc	NOUN
ajird-1099	104	12	doctor	doctor	NOUN
ajird-1099	104	13	of	of	ADP
ajird-1099	104	14	medicine	medicine	NOUN
ajird-1099	104	15	.	.	PUNCT
ajird-1099	105	1	sciences	science	NOUN
ajird-1099	105	2	,	,	PUNCT
ajird-1099	105	3	professor	professor	NOUN
ajird-1099	105	4	of	of	ADP
ajird-1099	105	5	the	the	DET
ajird-1099	105	6	department	department	PROPN
ajird-1099	105	7	of	of	ADP
ajird-1099	105	8	endocrinology	endocrinology	NOUN
ajird-1099	105	9	,	,	PUNCT
ajird-1099	105	10	pediatric	pediatric	ADJ
ajird-1099	105	11	endocrinology	endocrinology	NOUN
ajird-1099	105	12	of	of	ADP
ajird-1099	105	13	the	the	DET
ajird-1099	105	14	tashkent	tashkent	ADJ
ajird-1099	105	15	pediatric	pediatric	PROPN
ajird-1099	105	16	medical	medical	PROPN
ajird-1099	105	17	institute	institute	PROPN
ajird-1099	105	18	,	,	PUNCT
ajird-1099	105	19	and	and	CCONJ
ajird-1099	105	20	leading	lead	VERB
ajird-1099	105	21	researcher	researcher	NOUN
ajird-1099	105	22	of	of	ADP
ajird-1099	105	23	the	the	DET
ajird-1099	105	24	department	department	NOUN
ajird-1099	105	25	of	of	ADP
ajird-1099	105	26	neuroendocrinology	neuroendocrinology	NOUN
ajird-1099	105	27	of	of	ADP
ajird-1099	105	28	the	the	DET
ajird-1099	105	29	republican	republican	ADJ
ajird-1099	105	30	specialized	specialized	ADJ
ajird-1099	105	31	scientific	scientific	ADJ
ajird-1099	105	32	and	and	CCONJ
ajird-1099	105	33	practical	practical	ADJ
ajird-1099	105	34	medical	medical	ADJ
ajird-1099	105	35	center	center	NOUN
ajird-1099	105	36	of	of	ADP
ajird-1099	105	37	endocrinology	endocrinology	NOUN
ajird-1099	105	38	of	of	ADP
ajird-1099	105	39	the	the	DET
ajird-1099	105	40	republic	republic	NOUN
ajird-1099	105	41	of	of	ADP
ajird-1099	105	42	uzbekistan	uzbekistan	PROPN
ajird-1099	105	43	.	.	PUNCT
ajird-1099	106	1	service	service	NOUN
ajird-1099	106	2	address	address	PROPN
ajird-1099	106	3	:	:	PUNCT
ajird-1099	106	4	ruz	ruz	PROPN
ajird-1099	106	5	,	,	PUNCT
ajird-1099	106	6	tashkent	tashkent	PROPN
ajird-1099	106	7	,	,	PUNCT
ajird-1099	106	8	100125	100125	NUM
ajird-1099	106	9	,	,	PUNCT
ajird-1099	106	10	st	st	PROPN
ajird-1099	106	11	.	.	PROPN
ajird-1099	106	12	mirzo	mirzo	PROPN
ajird-1099	106	13	-	-	PUNCT
ajird-1099	106	14	ulugbek	ulugbek	ADJ
ajird-1099	106	15	56	56	NUM
ajird-1099	106	16	,	,	PUNCT
ajird-1099	106	17	tel	tel	NOUN
ajird-1099	106	18	/	/	SYM
ajird-1099	106	19	fax	fax	NOUN
ajird-1099	106	20	:	:	PUNCT
ajird-1099	106	21	+099871	+099871	NUM
ajird-1099	106	22	-	-	PUNCT
ajird-1099	106	23	2621509	2621509	NUM
ajird-1099	106	24	.	.	PUNCT
ajird-1099	107	1	mobile	mobile	ADJ
ajird-1099	107	2	tel	tel	PROPN
ajird-1099	107	3	.	.	PUNCT
ajird-1099	108	1	+99890	+99890	NUM
ajird-1099	108	2	-	-	PUNCT
ajird-1099	108	3	904	904	NUM
ajird-1099	108	4	-	-	PUNCT
ajird-1099	108	5	01	01	NUM
ajird-1099	108	6	-	-	SYM
ajird-1099	108	7	65	65	NUM
ajird-1099	108	8	2	2	NUM
ajird-1099	108	9	)	)	PUNCT
ajird-1099	108	10	abulaiuly	abulaiuly	ADV
ajird-1099	108	11	zhangentkhan	zhangentkhan	PROPN
ajird-1099	108	12	;	;	PUNCT
ajird-1099	108	13	dsc	dsc	PROPN
ajird-1099	108	14	,	,	PUNCT
ajird-1099	108	15	dr	dr	PROPN
ajird-1099	108	16	.	.	PROPN
ajird-1099	108	17	med	med	PROPN
ajird-1099	108	18	.	.	PUNCT
ajird-1099	109	1	sciences	sciences	PROPN
ajird-1099	109	2	,	,	PUNCT
ajird-1099	109	3	professor	professor	NOUN
ajird-1099	109	4	,	,	PUNCT
ajird-1099	109	5	head	head	NOUN
ajird-1099	109	6	of	of	ADP
ajird-1099	109	7	the	the	DET
ajird-1099	109	8	department	department	NOUN
ajird-1099	109	9	endocrinology	endocrinology	NOUN
ajird-1099	109	10	,	,	PUNCT
ajird-1099	109	11	kazakh	kazakh	PROPN
ajird-1099	109	12	national	national	PROPN
ajird-1099	109	13	medical	medical	PROPN
ajird-1099	109	14	university	university	PROPN
ajird-1099	109	15	named	name	VERB
ajird-1099	109	16	after	after	ADP
ajird-1099	109	17	sd	sd	ADP
ajird-1099	109	18	asfandiyarova	asfandiyarova	PROPN
ajird-1099	109	19	,	,	PUNCT
ajird-1099	109	20	the	the	DET
ajird-1099	109	21	republic	republic	NOUN
ajird-1099	109	22	of	of	ADP
ajird-1099	109	23	kazakhstan	kazakhstan	PROPN
ajird-1099	109	24	,	,	PUNCT
ajird-1099	109	25	almaty	almaty	PROPN
ajird-1099	109	26	st	st	PROPN
ajird-1099	109	27	.	.	PROPN
ajird-1099	109	28	tolebi	tolebi	PROPN
ajird-1099	109	29	,	,	PUNCT
ajird-1099	109	30	no	no	INTJ
ajird-1099	109	31	.	.	NOUN
ajird-1099	109	32	94	94	NUM
ajird-1099	109	33	american	american	PROPN
ajird-1099	109	34	journal	journal	PROPN
ajird-1099	109	35	of	of	ADP
ajird-1099	109	36	interdisciplinary	interdisciplinary	ADJ
ajird-1099	109	37	research	research	NOUN
ajird-1099	109	38	and	and	CCONJ
ajird-1099	109	39	development	development	NOUN
ajird-1099	109	40	issn	issn	PROPN
ajird-1099	109	41	online	online	NOUN
ajird-1099	109	42	:	:	PUNCT
ajird-1099	109	43	2771	2771	NUM
ajird-1099	109	44	-	-	SYM
ajird-1099	109	45	8948	8948	NUM
ajird-1099	109	46	website	website	NOUN
ajird-1099	109	47	:	:	PUNCT
ajird-1099	109	48	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1099	109	49	volume	volume	NOUN
ajird-1099	109	50	28	28	NUM
ajird-1099	109	51	,	,	PUNCT
ajird-1099	109	52	may	may	AUX
ajird-1099	109	53	2024	2024	NUM
ajird-1099	109	54	34	34	NUM
ajird-1099	110	1	|	|	ADV
ajird-1099	110	2	p	p	NOUN
ajird-1099	110	3	a	a	DET
ajird-1099	110	4	g	g	NOUN
ajird-1099	110	5	e	e	NOUN
ajird-1099	110	6	3	3	NUM
ajird-1099	110	7	)	)	PUNCT
ajird-1099	110	8	bolshakova	bolshakova	PROPN
ajird-1099	110	9	svetlana	svetlana	PROPN
ajird-1099	110	10	viktorovna	viktorovna	NOUN
ajird-1099	110	11	–	–	PUNCT
ajird-1099	110	12	phd	phd	NOUN
ajird-1099	110	13	,	,	PUNCT
ajird-1099	110	14	candidate	candidate	NOUN
ajird-1099	110	15	of	of	ADP
ajird-1099	110	16	medical	medical	ADJ
ajird-1099	110	17	sciences	science	NOUN
ajird-1099	110	18	,	,	PUNCT
ajird-1099	110	19	associate	associate	NOUN
ajird-1099	110	20	professor	professor	NOUN
ajird-1099	110	21	,	,	PUNCT
ajird-1099	110	22	head	head	NOUN
ajird-1099	110	23	of	of	ADP
ajird-1099	110	24	the	the	DET
ajird-1099	110	25	department	department	NOUN
ajird-1099	110	26	endocrinology	endocrinology	NOUN
ajird-1099	110	27	,	,	PUNCT
ajird-1099	110	28	kazakh	kazakh	PROPN
ajird-1099	110	29	national	national	PROPN
ajird-1099	110	30	medical	medical	PROPN
ajird-1099	110	31	university	university	PROPN
ajird-1099	110	32	named	name	VERB
ajird-1099	110	33	after	after	ADP
ajird-1099	110	34	sd	sd	ADP
ajird-1099	110	35	asfandiyarova	asfandiyarova	PROPN
ajird-1099	110	36	,	,	PUNCT
ajird-1099	110	37	the	the	DET
ajird-1099	110	38	republic	republic	NOUN
ajird-1099	110	39	of	of	ADP
ajird-1099	110	40	kazakhstan	kazakhstan	PROPN
ajird-1099	110	41	,	,	PUNCT
ajird-1099	110	42	almaty	almaty	PROPN
ajird-1099	110	43	st	st	PROPN
ajird-1099	110	44	.	.	PROPN
ajird-1099	110	45	tolebi	tolebi	PROPN
ajird-1099	110	46	,	,	PUNCT
ajird-1099	110	47	no	no	INTJ
ajird-1099	110	48	.	.	NOUN
ajird-1099	110	49	94	94	NUM
ajird-1099	110	50	4	4	NUM
ajird-1099	110	51	)	)	PUNCT
ajird-1099	110	52	nasyrova	nasyrova	NOUN
ajird-1099	111	1	khurshida	khurshida	PROPN
ajird-1099	111	2	kudratullayevna	kudratullayevna	PROPN
ajird-1099	111	3	–	–	PUNCT
ajird-1099	111	4	dsc	dsc	NOUN
ajird-1099	111	5	,	,	PUNCT
ajird-1099	111	6	doctor	doctor	NOUN
ajird-1099	111	7	of	of	ADP
ajird-1099	111	8	medical	medical	ADJ
ajird-1099	111	9	sciences	science	NOUN
ajird-1099	111	10	,	,	PUNCT
ajird-1099	111	11	associate	associate	NOUN
ajird-1099	111	12	professor	professor	NOUN
ajird-1099	111	13	,	,	PUNCT
ajird-1099	111	14	head	head	NOUN
ajird-1099	111	15	of	of	ADP
ajird-1099	111	16	the	the	DET
ajird-1099	111	17	department	department	NOUN
ajird-1099	111	18	of	of	ADP
ajird-1099	111	19	endocrinology	endocrinology	NOUN
ajird-1099	111	20	with	with	ADP
ajird-1099	111	21	pediatric	pediatric	ADJ
ajird-1099	111	22	endocrinology	endocrinology	NOUN
ajird-1099	111	23	,	,	PUNCT
ajird-1099	111	24	tashkent	tashkent	ADJ
ajird-1099	111	25	pediatric	pediatric	PROPN
ajird-1099	111	26	medical	medical	PROPN
ajird-1099	111	27	institute	institute	PROPN
ajird-1099	111	28	service	service	PROPN
ajird-1099	111	29	address	address	PROPN
ajird-1099	111	30	:	:	PUNCT
ajird-1099	111	31	ruz	ruz	PROPN
ajird-1099	111	32	,	,	PUNCT
ajird-1099	111	33	tashkent	tashkent	PROPN
ajird-1099	111	34	,	,	PUNCT
ajird-1099	111	35	100125	100125	NUM
ajird-1099	111	36	,	,	PUNCT
ajird-1099	111	37	st	st	PROPN
ajird-1099	111	38	.	.	PROPN
ajird-1099	111	39	mirzo	mirzo	PROPN
ajird-1099	111	40	-	-	PUNCT
ajird-1099	111	41	ulugbek	ulugbek	ADJ
ajird-1099	111	42	56	56	NUM
ajird-1099	111	43	,	,	PUNCT
ajird-1099	111	44	tel	tel	NOUN
ajird-1099	111	45	/	/	SYM
ajird-1099	111	46	fax	fax	NOUN
ajird-1099	111	47	:	:	PUNCT
ajird-1099	111	48	+099871	+099871	NUM
ajird-1099	111	49	-	-	PUNCT
ajird-1099	111	50	2621509	2621509	NUM
ajird-1099	111	51	.	.	PUNCT
ajird-1099	112	1	the	the	DET
ajird-1099	112	2	contact	contact	NOUN
ajird-1099	112	3	person	person	NOUN
ajird-1099	112	4	:	:	PUNCT
ajird-1099	112	5	urmanova	urmanova	ADJ
ajird-1099	112	6	yulduz	yulduz	NOUN
ajird-1099	112	7	makhkamovna	makhkamovna	NOUN
ajird-1099	112	8	–	–	PUNCT
ajird-1099	112	9	doctor	doctor	NOUN
ajird-1099	112	10	of	of	ADP
ajird-1099	112	11	medicine	medicine	NOUN
ajird-1099	112	12	.	.	PUNCT
ajird-1099	113	1	sciences	science	NOUN
ajird-1099	113	2	,	,	PUNCT
ajird-1099	113	3	professor	professor	NOUN
ajird-1099	113	4	of	of	ADP
ajird-1099	113	5	the	the	DET
ajird-1099	113	6	department	department	NOUN
ajird-1099	113	7	of	of	ADP
ajird-1099	113	8	endocrinology	endocrinology	NOUN
ajird-1099	113	9	with	with	ADP
ajird-1099	113	10	pediatric	pediatric	ADJ
ajird-1099	113	11	endocrinology	endocrinology	NOUN
ajird-1099	113	12	of	of	ADP
ajird-1099	113	13	the	the	DET
ajird-1099	113	14	tashkent	tashkent	ADJ
ajird-1099	113	15	pediatric	pediatric	PROPN
ajird-1099	113	16	medical	medical	PROPN
ajird-1099	113	17	institute	institute	PROPN
ajird-1099	113	18	,	,	PUNCT
ajird-1099	113	19	service	service	NOUN
ajird-1099	113	20	address	address	NOUN
ajird-1099	113	21	:	:	PUNCT
ajird-1099	113	22	ruz	ruz	PROPN
ajird-1099	113	23	,	,	PUNCT
ajird-1099	113	24	tashkent	tashkent	PROPN
ajird-1099	113	25	,	,	PUNCT
ajird-1099	113	26	100125	100125	NUM
ajird-1099	113	27	,	,	PUNCT
ajird-1099	113	28	st	st	PROPN
ajird-1099	113	29	.	.	PROPN
ajird-1099	113	30	mirzo	mirzo	PROPN
ajird-1099	113	31	-	-	PUNCT
ajird-1099	113	32	ulugbek	ulugbek	ADJ
ajird-1099	113	33	56	56	NUM
ajird-1099	113	34	,	,	PUNCT
ajird-1099	113	35	mobile	mobile	ADJ
ajird-1099	113	36	tel	tel	NOUN
ajird-1099	113	37	.	.	PUNCT
ajird-1099	114	1	+99890	+99890	VERB
ajird-1099	114	2	-	-	SYM
ajird-1099	114	3	9040165	9040165	NUM
ajird-1099	114	4	emailyulduz.urmanova@mail.ru	emailyulduz.urmanova@mail.ru	PROPN
ajird-1099	114	5	references	reference	NOUN
ajird-1099	114	6	1	1	NUM
ajird-1099	114	7	.	.	PUNCT
ajird-1099	115	1	abraham	abraham	PROPN
ajird-1099	115	2	s.b.1,abel	s.b.1,abel	PROPN
ajird-1099	116	1	b.s	b.s	PROPN
ajird-1099	116	2	.	.	PROPN
ajird-1099	116	3	,rubino	,rubino	PUNCT
ajird-1099	116	4	d.	d.	PROPN
ajird-1099	116	5	a	a	DET
ajird-1099	116	6	direct	direct	ADJ
ajird-1099	116	7	comparison	comparison	NOUN
ajird-1099	116	8	of	of	ADP
ajird-1099	116	9	quality	quality	NOUN
ajird-1099	116	10	of	of	ADP
ajird-1099	116	11	life	life	NOUN
ajird-1099	116	12	in	in	ADP
ajird-1099	116	13	obese	obese	NOUN
ajird-1099	116	14	and	and	CCONJ
ajird-1099	116	15	cushing	cushing	NOUN
ajird-1099	116	16	's	's	PART
ajird-1099	116	17	syndrome	syndrome	NOUN
ajird-1099	116	18	patients	patient	NOUN
ajird-1099	116	19	.	.	PUNCT
ajird-1099	117	1	//eur	//eur	PROPN
ajird-1099	118	1	j	j	PROPN
ajird-1099	119	1	endocrinol.2013	endocrinol.2013	PROPN
ajird-1099	119	2	apr	apr	PROPN
ajird-1099	119	3	15;168(5):787	15;168(5):787	NUM
ajird-1099	119	4	-	-	SYM
ajird-1099	119	5	93	93	NUM
ajird-1099	119	6	.	.	PUNCT
ajird-1099	120	1	doi	doi	NOUN
ajird-1099	120	2	:	:	PUNCT
ajird-1099	120	3	10.1530	10.1530	NUM
ajird-1099	120	4	/	/	SYM
ajird-1099	120	5	eje-12	eje-12	NOUN
ajird-1099	120	6	-	-	PUNCT
ajird-1099	120	7	1078	1078	NUM
ajird-1099	120	8	.	.	PUNCT
ajird-1099	121	1	print	print	NOUN
ajird-1099	121	2	2013	2013	NUM
ajird-1099	121	3	may	may	NOUN
ajird-1099	121	4	.	.	PUNCT
ajird-1099	122	1	2	2	X
ajird-1099	122	2	.	.	X
ajird-1099	122	3	grossman	grossman	PROPN
ajird-1099	122	4	ab	ab	PROPN
ajird-1099	122	5	/clinical	/clinical	PROPN
ajird-1099	122	6	endocrinology//chapter7	endocrinology//chapter7	PROPN
ajird-1099	122	7	.	.	PUNCT
ajird-1099	123	1	cushing	cushe	VERB
ajird-1099	123	2	syndrome	syndrome	NOUN
ajird-1099	123	3	.	.	PUNCT
ajird-1099	124	1	uk	uk	PROPN
ajird-1099	124	2	.	.	PROPN
ajird-1099	124	3	2011	2011	NUM
ajird-1099	124	4	,	,	PUNCT
ajird-1099	124	5	950	950	NUM
ajird-1099	124	6	pg	pg	NOUN
ajird-1099	124	7	.	.	PUNCT
ajird-1099	125	1	3	3	X
ajird-1099	125	2	.	.	X
ajird-1099	125	3	hammer	hammer	NOUN
ajird-1099	125	4	g	g	PROPN
ajird-1099	125	5	et	et	PROPN
ajird-1099	125	6	al	al	PROPN
ajird-1099	125	7	.	.	PUNCT
ajird-1099	125	8	transsphenoidal	transsphenoidal	ADJ
ajird-1099	125	9	microsurgery	microsurgery	NOUN
ajird-1099	125	10	for	for	ADP
ajird-1099	125	11	cushing	cushing	NOUN
ajird-1099	125	12	,	,	PUNCT
ajird-1099	125	13	s	s	PART
ajird-1099	125	14	disease	disease	NOUN
ajird-1099	125	15	:	:	PUNCT
ajird-1099	125	16	initial	initial	ADJ
ajird-1099	125	17	outcome	outcome	NOUN
ajird-1099	125	18	and	and	CCONJ
ajird-1099	125	19	long	long	ADJ
ajird-1099	125	20	-	-	PUNCT
ajird-1099	125	21	term	term	NOUN
ajird-1099	125	22	results	result	NOUN
ajird-1099	125	23	.	.	PUNCT
ajird-1099	126	1	j	j	PROPN
ajird-1099	126	2	clin	clin	PROPN
ajird-1099	126	3	endocrinol	endocrinol	PROPN
ajird-1099	126	4	metab	metab	PROPN
ajird-1099	126	5	2004	2004	NUM
ajird-1099	126	6	;	;	PUNCT
ajird-1099	126	7	89:6348–6357	89:6348–6357	NUM
ajird-1099	126	8	.	.	NOUN
ajird-1099	127	1	4	4	NUM
ajird-1099	127	2	.	.	X
ajird-1099	127	3	kirk	kirk	PROPN
ajird-1099	127	4	lf	lf	PROPN
ajird-1099	127	5	,	,	PUNCT
ajird-1099	127	6	hash	hash	NOUN
ajird-1099	127	7	rb	rb	NOUN
ajird-1099	127	8	,	,	PUNCT
ajird-1099	127	9	katner	katner	NOUN
ajird-1099	127	10	hp	hp	PROPN
ajird-1099	127	11	,	,	PUNCT
ajird-1099	127	12	jones	jones	PROPN
ajird-1099	127	13	t.	t.	PROPN
ajird-1099	127	14	cushing	cushing	PROPN
ajird-1099	127	15	's	's	PART
ajird-1099	127	16	disease	disease	NOUN
ajird-1099	127	17	:	:	PUNCT
ajird-1099	127	18	clinical	clinical	ADJ
ajird-1099	127	19	manifestations	manifestation	NOUN
ajird-1099	127	20	and	and	CCONJ
ajird-1099	127	21	diagnostic	diagnostic	ADJ
ajird-1099	127	22	evaluation	evaluation	NOUN
ajird-1099	127	23	.	.	PUNCT
ajird-1099	128	1	//am	//am	PROPN
ajird-1099	128	2	.	.	PUNCT
ajird-1099	129	1	fam	fam	PROPN
ajird-1099	129	2	.	.	PUNCT
ajird-1099	130	1	physician	physician	PROPN
ajird-1099	130	2	2000	2000	NUM
ajird-1099	130	3	vol	vol	NOUN
ajird-1099	130	4	.	.	PUNCT
ajird-1099	130	5	62	62	NUM
ajird-1099	131	1	-p	-p	SYM
ajird-1099	131	2	.	.	PROPN
ajird-1099	131	3	1119	1119	NUM
ajird-1099	131	4	-	-	SYM
ajird-1099	131	5	27	27	NUM
ajird-1099	131	6	5	5	NUM
ajird-1099	131	7	.	.	PUNCT
ajird-1099	132	1	koch	koch	PROPN
ajird-1099	132	2	ca	ca	PROPN
ajird-1099	132	3	,	,	PUNCT
ajird-1099	132	4	bernstein	bernstein	PROPN
ajird-1099	132	5	s	s	PROPN
ajird-1099	132	6	r.	r.	PROPN
ajird-1099	132	7	,	,	PUNCT
ajird-1099	132	8	chrousos	chrousos	PROPN
ajird-1099	132	9	gp	gp	NOUN
ajird-1099	132	10	,	,	PUNCT
ajird-1099	132	11	stratakis	stratakis	PROPN
ajird-1099	132	12	ca	can	AUX
ajird-1099	132	13	primaiy	primaiy	VERB
ajird-1099	132	14	pigmented	pigment	VERB
ajird-1099	132	15	nodular	nodular	ADJ
ajird-1099	132	16	adrenocortical	adrenocortical	ADJ
ajird-1099	132	17	dysplasia	dysplasia	NOUN
ajird-1099	132	18	(	(	PUNCT
ajird-1099	132	19	ppnad	ppnad	PROPN
ajird-1099	132	20	)	)	PUNCT
ajird-1099	132	21	within	within	ADP
ajird-1099	132	22	the	the	DET
ajird-1099	132	23	scope	scope	NOUN
ajird-1099	132	24	of	of	ADP
ajird-1099	132	25	carney	carney	NOUN
ajird-1099	132	26	complex	complex	NOUN
ajird-1099	132	27	as	as	ADP
ajird-1099	132	28	the	the	DET
ajird-1099	132	29	etiology	etiology	NOUN
ajird-1099	132	30	of	of	ADP
ajird-1099	132	31	cushing	cushing	NOUN
ajird-1099	132	32	syndrome	syndrome	NOUN
ajird-1099	132	33	.	.	PUNCT
ajird-1099	133	1	//med	//med	PROPN
ajird-1099	133	2	.	.	PUNCT
ajird-1099	134	1	klin	klin	PROPN
ajird-1099	134	2	.	.	PROPN
ajird-1099	134	3	2000	2000	NUM
ajird-1099	134	4	vol	vol	NOUN
ajird-1099	134	5	.	.	NOUN
ajird-1099	134	6	95	95	NUM
ajird-1099	134	7	p.224	p.224	NOUN
ajird-1099	134	8	-	-	SYM
ajird-1099	134	9	30	30	NUM
ajird-1099	134	10	6	6	NUM
ajird-1099	134	11	.	.	PUNCT
ajird-1099	135	1	lindholm	lindholm	ADJ
ajird-1099	135	2	j	j	PROPN
ajird-1099	135	3	et	et	PROPN
ajird-1099	135	4	al	al	PROPN
ajird-1099	135	5	.	.	PROPN
ajird-1099	135	6	incidence	incidence	NOUN
ajird-1099	135	7	and	and	CCONJ
ajird-1099	135	8	late	late	ADJ
ajird-1099	135	9	prognosis	prognosis	NOUN
ajird-1099	135	10	of	of	ADP
ajird-1099	135	11	cushingꞌs	cushingꞌs	NOUN
ajird-1099	135	12	syndrome	syndrome	NOUN
ajird-1099	135	13	:	:	PUNCT
ajird-1099	135	14	a	a	DET
ajird-1099	135	15	populationbased	populationbase	VERB
ajird-1099	135	16	study	study	NOUN
ajird-1099	135	17	.	.	PUNCT
ajird-1099	136	1	j	j	PROPN
ajird-1099	136	2	clin	clin	PROPN
ajird-1099	136	3	endocrinol	endocrinol	PROPN
ajird-1099	136	4	metab	metab	PROPN
ajird-1099	136	5	2001	2001	NUM
ajird-1099	136	6	;	;	PUNCT
ajird-1099	136	7	86:117	86:117	NUM
ajird-1099	136	8	-	-	SYM
ajird-1099	136	9	123	123	NUM
ajird-1099	136	10	.	.	PUNCT
ajird-1099	137	1	7	7	X
ajird-1099	137	2	.	.	X
ajird-1099	137	3	romanholi	romanholi	NOUN
ajird-1099	137	4	dj	dj	PROPN
ajird-1099	137	5	,	,	PUNCT
ajird-1099	137	6	machado	machado	PROPN
ajird-1099	137	7	mc	mc	PROPN
ajird-1099	137	8	,	,	PUNCT
ajird-1099	137	9	pereira	pereira	PROPN
ajird-1099	137	10	cc./role	cc./role	PROPN
ajird-1099	137	11	for	for	ADP
ajird-1099	137	12	postoperative	postoperative	ADJ
ajird-1099	137	13	cortisol	cortisol	ADJ
ajird-1099	137	14	response	response	NOUN
ajird-1099	137	15	to	to	PART
ajird-1099	137	16	desmopressin	desmopressin	VERB
ajird-1099	137	17	in	in	ADP
ajird-1099	137	18	predicting	predict	VERB
ajird-1099	137	19	the	the	DET
ajird-1099	137	20	risk	risk	NOUN
ajird-1099	137	21	for	for	ADP
ajird-1099	137	22	recurrent	recurrent	ADJ
ajird-1099	137	23	cushing	cushing	NOUN
ajird-1099	137	24	's	's	PART
ajird-1099	137	25	disease.//clin	disease.//clin	NOUN
ajird-1099	137	26	endocrinol	endocrinol	NOUN
ajird-1099	137	27	(	(	PUNCT
ajird-1099	137	28	oxf).2008	oxf).2008	NOUN
ajird-1099	137	29	jul;69(1):117	jul;69(1):117	PROPN
ajird-1099	137	30	-	-	PUNCT
ajird-1099	137	31	22	22	NUM
ajird-1099	137	32	.	.	NOUN
ajird-1099	137	33	8	8	NUM
ajird-1099	137	34	.	.	X
ajird-1099	138	1	sonino	sonino	PROPN
ajird-1099	138	2	n	n	CCONJ
ajird-1099	138	3	,	,	PUNCT
ajird-1099	138	4	fava	fava	PROPN
ajird-1099	138	5	ga	ga	PROPN
ajird-1099	138	6	.	.	PROPN
ajird-1099	138	7	psychosomatic	psychosomatic	ADJ
ajird-1099	138	8	aspects	aspect	NOUN
ajird-1099	138	9	of	of	ADP
ajird-1099	138	10	cushmg	cushmg	NOUN
ajird-1099	138	11	's	's	PART
ajird-1099	138	12	disease	disease	NOUN
ajird-1099	138	13	.	.	PUNCT
ajird-1099	139	1	//	//	NUM
ajird-1099	139	2	psychother	psychother	ADJ
ajird-1099	139	3	.	.	PUNCT
ajird-1099	140	1	psychosom	psychosom	NOUN
ajird-1099	140	2	.	.	PUNCT
ajird-1099	141	1	-1998	-1998	PROPN
ajird-1099	141	2	vol	vol	NOUN
ajird-1099	141	3	.	.	PROPN
ajird-1099	141	4	67	67	NUM
ajird-1099	141	5	,	,	PUNCT
ajird-1099	141	6	n.3	n.3	PROPN
ajird-1099	142	1	p.	p.	NOUN
ajird-1099	142	2	140	140	NUM
ajird-1099	142	3	-	-	SYM
ajird-1099	142	4	6	6	NUM
ajird-1099	142	5	9	9	NUM
ajird-1099	142	6	.	.	PUNCT
ajird-1099	143	1	roset	roset	PROPN
ajird-1099	143	2	m1,badia	m1,badia	PROPN
ajird-1099	143	3	x	x	PROPN
ajird-1099	143	4	,	,	PUNCT
ajird-1099	143	5	forsythe	forsythe	PROPN
ajird-1099	143	6	a	a	PRON
ajird-1099	143	7	,	,	PUNCT
ajird-1099	143	8	/mapping	/mappe	VERB
ajird-1099	143	9	cushingqol	cushingqol	NOUN
ajird-1099	143	10	scores	score	NOUN
ajird-1099	143	11	onto	onto	ADP
ajird-1099	143	12	sf-6d	sf-6d	PROPN
ajird-1099	143	13	utility	utility	NOUN
ajird-1099	143	14	values	value	NOUN
ajird-1099	143	15	in	in	ADP
ajird-1099	143	16	patients	patient	NOUN
ajird-1099	143	17	with	with	ADP
ajird-1099	143	18	cushing'ssyndrome.//patient.2013;6(2):103	cushing'ssyndrome.//patient.2013;6(2):103	NOUN
ajird-1099	143	19	-	-	SYM
ajird-1099	143	20	11	11	NUM
ajird-1099	143	21	.	.	PUNCT
ajird-1099	144	1	doi:10.1007	doi:10.1007	VERB
ajird-1099	144	2	/	/	SYM
ajird-1099	144	3	s40271013	s40271013	PROPN
ajird-1099	144	4	-	-	NOUN
ajird-1099	144	5	0010	0010	NUM
ajird-1099	144	6	-	-	PUNCT
ajird-1099	144	7	7	7	NUM
ajird-1099	144	8	.	.	PUNCT
ajird-1099	145	1	mailto:yulduz.urmanova@mail.ru	mailto:yulduz.urmanova@mail.ru	PROPN
ajird-1099	145	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=abraham%20sb%5bauthor%5d&cauthor=true&cauthor_uid=23444412	https://www.ncbi.nlm.nih.gov/pubmed/?term=abraham%20sb%5bauthor%5d&cauthor=true&cauthor_uid=23444412	VERB
ajird-1099	145	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=abel%20bs%5bauthor%5d&cauthor=true&cauthor_uid=23444412	https://www.ncbi.nlm.nih.gov/pubmed/?term=abel%20bs%5bauthor%5d&cauthor=true&cauthor_uid=23444412	ADJ
ajird-1099	145	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=rubino%20d%5bauthor%5d&cauthor=true&cauthor_uid=23444412	https://www.ncbi.nlm.nih.gov/pubmed/?term=rubino%20d%5bauthor%5d&cauthor=true&cauthor_uid=23444412	PROPN
ajird-1099	145	5	https://www.ncbi.nlm.nih.gov/pubmed/23444412	https://www.ncbi.nlm.nih.gov/pubmed/23444412	NUM
ajird-1099	145	6	http://www.ncbi.nlm.nih.gov/pubmed?term=romanholi%20dj%5bauthor%5d&cauthor=true&cauthor_uid=18182093	http://www.ncbi.nlm.nih.gov/pubmed?term=romanholi%20dj%5bauthor%5d&cauthor=true&cauthor_uid=18182093	NOUN
ajird-1099	145	7	http://www.ncbi.nlm.nih.gov/pubmed?term=machado%20mc%5bauthor%5d&cauthor=true&cauthor_uid=18182093	http://www.ncbi.nlm.nih.gov/pubmed?term=machado%20mc%5bauthor%5d&cauthor=true&cauthor_uid=18182093	PROPN
ajird-1099	145	8	http://www.ncbi.nlm.nih.gov/pubmed?term=pereira%20cc%5bauthor%5d&cauthor=true&cauthor_uid=18182093	http://www.ncbi.nlm.nih.gov/pubmed?term=pereira%20cc%5bauthor%5d&cauthor=true&cauthor_uid=18182093	PROPN
ajird-1099	146	1	http://www.ncbi.nlm.nih.gov/pubmed/18182093	http://www.ncbi.nlm.nih.gov/pubmed/18182093	NUM
ajird-1099	146	2	http://www.ncbi.nlm.nih.gov/pubmed/18182093	http://www.ncbi.nlm.nih.gov/pubmed/18182093	NUM
ajird-1099	147	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=roset%20m%5bauthor%5d&cauthor=true&cauthor_uid=23549927	https://www.ncbi.nlm.nih.gov/pubmed/?term=roset%20m%5bauthor%5d&cauthor=true&cauthor_uid=23549927	NUM
ajird-1099	147	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=badia%20x%5bauthor%5d&cauthor=true&cauthor_uid=23549927	https://www.ncbi.nlm.nih.gov/pubmed/?term=badia%20x%5bauthor%5d&cauthor=true&cauthor_uid=23549927	X
ajird-1099	148	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=forsythe%20a%5bauthor%5d&cauthor=true&cauthor_uid=23549927	https://www.ncbi.nlm.nih.gov/pubmed/?term=forsythe%20a%5bauthor%5d&cauthor=true&cauthor_uid=23549927	PRON
ajird-1099	148	2	https://www.ncbi.nlm.nih.gov/pubmed/23549927	https://www.ncbi.nlm.nih.gov/pubmed/23549927	PUNCT
ajird-1099	148	3	american	american	PROPN
ajird-1099	148	4	journal	journal	PROPN
ajird-1099	148	5	of	of	ADP
ajird-1099	148	6	interdisciplinary	interdisciplinary	ADJ
ajird-1099	148	7	research	research	NOUN
ajird-1099	148	8	and	and	CCONJ
ajird-1099	148	9	development	development	NOUN
ajird-1099	148	10	issn	issn	PROPN
ajird-1099	148	11	online	online	NOUN
ajird-1099	148	12	:	:	PUNCT
ajird-1099	148	13	2771	2771	NUM
ajird-1099	148	14	-	-	SYM
ajird-1099	148	15	8948	8948	NUM
ajird-1099	148	16	website	website	NOUN
ajird-1099	148	17	:	:	PUNCT
ajird-1099	148	18	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-1099	148	19	volume	volume	NOUN
ajird-1099	148	20	28	28	NUM
ajird-1099	148	21	,	,	PUNCT
ajird-1099	148	22	may	may	AUX
ajird-1099	148	23	2024	2024	NUM
ajird-1099	148	24	35	35	NUM
ajird-1099	149	1	|	|	ADV
ajird-1099	149	2	p	p	NOUN
ajird-1099	149	3	a	a	DET
ajird-1099	149	4	g	g	NOUN
ajird-1099	149	5	e	e	NOUN
ajird-1099	149	6	10	10	NUM
ajird-1099	149	7	.	.	PUNCT
ajird-1099	150	1	santos	santos	PROPN
ajird-1099	150	2	a1	a1	PROPN
ajird-1099	150	3	,	,	PUNCT
ajird-1099	150	4	crespo	crespo	PROPN
ajird-1099	150	5	i	i	PRON
ajird-1099	150	6	,	,	PUNCT
ajird-1099	150	7	aulinas	aulinas	PROPN
ajird-1099	150	8	a	a	PRON
ajird-1099	150	9	,	,	PUNCT
ajird-1099	150	10	resmini	resmini	PROPN
ajird-1099	150	11	e.	e.	PROPN
ajird-1099	150	12	/quality	/quality	PROPN
ajird-1099	150	13	of	of	ADP
ajird-1099	150	14	life	life	NOUN
ajird-1099	150	15	in	in	ADP
ajird-1099	150	16	cushing	cushing	NOUN
ajird-1099	150	17	's	's	PART
ajird-1099	150	18	syndrome.//pituitary	syndrome.//pituitary	NOUN
ajird-1099	150	19	.	.	NOUN
ajird-1099	150	20	2015	2015	NUM
ajird-1099	150	21	apr;18(2):195	apr;18(2):195	NOUN
ajird-1099	150	22	-	-	SYM
ajird-1099	150	23	200	200	NUM
ajird-1099	150	24	.	.	PUNCT
ajird-1099	151	1	doi	doi	NOUN
ajird-1099	151	2	:	:	PUNCT
ajird-1099	151	3	10.1007	10.1007	NUM
ajird-1099	151	4	/	/	SYM
ajird-1099	151	5	s11102	s11102	NOUN
ajird-1099	151	6	-	-	PUNCT
ajird-1099	151	7	015	015	NUM
ajird-1099	151	8	-	-	PUNCT
ajird-1099	151	9	0640	0640	NUM
ajird-1099	151	10	-	-	PUNCT
ajird-1099	151	11	y.	y.	NOUN
ajird-1099	151	12	11	11	NUM
ajird-1099	151	13	.	.	PUNCT
ajird-1099	152	1	yasuda	yasuda	PROPN
ajird-1099	152	2	k.	k.	PROPN
ajird-1099	152	3	cyclic	cyclic	PROPN
ajird-1099	152	4	cushing	cushing	PROPN
ajird-1099	152	5	's	's	PART
ajird-1099	152	6	disease	disease	NOUN
ajird-1099	152	7	:	:	PUNCT
ajird-1099	152	8	pitfalls	pitfall	NOUN
ajird-1099	152	9	m	m	VERB
ajird-1099	152	10	the	the	DET
ajird-1099	152	11	diagnosis	diagnosis	NOUN
ajird-1099	152	12	and	and	CCONJ
ajird-1099	152	13	problems	problem	NOUN
ajird-1099	152	14	with	with	ADP
ajird-1099	152	15	the	the	DET
ajird-1099	152	16	pathogenesis	pathogenesis	NOUN
ajird-1099	152	17	.	.	PUNCT
ajird-1099	153	1	//intern	//intern	PUNCT
ajird-1099	153	2	.	.	PUNCT
ajird-1099	154	1	med	med	PROPN
ajird-1099	154	2	.	.	PUNCT
ajird-1099	155	1	1996	1996	NUM
ajird-1099	155	2	vol	vol	NOUN
ajird-1099	155	3	.	.	PROPN
ajird-1099	155	4	35	35	NUM
ajird-1099	155	5	,	,	PUNCT
ajird-1099	155	6	n.	n.	NOUN
ajird-1099	155	7	3	3	NUM
ajird-1099	155	8	p.	p.	NOUN
ajird-1099	155	9	169	169	NUM
ajird-1099	155	10	-	-	SYM
ajird-1099	155	11	70	70	NUM
ajird-1099	155	12	12	12	NUM
ajird-1099	155	13	.	.	PUNCT
ajird-1099	156	1	valassi	valassi	PROPN
ajird-1099	156	2	e	e	NOUN
ajird-1099	156	3	,	,	PUNCT
ajird-1099	156	4	biller	biller	PROPN
ajird-1099	156	5	bm	bm	PROPN
ajird-1099	156	6	,	,	PUNCT
ajird-1099	156	7	swearingen	swearingen	PROPN
ajird-1099	156	8	b./delayed	b./delayed	PROPN
ajird-1099	156	9	remission	remission	NOUN
ajird-1099	156	10	after	after	ADP
ajird-1099	156	11	transsphenoidal	transsphenoidal	ADJ
ajird-1099	156	12	surgery	surgery	NOUN
ajird-1099	156	13	in	in	ADP
ajird-1099	156	14	patients	patient	NOUN
ajird-1099	156	15	with	with	ADP
ajird-1099	156	16	cushing	cushing	NOUN
ajird-1099	156	17	's	's	PART
ajird-1099	156	18	disease//.j	disease//.j	ADP
ajird-1099	156	19	clin	clin	PROPN
ajird-1099	156	20	endocrinol	endocrinol	VERB
ajird-1099	156	21	metab.2010	metab.2010	PROPN
ajird-1099	156	22	feb;95(2):601	feb;95(2):601	NOUN
ajird-1099	156	23	-	-	PUNCT
ajird-1099	156	24	10	10	NUM
ajird-1099	156	25	.	.	PUNCT
ajird-1099	157	1	http://www.ncbi.nlm.nih.gov/pubmed?term=valassi%20e%5bauthor%5d&cauthor=true&cauthor_uid=20080848	http://www.ncbi.nlm.nih.gov/pubmed?term=valassi%20e%5bauthor%5d&cauthor=true&cauthor_uid=20080848	PROPN
ajird-1099	157	2	http://www.ncbi.nlm.nih.gov/pubmed?term=biller%20bm%5bauthor%5d&cauthor=true&cauthor_uid=20080848	http://www.ncbi.nlm.nih.gov/pubmed?term=biller%20bm%5bauthor%5d&cauthor=true&cauthor_uid=20080848	PROPN
ajird-1099	157	3	http://www.ncbi.nlm.nih.gov/pubmed?term=swearingen%20b%5bauthor%5d&cauthor=true&cauthor_uid=20080848	http://www.ncbi.nlm.nih.gov/pubmed?term=swearingen%20b%5bauthor%5d&cauthor=true&cauthor_uid=20080848	PROPN
ajird-1099	157	4	http://www.ncbi.nlm.nih.gov/pubmed/20080848	http://www.ncbi.nlm.nih.gov/pubmed/20080848	NUM